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ABSTRACT 
Leukocyte recruitment to sites of inflammation is a crucial event in host defense 
against pathogens and tissue injury. Although there is at present much interest in 
deciphering the mechanisms of leukocyte transendothelial cell migration, little 
attention has been paid to the subsequent steps, i.e. leukocyte migration through 
the pericyte layer and the venular basement membrane. In this context, results from 
this group previously demonstrated that neutrophils preferentially transmigrate 
through gaps between adjacent pericytes, regions associated with sites of low 
matrix protein expression within the vascular basement membrane. The aim of this 
thesis was to extend these findings by investigating the impact of inflammatory 
mediators on pericyte morphology and vascular basement membrane deposition 
using both in vitro and in vivo models. 
Flow cytometry analysis of pericyte-like C3H/10T1/2 cells and primary lung 
pericytes revealed the expression of key pro-inflammatory molecules on their 
surface (including cytokine receptors and adhesion molecules) and the regulation of 
these molecules upon cytokine stimulation. Using the murine cremaster muscle 
model it was further demonstrated that key neutrophil chemoattractants (i.e. LTB4, 
KC, C5a and fMLP) induced neutrophil transmigration that was associated with a 
change in pericyte morphology (as quantified through enlargement of gaps between 
adjacent pericytes). These changes in pericyte gap size were neutrophil-dependent 
and mediated by endogenously generated TNF as demonstrated in neutrophil-
depleted mice and TNFR-/- mice, respectively. In addition, TNF appeared to mediate 
post-inflammatory BM deposition in response to LTB4 and was required for 
chemoattractant-induced vascular permeability.  
Hence, the results of the present work have demonstrated the ability of pericytes to 
respond to both cytokines and chemoattractants, suggesting an active role for 
pericytes in the regulation of inflammatory responses. In addition, findings provide 
the first evidence for chemoattractant-induced changes in vascular morphology and 
barrier functions of venular walls in vivo via the release of endogenous TNF as a 
secondary mediator, effects that may contribute to the pro-inflammatory properties 
of these stimuli.  
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CHAPTER 1: GENERAL INTRODUCTION 
 
1.1 General vascular biology 
The cardiovascular system is an organ system that provides distribution of blood 
throughout the body. This process of circulation serves to transport oxygen, 
proteins, nutrients, blood cells, hormones, enzymes and other molecules to and 
from tissues. Thereby, it plays a role in maintaining homeostasis, tissue 
regeneration and reorganisation, regulation of body temperature and pH and 
immune response. The cardiovascular system is formed by the heart, blood, and 
blood vessels. Higher developed organisms such as vertebrates exhibit a closed 
cardiovascular system with blood flowing within a closed network of blood vessels. 
Blood vessel walls are composed of three layers – tunica interna, tunica media and 
tunica externa – composed of a variety of cell types such as endothelial cells (ECs), 
perivascular cells (including both pericytes and vascular smooth muscle cells 
(vSMCs)) and fibroblasts (Figure 1). Depending on the composition of vessel walls, 
different types of blood vessels (arteries, veins and capillaries) exhibit distinct 
properties to allow varying levels of blood flow, pressure and vascular permeability 
for active and passive transport of molecules and cells. 
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Figure 1.1: Components of blood vessel walls. Blood vessel walls consist of three 
structural layers: the tunica intima, tunica media and tunica externa. The tunica intima forms 
the inner lining of blood vessels and includes the endothelium surrounded by connective 
tissue basement membrane and elastic lamina. The tunica media (middle layer) is primarily 
muscular tissue with high variations among different vessel types and a role in regulating 
vessel diameter and blood flow. The outermost layer of vessel walls is the tunica externa 
(also called tunica adventia) which consists of elastic and collagenous fibres and plays a role 
in anchoring the vessel to surrounding tissue. Modifications of the composition of vessel 
walls among different vessel types (such as arteries, veins and capillaries) account for their 
specific function to accommodate varying levels of blood flow and pressure. Arteries (a) 
comprise a high amount of smooth muscle cells, which makes the walls thicker than those of 
veins (b) and enables high blood pressure and flow in arteries. In contrast, capillaries (c) 
have extremely thin walls, with only the tunica interna and sporadic perivascular cells. The 
thin wall of capillaries permits molecule exchange between blood and tissue. (Figure from 
Tortora and Derrickson, 2009, Principles of Anatomy & Physiology, 12
th
 edition). 
 
 
 
 
  
22 
 
1.2 Pericytes at a glance 
1.2.1 Location, characteristics and identification of pericytes 
Pericytes are located around the endothelium of all vessel types and are generally 
described as mural cells which are embedded within vascular basement membrane 
(BM)(Shimada et al., 1992; Wang et al., 2006) (Figure 1.2). 
 
 
Figure 1.2: Location of pericytes within vascular walls. Confocal images of postcapillary 
venules of immunofluorescently labelled cremaster muscle are shown. Vessel walls are 
composed of endothelial cells (ECs) (shown in blue, labelled for platelet endothelial cell 
adhesion molecule, PECAM-1), pericytes (shown in red, labelled for α-smooth muscle actin, 
αSMA) and BM proteins (shown in green, labelled for laminin). The endothelium provides the 
first barrier to components of the blood and shows a confluent cell layer surrounding the 
lumen. In contrast, pericytes and BM exhibit a discontinuous network with pericytes 
exhibiting gaps between adjacent cells and BM exhibiting low expression regions (LERs). 
Pericytes are embedded in the vascular BM, which is thought to be generated by both 
pericytes and ECs. (Figure from (Nourshargh et al., 2010). 
 
 
Pericytes are also known as adventitial cells, perivascular cells, mural cells, Rouget 
cells, periendothelial cells and pericapillary cells and were first described in 1871 
and 1873 by the scientists Eberth and Rouget as cells closely associated with 
underlying endothelium of small blood vessels. More than 50 years later, in 1923, 
the term “pericyte” was introduced by Zimmermann due to their close proximity to 
ECs. Pericytes are long cells (~50-70 µm length), possess a large kidney-shaped 
nucleus and processes along the abluminal surface of EC tubes. However, 
pericytes are multipotent cells and morphological differences exist depending on 
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vessel type (Figure 1.3), vascular bed, developmental stage, species and 
pathological conditions (Diaz-Flores et al., 1991; Morikawa et al., 2002b). Similar to 
pericytes, also vSMC and other cells such as astrocytes, epithelial cells, fibroblasts 
and macrophages occupy the periendothelial compartments. This makes the correct 
identification of pericytes difficult. Being derived from the same mesenchymal stem 
cell lineage (Armulik et al., 2005), pericytes and vSMC are especially hard to be 
distinguished from each other. vSMC are located at arteries and arterioles with 
intermediate cells – resembling both pericytes and vSMCs – around capillaries 
(Diaz-Flores et al., 1991; Hirschi and D'Amore, 1996; Shimada et al., 1992). On the 
other side of the capillary bed, pericytes are thought to be located at post-capillary 
venules and collecting venules. Whereas pericytes form a loose network with gaps 
between adjacent cells, classical vSMCs are tightly wrapped around arterioles, 
arteries and veins. However, both, pericytes and vSMCs are closely related and 
thus, clear differentiation between these cell types is not always possible.  
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a        b 
 
Figure 1.3: Morphology of perivascular cells on different vessel types. Schematic 
diagram (a) and electron microscopic images (b) of perivascular cells illustrating 
morphological differences between vSMCs and pericytes depending on the vessel type.  
vSMCs on arterioles (SM in “b”) exhibit a spindle-shaped morphology with few cytoplasmic 
processes and are tightly wrapped around the entire abluminal side of the endothelium. 
Capillary pericytes (P in “b”) in contrast cover only a small proportion of the endothelium. 
They show a rounded cell body with few major processes running parallel to the vessel. 
These primary processes give rise to multiple secondary processes that are perpendicularly 
orientated. Pericytes investing venules exhibit a stellate shape with many branching 
processes covering a great part of the underlying endothelium. ((a) figure modified from 
(Armulik et al., 2011); (b) modified from (Shimada et al., 1992)). 
 
 
The lack of an absolute marker for pericytes significantly hampered the study of 
these mural cells. Although several markers for pericytes have been described, 
including neuron-glia antigen 2 (NG-2), alpha smooth muscle actin (αSMA), platelet-
derived growth factor receptor beta (PDGFR-β) and desmin, none of them is 
completely specific for pericytes or recognises all pericytes. Differences in their 
expression are seen in different species, vascular beds, developmental stage and 
vessel types (Chan-Ling et al., 2004; Hughes and Chan-Ling, 2004; Murfee et al., 
2005; Nehls and Drenckhahn, 1991). Furthermore, pericytes have been shown to 
be able to differentiate into vSMCs and vice versa (Nehls and Drenckhahn, 1993) 
and also into other cell types such fibroblasts (Sundberg et al., 1996), chondroblasts 
(Farrington-Rock et al., 2004), osteoblasts (Brighton et al., 1992; Diaz-Flores et al., 
1992; Canfield et al., 1996; Doherty et al., 1998) and adipocytes (Farrington-Rock et 
al., 2004; Schor et al., 1995), which makes the study of pericytes especially in vitro 
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even harder. Thus, today a series of criteria (location, morphology and gene/protein 
expression) are used to define pericytes and the interpretation of data needs to be 
handled with care (Armulik et al., 2011). 
 
1.2.2 Physiological functions of pericytes 
Role of pericytes in vessel development (vasculogenesis and angiogenesis)  
The close association of pericytes with ECs provides mechanical support and 
stability for the vessel wall, and mediates EC functions (Lindahl et al., 1997). 
Pericyte-EC crosstalk occurs through soluble factors as well as direct contact 
between these two cell types via membrane invaginations extending from the 
pericyte into EC vaginations (“peg and socket” connections) (Diaz-Flores et al., 
1991) (Figure 1.4). These membrane invaginations might contain tight junction- and 
gap junction-like structures as suggested by a study using human brain sections 
and electron microscopy (Cuevas et al., 1984), or with freeze fracture replicas of 
human brain ECs and pericytes in vitro (Larson et al., 1987). In addition, electron 
microscopic studies have described adhesion plaques between ECs and pericytes 
(Courtoy and Boyles, 1983). These connection points provide mechanical linkage 
via endothelial fibronectin-rich cytoplasmic fibrils that are attached to the plasma 
membrane of pericytes and opposing ECs. However, the functional evidence for 
these pericyte-EC interactions in vivo is less known. 
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Figure 1.4: Pericyte-EC interactions. Connection points between EC and pericytes include 
“peg and socket” contacts, representing specific pericyte protrusions into EC invaginations, 
and adhesive plaques, which often coincide with gaps in the BM. (Figure from (Armulik et al., 
2005)). 
 
 
Recent development of genetic mouse models has helped to gain a better 
understanding into signaling through soluble factors between pericytes and ECs. A 
principal function of pericytes appears to be during vessel maturation and 
remodelling by regulating endothelial metabolism, growth and motility through 
paracrine and juxtacrine signaling. Several mediators have been identified which 
are involved in pericyte recruitment to the endothelium and vessel stabilization 
during developmental vasculogenesis or angiogenesis: transforming growth factor 
(TGF)-β, angiopoietins (Ang) 1 and 2, platelet-derived growth factor (PDGF)-B, 
stromal-derived factor (SDF)-1α, sphingosine-1-phosphate (S1P) and vascular 
endothelial growth factor (VEGF) (Armulik et al., 2005). The interplay between these 
signaling factors is highly complex and most factors involved are pleiotropic with 
different effects on pericytes and/or ECs. TGF-β initiates the differentiation of 
precursor cells (undifferentiated mesenchymal cells) into pericytes or vSMCs in vitro 
(Darland and D'Amore, 2001). On the other hand, after recruitment TGF-β 
suppresses EC proliferation, a process that is dependent on direct contact of the 
ECs with pericytes (Orlidge and D'Amore, 1986; Orlidge and D'Amore, 1987). 
Genetic depletion of genes involved in the TGF-β signaling pathways (e.g. tgfb1, 
alk1, alk5 and tgfbr2) leads to embryonic lethality with severe vascular defects, 
similar effects that were also described for knockouts of PDGF-B pathway genes or 
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ang1 or tie2 null mice (Armulik et al., 2011). Mice deficient for pdgfb, pdgfrb, ang1 or 
tie2 genes die prenatally due to mural cell deficiency and consequently vascular 
dysfunction (Leveen et al., 1994; Soriano, 1994; Patan, 1998; Suri et al., 1996), 
indicating an important role for pericytes in vascular development and stabilisation. 
Besides promoting EC differentiation and quiescence, pericyte-EC interactions 
during pericyte recruitment to newly formed vascular tubes is associated with BM 
matrix deposition and assembly (Stratman et al., 2009). Both, ECs and pericytes 
generate components of the vascular BM (Mandarino et al., 1993; Cohen et al., 
1980; Hallmann et al., 2005; Stratman et al., 2009) in which they are embedded and 
which further contributes to the mechanical stability of the vessel. 
 
Pericyte contractility: Role in regulation of blood flow? 
Pericytes were first described as contractile cells more than 100 years ago by 
Rouget in 1873 and Zimmermann in 1923. These mural cells envelope the 
underlying endothelium with their processes and express contractile microfilaments 
(e.g. actin and myosin) and intermediate filaments (e.g. desmin and vimentin) 
(Herman and D'Amore, 1985; Fujimoto and Singer, 1987; Nakano et al., 2000), 
suggesting a potential role for pericytes in regulation of vascular tone and blood 
flow. Furthermore, primary bovine retinal pericytes and pericytes of rat brain 
sections possess receptors for vasoactive factors such as endothelin-1, angiotensin 
II, prostacyclin, catecholamines and vasopressin (Takahashi et al., 1989; Ferrari-
Dileo et al., 1996; van Zwieten et al., 1988). In vitro studies using primary rat 
pericytes demonstrated cell contraction or shape change in response to angiotensin 
II (Ang II), bradykinin, serotonin, lipopolysaccharide (LPS) and reactive oxygen 
metabolites (ROMs) (Khoury and Langleben, 1998; Speyer et al., 2000; Murphy and 
Wagner, 1994; Kerkar et al., 2001). Contractility changes of pericytes were further 
seen ex vivo in brain slices or whole retinas, resulting in pericyte-mediated 
constriction of capillaries (Peppiatt et al., 2006). An indication for the role of pericyte 
contraction in regulating capillary blood flow is given by a recent study using brain 
slices and isolated retinas, and in vivo imaging (Yemisci et al., 2009). In this study, 
oxidative-nitrative stress induced pericyte contraction in a model of ischemia 
reperfusion injury (I/R), causing capillary constriction and erythrocyte flow 
obstruction. However, direct evidence of pericyte contraction or indeed regulation of 
vascular tone and blood flow in vivo is limited. A study by Fernandez-Klett et al., 
recently showed impaired erythrocyte flow caused by pericyte-dependent capillary 
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constriction in vivo using real-time imaging of pericytes in the cerebral cortex of 
mice (Fernandez-Klett et al., 2010). In contrast to arterioles, however, there was no 
evidence for capillary-mediated functional hyperemia in this model. In summary, the 
mechanisms and impact of pericyte contraction are poorly understood at present 
and this issue was addressed as part of the present project. 
 
Pericytes and the blood-brain barrier (BBB) 
The degree of pericyte coverage lies between 10-70% of the vessel area and 
depends on the organ and vessel-type. Their density and coverage seem to be 
positively correlated with the endothelial barrier properties in distinct organs. In fact, 
the highest ratio of pericytes to ECs is found in the central nervous system (CNS) 
and retina (1:1, 1:3, respectively) as compared to a reported 1:100 in striated 
muscles (Shepro and Morel, 1993; Dalkara et al., 2011). This is likely due to 
pericytes having a role in supporting the blood-brain and the blood-retinal barrier 
where higher levels of barrier function are necessary.  Indeed, recent studies have 
demonstrated a crucial role of pericytes in the maturation and maintenance of the 
BBB both in vitro and in vivo (Armulik et al., 2010; Daneman et al., 2010; Dohgu et 
al., 2005; Nakagawa et al., 2007; Bell et al., 2010). In this context, pericytes 
negatively regulate both paracellular and transcellular permeability via the 
establishment and tightening of BBB-specific intercellular junctions as shown in in 
vitro models of the BBB (Dohgu et al., 2005; Nakagawa et al., 2007; Al et al., 2011)  
and by inhibiting EC transcytosis in vivo by a yet unknown mechanism (Armulik et 
al., 2010; Daneman et al., 2010). 
 
Further functions of pericytes 
Pericytes are considered to possess multipotent stem and/or progenitor cell 
properties similar to mesenchymal stem cells, adipocyte progenitors, muscle stem 
cells and even neural stem cells. In fact, pericytes isolated from multiple tissues 
(e.g. skeletal muscle, pancreas, retina and adipose tissue) exhibit multilineage 
progenitor properties and are able to differentiate into osteocytes, adipocytes, 
macrophages/dentritic cells (DCs), ECs, vSMCs, skeletal muscle, neural cells and 
chondrocytes (Diaz-Flores et al., 1992; Doherty et al., 1998; Farrington-Rock et al., 
2004; Schor et al., 1990; Crisan et al., 2008; Cai et al., 2009; Dore-Duffy et al., 
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2006). The capability of pericytes to differentiate into several cell types harbours 
their potential use in regenerative medicine in the future, however, a closer 
identification and function of these cells in vivo is required. 
Recent studies have indicated that pericytes are much more heterogeneous within 
tissues and across different tissue beds (specialised pericytes e.g. in glomeruli, 
brain, retina, liver) than previously believed. Besides the specialised pericytes of the 
CNS regulating BBB functions, hepatic stellate cells (also called Itoh cells) are 
considered as specialised pericytes in the liver with a role in hepatocyte proliferation 
and liver regeneration (Sato et al., 2003). In addition, pericytes in the kidney (also 
known as mesangial cells) are important for blood ultrafiltration by branching or 
splitting glomerular capillaries and thereby increasing capillary surface area 
(Betsholtz, 2004). 
In conclusion, the heterogeneous morphology and similarity of pericytes to other cell 
types led to misinterpretation of results in the past and has hampered the study of 
pericytes in general. Thus, pericyte functions are still poorly understood. 
 
1.2.3 Pericytes and disease 
Loss of pericytes or disrupted pericyte functions are associated with several 
pathologies including diabetic retinopathy, multiple sclerosis, tumour angiogenesis, 
calcification of vascular tissue, central nervous system dementia and hypertension 
(Wallow et al., 1993; Verbeek et al., 1999; Yamagishi et al., 1999; Collett and 
Canfield, 2005; Sima et al., 1985; Morikawa et al., 2002a). These pathologies often 
go along with changes in pericyte morphology, decreased pericyte/EC interactions 
and increased vessel permeability. Diabetic retinopathy for example is associated 
with apoptosis of retinal capillary pericytes, leading to decreased capillary tone, 
dilatation and in turn the formation of micro-aneurysms (Sima et al., 1985; Barber et 
al., 2011). By supporting angiogenesis and stabilising the tumour neovasculature, 
there is currently much interest in the role of pericytes in tumour development. 
Similar to physiological angiogenesis, PDGFR-B/PDGFR-β signalling appears to 
recruit pericytes to tumour blood vessels (Abramsson et al., 2002; Furuhashi et al., 
2004). However, compared to healthy tissue, pericyte recruitment occurs to a lesser 
extent and pericyte-EC contact is diminished with pericyte processes extending 
away from the endothelium into the tumour parenchyma (Morikawa et al., 2002b).  
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Defective pericyte coverage and impaired EC-pericyte crosstalk may contribute to 
the leakiness of tumour vessels (Hobbs et al., 1998; Hashizume et al., 2000). In 
addition to morphological changes, tumour pericytes exhibit variations in marker 
expression. The exact cause of the abnormal behaviour of pericyte on tumour 
vessels, however, is still unknown and variations exist in the involvement of certain 
pathways between different tumor-types (Nisancioglu et al., 2010; Bergers and 
Song, 2005). Recent studies have further suggested that pericytes may serve as 
myofibroblast precursors and as such, to have a potential role in fibrogenesis in 
several organs, as well as in cystic fibrosis (Fabris and Strazzabosco, 2011; 
Schrimpf and Duffield, 2011; Wei et al., 2011). Specifically, fibrosis develops under 
conditions of chronic inflammation and is characterised by excessive deposition of 
extracellular matrix proteins by myofibroblasts, leading to scar formation and finally 
organ failure. Similar to tumour pericytes, pericytes involved in fibrosis display 
changes in marker expression and morphology (Armulik et al., 2011). The exact 
source of myofibroblast progenitors is currently unknown, but might include several 
other cells beside pericytes, including resident fibroblasts, epithelial cells, bone 
marrow-derived cells and ECs. 
 
1.3 Pericytes and inflammation 
Pericytes are associated with several diseases characterised by inflammatory 
components (see previous paragraph). Thus, these mural cells are considered to 
play a role in inflammation. Inflammation is characterised by the recruitment and 
migration of leukocytes from the vascular lumen through the vessel wall into the 
surrounding tissue. Being located at the interface between circulating blood and 
interstitial tissue, pericytes possess a potential strategic position in the vasculature 
to regulate immunological responses. In the following sections an introduction into 
the general aspects of inflammation is given in order to give an entry into the 
possible roles of pericytes in this process. 
 
1.3.1 Inflammation and immunity 
Inflammation is part of a multi-cellular response in host defence initiated by invasion 
of pathogens such as viruses, bacteria, fungi or parasites and/or cell damage. It 
serves as a protective mechanism to overcome the initial cause of infection or injury 
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by eliminating these harmful stimuli, and promoting tissue repair (Serhan et al., 
2008). Inflammatory responses occur in vascularised tissue and are defined by the 
activation and transmigration of leukocytes, and plasma protein efflux to sites of 
infection or injury. The classical signs of inflammation include dolor (pain), calor 
(heat), rubor (redness), tumor (swelling) and functio laesa (loss of function) (Majno 
and Joris, 2004). These symptoms are largely induced by the effects of 
inflammatory mediators on local blood vessels. Redness and heat develop due to 
increased blood flow; swelling is caused by increased vascular permeability that 
allows leakage of plasma fluid (exudates) and pain is caused by the release of 
chemicals that stimulate local sensory nerve endings. However, if uncontrolled, all 
these symptoms can also eventually lead to loss of organ/tissue function.  
Immunity is also known as host defence, which in higher developed organisms 
involves both, non-specific (innate immunity) and specific components (adaptive 
immunity). The non-specific or innate immunity is the first line of the body’s defence 
mechanism, representing the natural resistance defence response and has a vital 
role in initiating subsequent adaptive immune responses (Abbas A and Lichtman A, 
2005). It consists of physical and chemical components (such as ECs and 
antimicrobial factors presented on their surface), phagocytic leukocytes (such as 
neutrophils, monocytes and macrophages) and soluble proteins (e.g. components of 
the complement system, chemokines and cytokines). Resident cells (e.g. tissue 
macrophages, dentritic cells and mast cells) mediate the earliest steps of 
inflammation (Figure 1.5). They express surface and intracellular pattern recognition 
receptors (PRR) such as toll-like receptors (TLRs) (Takeuchi and Akira, 2010) 
through which they are able to recognise broad structures of potentially harmful 
material released by invading microorganisms (pathogen-associated molecular 
patterns; PAMPs) or damaged cells (damage-associated molecular patterns; 
DAMPs) (Bianchi, 2007). Following activation, resident cells release pro-
inflammatory mediators such as cytokines (e.g. tumour necrosis factor α (TNF) and 
interleukin-1β (IL-1β)), chemokines (e.g. macrophage chemotactic protein-1 (MCP-
1/CCL2) and macrophage inflammatory protein-2 (MIP-2/CXCL2) and other 
chemoattractants (e.g. leukotriene B4 (LTB4)) to indicate the site of infection 
(Bianchi, 2007; McDonald et al., 2010; Sadik et al., 2011). These mediators trigger a 
cascade of events leading to a transient vasoconstriction of arterioles and 
consequently increase in blood flow, increased permeability of the microvasculature 
to protein-rich plasma and transmigration of leukocytes. These events can 
collectively lead to the triggering of the infection being resolved or confined. 
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Figure 1.5: Leukocyte Recruitment.  During inflammation, tissue macrophages recognise 
and phagocytose pathogens such as microbes and release pro-inflammatory mediators (e.g. 
TNF and IL-1β), that act on local ECs as well as circulating leukocytes. Following 
upregulation of adhesion molecules (e.g. selectins and ligands for integrins) on ECs and 
generation of chemokines, leukocyte capturing and rolling is initiated. Arrest and firm 
adhesion of chemokine-activated leukocytes is mediated by integrins, which switch from a 
low affinity state to a high-affinity state. After adhesion strengthening, leukocytes crawl along 
the EC layer to preferred sites, where they finally transmigrate through the vessel wall. This 
process is known as the leukocyte adhesion cascade. (Figure modified from (Abbas A and 
Lichtman A, 2005)). 
 
 
Neutrophils are the most abundant type of leukocytes in human blood (40-60%) and 
are the first cells to be recruited to the tissue. Their main roles are to phagocytose 
and finally destroy pathogens. During inflammation, neutrophils mobilise from the 
bone marrow, resulting in neutrophilia and ensuring sufficient supply during tissue 
inflammation (Phillipson and Kubes, 2011). Like macrophages, neutrophils express 
surface receptors for common bacterial components and are able to engulf and 
phagocytose microorganisms and cellular debris (Finlay and Hancock, 2004). When 
activated, neutrophils themselves release numerous factors such as granular anti-
microbial substances and degrading proteases as well as oxygen-derived free 
radicals that can be cytotoxic for both pathogens and host tissue (Finlay and 
Hancock, 2004). Thus, excessive and uncontrolled neutrophil activation may lead to 
injury of host cells and vascular and/or tissue damage.  
Furthermore, neutrophils generate and secrete pro-inflammatory cytokines and 
chemokines that can in turn amplify inflammatory reactions via recruitment and/or 
activation of other cell types. Neutrophil influx in acute inflammation is commonly 
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followed by an influx of monocytes that mature into macrophages and help in the 
clearing the infections via phagocytosis of pathogens (Finlay and Hancock, 2004). 
In conditions where pathogens are able to resist innate immunity, priming of the 
adaptive immune response, which initiates the slower but highly specific immune 
response, is critical (Abbas A and Lichtman A, 2005).  In contrast to innate immune 
cells, cells of the adaptive immunity (B- and T-lymphocytes) target highly specific 
structures of microbial molecules (antigens) and develop memory to specific 
pathogens. Following pathogen elimination, in the final resolving phase of 
inflammation, repair mechanisms are activated promoting tissue healing (e.g. by 
promoting fibroblast growth and adherence) (Finlay and Hancock, 2004). 
Inflammation can be acute - lasting for a short period of time (minutes to days) - or 
chronic (lasting days to years). Whereas acute inflammatory responses are 
transient and generally involve neutrophils and plasma exudation, chronic 
inflammation occurs when the inflammatory insult/trigger is persistent (e.g. during 
autoimmune diseases) and involves primarily macrophages/monocytes and 
lymphocytes. Collectively, immunity is a highly regulated and carefully balanced 
process. Disruption of regulatory mechanisms can lead to chronic inflammation and 
severe pathological conditions such as rheumatoid arthritis (RA), atherosclerosis 
and asthma. Therefore, understanding the intricacies of the immune system - 
especially the mechanisms mediating leukocyte recruitment - is key to the 
development of novel anti-inflammatory therapies. 
 
 
1.3.2 The leukocyte adhesion cascade  
During inflammation, leukocytes have to breach the vessel wall, which forms a 
complex physical barrier of cellular (the endothelium and the pericyte sheath) and 
non-cellular components (vascular BM) between the blood and the extravascular 
tissue (Nourshargh et al., 2010). Extensive studies and development of advanced 
microscopy techniques over the last decades have considerably extended our 
knowledge of the mechanisms of leukocyte transmigration. Transmigration of 
inflammatory cells largely occurs within postcapillary venules and involves 
penetration of the endothelium as a first barrier. ECs form a confluent monolayer of 
cobble-stone shaped cells (10-15 µm wide and 25-40 µm long) lining the vascular 
lumen. It is now well established that leukocyte transendothelial migration is driven 
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by specific interactions between adhesion molecules on immune cells and ECs (Ley 
et al., 2007) (Figure 1.6). The sequence of cellular and molecular responses 
involved in this process is commonly known as the leukocyte adhesion cascade 
which involves multifactorial and complex steps: capture of circulating leukocytes, 
rolling of these cells on the luminal side of the endothelium, followed by slow rolling 
and arrest, adhesion strengthening, intraluminal crawling and paracellular and 
transcellular migration through the endothelium.  
 
 
Figure 1.6: The leukocyte adhesion cascade. Initially, the leukocyte adhesion cascade 
was divided into three steps: rolling (mediated by selectins), activation (mediated by 
chemokines) and arrest/firm adhesion of leukocytes (mediated by integrins). These original 
steps are shown in bold. Recent insight into the mechanism of leukocyte transendothelial 
migration has identified additional steps such as slow rolling, adhesion strengthening, 
intraluminal crawling and transcellular migration through the endothelium. Selectin signalling 
initiates the transition from rolling into slow rolling and eventually adhesion and cell 
spreading. Intravascular crawling of leukocytes to preferred sites of transmigration occurs 
via adhesion molecules such as macrophage antigen-1 (Mac-1) and intercellular adhesion 
molecule -1 (ICAM-1). Final transmigration through the endothelium involves molecules such 
as PECAM-1, junctional adhesion molecules (JAMs), cellular adhesion molecules (CAMs) 
and CD99. (Figure from (Ley et al., 2007)). 
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Leukocyte capture and rolling 
Pro-inflammatory mediators released by resident cells act transiently by binding to 
specific high-affinity receptors on their target cell such as leukocytes and ECs. 
Activation of the endothelium results in the upregulation and/or redistribution of 
adhesion molecules (such as selectins) (Nourshargh et al., 2010). Selectin 
expression (E-selectin and P-selectin) on ECs initiates leukocyte capture (also 
called tethering) through binding to leukocytic P-selectin glycoprotein ligand-1 
(PSGL-1), E-selectin ligand-1 (ESL-1), CD44 and other glycosylated ligands 
(Kansas, 1996; Vestweber and Blanks, 1999). To date three selectins have been 
described in the literature: E-selectin, which is specifically expressed by inflamed 
ECs, L-selectin, found on most leukocytes and P-selectin which is expressed on 
ECs and activated platelets (Ley et al., 2007). Selectin ligands are all fucosylated 
carbohydrate structures containing sulphated-sialyl-Lewisx and are expressed on 
leukocytes (McEver, 2002). Leukocyte binding to selectins further mediates 
secondary leukocyte tethering, allowing cells that do not express ligands for 
selectins to get recruited to sites of inflammation (Sperandio et al., 2003). 
Leukocyte capture is followed by rolling along the endothelial surface which is 
enabled by a high on- and off-rate of formed selectin bonds to leukocyte receptors, 
leading leukocytes to detach from the endothelium and subsequently form new 
adhesive interactions (Alon et al., 1995).  These selectin bonds are so-called catch 
bonds that rely on high shear rates along the vessel wall and become stronger 
under conditions of pulling forces, such as shear stress (Finger et al., 1996; 
Lawrence et al., 1997). Formation of long membrane tethers containing PSGL-1 at 
discrete sticky patches, so-called “slings”, allow leukocytes to roll along the 
endothelium at conditions of high shear stress (Sundd et al., 2012). These “slings” 
are formed at the back of rolling neutrophils and swing to the front of the cells as 
they roll forward to reattach to the underlying endothelium. Rolling of leukocytes 
along the luminal side of the vessel wall is prerequisite for the subsequent steps of 
the leukocyte adhesion cascade as blockade of selectins using antibodies 
completely abolishes leukocyte adhesion and transmigration (Kanwar et al., 1997). 
Besides mediating direct interaction between leukocytes and ECs, selectins also 
provide signalling properties. Selectin-mediated binding triggers signalling events in 
both leukocytes and ECs which further induces integrin activation and subsequent 
integrin-mediated firm adhesion (Simon et al., 2000). Selectin engagement can 
induce phosphoinositide 3-kinase-γ (PI3Kγ) (Puri et al., 2005), spleen tyrosine 
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kinase (SYK) (Zarbock et al., 2007) and p38 mitogen-activated protein kinase 
(MAPK)-dependent pathways (Simon et al., 2000), but the precise mechanisms 
remain unclear. 
 
Leukocyte adhesion, arrest and intravascular crawling to sites of transmigration 
Leucocyte activation and arrest is primarily triggered by chemokines (e.g. CXCL1 
and CXCL2) that are presented on the abluminal surface of ECs by 
glycoaminoglycans (GAGs) (Rot, 2010). This leads to the formation of a 
chemotactic gradient which guides neutrophils through the vasculature to sites of 
injury (Phillipson and Kubes, 2011). Chemokines and chemoattractants act through 
specific G-protein-coupled receptors (GPCRs) on leukocytes. Following binding to 
GPCRs, a complex intracellular signalling network triggers rapid integrin activation 
by increasing integrin avidity, a mechanism that is referred to as inside-out 
signalling (Ley et al., 2007). 
Integrins are heterodimeric proteins consisting of an α- and a β-subunit and are 
expressed on the cell surface of leukocytes. Under quiescent conditions, integrins 
exhibit a non-active conformation associated with low affinity (Kinashi, 2005) (Figure 
1.7a). Increase in integrin affinity corresponds to changes of the molecule 
conformation and signal transduction properties. This leads from a low-affinity state 
to intermediate affinity and finally high-affinity state that increases their affinity to 
adhesion molecules on ECs through the opening of the ligand-binding pocket, 
increased ligand-binding energy and decreased ligand dissociation (Kinashi, 2005). 
Integrin valency on the other hand is associated with lateral clustering of integrin 
molecules on the cell surface which allows multivalent interactions with the ligand 
and therefore increases integrin binding avidity (Figure 1.7b). Activation of integrins 
thus, induces binding of leukocyte integrins (mainly β1 and β2 integrins) to EC 
adhesion molecules (e.g. intercellular adhesion molecule 1 (ICAM-1) and vascular 
cell adhesion molecule 1 (VCAM-1)) (Campbell et al., 1996; Campbell et al., 1998; 
Constantin et al., 2000; Kim et al., 2003; Shamri et al., 2005). This process 
represents the transition from selectin-mediated rolling to integrin-mediated firm 
arrest. The main integrins involved in adhesion strengthening and consequently 
leukocyte arrest are lymphocyte function-associated antigen 1 (LFA-1; also known 
as αLβ2 integrin), macrophage antigen-1 (Mac-1; αMβ2) with a high affinity to ICAM-1, 
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and very late antigen 4 (VLA-4; α4β1 integrin) with a high affinity to its ligand VCAM-
1.  
 
a b 
 
Figure 1.7: Regulation of integrin avidity. Integrin avidity is regulated by their affinity state 
and valency. (a) Integrins (αβ heterodimers) can exhibit three conformational states that are 
associated with different ligand affinities. In the bent head-piece conformation (left), integrins 
exhibit low ligand affinity. Conformational changes triggered through inside-out signalling 
leads to an extension of the head-piece and an increase in ligand affinity (intermediate 
affinity, middle; high affinity state, right). (b) Valency regulation of integrin avidity is 
described by the clustering of integrins on the cells’ surface, which allows multivalent 
interactions with ligands. (Figure modified from (Kinashi, 2005)). 
 
 
Upon arrest, the cytoskeleton of leukocytes reorganises itself resulting in marked 
morphological changes from a round, rolling phenotype to a flattened and polarised 
morphology exhibiting a leading (lamellopodia) and a trailing edge (uropod) 
(Nourshargh et al., 2010). This process is termed cell spreading and is initiated by 
outside-in signalling. The induction of F-actin polymerisation at the front and actin-
myosin contraction and retraction at the back of the leukocyte allows the cell to 
crawl intraluminally along a haptotactic gradient of chemoattractants to favoured 
sites of transmigration (Phillipson et al., 2006; Schenkel et al., 2004). Binding of 
leukocytic Mac-1 (αMβ2 integrin) to endothelial ICAM-1 mediates the extension of 
leukocyte protrusions into ECs and EC-junctions, which is further associated with 
EC contraction and opening of interendothelial contacts. Thereby directional 
crawling might be important for neutrophils and monocytes to enable them to move 
towards nearby junctions and facilitate subsequent leukocyte transmigration through 
the endothelium layer (Phillipson et al., 2006; Schenkel et al., 2004). 
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Leukocyte transendothelial migration (TEM) 
Leukocyte migration through the endothelium layer can occur via both paracellular 
(through endothelial junctions) and to a lesser extent transcellular routes (through 
the body of the cell) (Ley et al., 2007). To maintain the barrier function of the vessel 
wall to macromolecules, penetration of leukocytes must occur with minimal 
disruption of the endothelium. In vitro studies have suggested that ECs support 
leukocyte transmigration via endothelial adhesive platforms (EAP) - acting as pro-
adhesive sites - and the formation of docking structures - endothelial projections - 
around the penetrating leukocyte (Barreiro et al., 2004; Barreiro et al., 2008; Ley 
and Zhang, 2008; Petri et al., 2011; Carman and Springer, 2004). The formation of 
these docking structures, which are enriched in ICAM-1 and VCAM-1 might form an 
air lock type seal around adherent leukocytes and thereby maintain the endothelial 
barrier function (Phillipson et al., 2008). Furthermore, this encapsulation of the 
leukocytes might prepare the leukocyte for diapedesis and thus, initiate leukocyte 
passage through the endothelium. Numerous adhesion molecules, including 
PECAM-1, ICAM-1, JAM-A, JAM-B, JAM-C, ICAM-2, CD99, CD99L2 and 
endothelial cell-selective adhesion molecule (ESAM) have been implicated in the 
response of transendothelial migration (Wegmann et al., 2006; Muller, 2003; Bixel et 
al., 2007; Thompson et al., 2001; Woodfin et al., 2007; Huang et al., 2006). 
However, the adhesion molecules involved in diapedesis vary depending on the 
type of penetrating leukocyte, phase of transmigration and the inflammatory 
stimulus (Woodfin et al., 2007; Huang et al., 2006; Woodfin et al., 2009; Nourshargh 
et al., 2006). 
Paracellular transmigration - migration of leukocytes through EC junctions appears 
to be the dominant route. ECs exhibit highly organised molecular complexes that 
connect adjacent cells. These intercellular junctions are composed of tight junctions 
(e.g. JAMs and claudins) and adherens junctions (such as VE-Cadherin) (Figure 
1.8). Junctional molecules are mostly transmembrane proteins linked to cytoskeletal 
and intravascular signalling structures. They provide stability of the vessel wall, 
transfer intracellular signals, and act as paracellular seals controlling vascular 
permeability to plasma proteins and support controlled passage of circulating cells 
into the tissue (reviewed in (Dejana et al., 2001)).  
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Figure 1.8: Summary of adhesion molecules connecting adjacent ECs. EC-EC 
junctional molecules include tight junctions and adherens junctions which involve 
transmembrane proteins (such as JAMs, ESAM, Claudins and VE-Cadherin, respectively) 
which are linked to cytoskeletal structures and signalling pathways. (Figure from Dejana et 
(Dejana, 2004)).  
 
 
Paracellular transmigration as a dominant route has been directly demonstrated in 
genetically modified mice with highly stabilized endothelial junctions (Schulte et al., 
2011). Under physiological conditions, junctional molecules that are not directly 
involved in the migration process themselves (e.g. VE-Cadherin), transiently 
translocate away from the junctions (Allport et al., 2000; Shaw et al., 2001). The 
stabilisation of VE-Cadherin in mutant mice led to a resistance to permeability-
inducing factors (e.g. VEGF and histamine) due to inhibition of junction dissociation 
(Schulte et al., 2011). Furthermore, leukocyte transmigration in response to LPS, IL-
1β and in a model of immunogen-challenged skin was markedly reduced in this 
model, indicating the trans-junctional pathway as the main route of leukocyte 
extravasation. Data from our group suggest that 90% of transmigrating neutrophils 
use the route through EC junctions as shown in 3 different models of inflammation 
in vivo (inflammation induced by the pro-inflammatory cytokine IL-β, the chemotactic 
formyl-methionyl-leucyl-phenylalanine (fMLP) and in pathological I/R injury) 
(Woodfin et al., 2011). Paracellular transmigration is controlled by a well-
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coordinated interplay between EC and leukocytic adhesion molecules (Figure 1.9a). 
Adhesion molecules located within different junctional regions may act at different 
stages in the process of leukocytes breaching endothelial cell junction (Muller, 
2003). In this context, our group recently demonstrated that EC adhesion molecules 
facilitate leukocyte diapedesis in a sequential manner (Woodfin et al., 2009). Using 
mice deficient in either ICAM-2, JAM-A or PECAM-1 and IL-1β as a stimulus, ICAM-
2 could be identified as an early mediator of leukocyte migration guiding leukocytes 
to EC junctions, followed by JAM-A, which mediates leukocyte migration through 
endothelial junctions, with PECAM-1 mediating leukocyte migration through the 
venular BM. However, this sequential process occurred in a stimulus-specific 
manner, and in contrast to IL-1β, neutrophil transmigration in response to other 
inflammatory mediators such as TNF, fMLP or LTB4 occurred independently of 
ICAM-2, JAM-A and PECAM-1 (Huang et al., 2006; Nourshargh et al., 2006; 
Woodfin et al., 2007). 
The same adhesion molecules involved in leukocyte migration via the paracellular 
route are suggested to be involved also in transcellular migration (Feng et al., 1998; 
Millan et al., 2006; Carman et al., 2007; Marmon et al., 2009a; Marmon et al., 
2009b). However, the distinctive mechanisms involved in transcellular migration are 
not fully understood yet. Transcellular migration is described as the process where 
leukocytes get engulfed and transported through channels within an endothelial cell 
(Figure 1.9b). This route of endothelial penetration might be initiated by the 
formation of leukocyte protrusions that may extend into endothelial invaginations to 
search for permissive sites (Ley et al., 2007). Interaction of leukocyte protrusions 
with EC ICAM-1 may lead to the translocation of apical ICAM-1 into vesiculo-
vacuolar organelles (VVOs), which might in turn act as a gateway for leukocytes 
through ECs (Millan et al., 2006). However the physiological relevance of this 
pathway remains unclear. In mice deficient for CD11b (Mac-1), leukocyte crawling is 
specifically blocked (Phillipson et al., 2006). In addition, these mice reportedly show 
a marked increase in incidents of transcellular transmigration through ECs as 
compared to paracellular transmigration. These findings suggest that blocking 
migration of leukocytes to preferred junctions may force leukocytes to breach the 
body of ECs via the transcellular route. Indeed, transcellular leukocyte 
transmigration appears to predominate in the CNS, where high barrier function is 
crucial in maintaining the BBB (Engelhardt and Wolburg, 2004). 
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Figure 1.9: Transmigration though the endothelial cell layer. Leukocytes are able to 
penetrate the endothelial layer through a paracellular or a transcellular route. (a) Paracellular 
migration involves the loosening of interendothelial interactions and migration of leukocytes 
through these junctions. This process is facilitated by several adhesion molecules, including 
JAM-A, PECAM-1, ESAM, ICAM-2 and CD99. (b) Transcellular migration was shown at 
thinner and actin-rich areas of endothelial cells through vesiculo-vacuolar organelles 
(VVOs). These VVOs are formed by ICAM-1-containing calveolae and function as an 
intracellular “channel” through which leukocytes can migrate. (Figure from (Ley et al., 2007)). 
 
 
1.3.3 Penetration of the venular BM 
After leukocytes breach the endothelium, they then need to cross the vascular BM 
and the pericytes embedded within it. Whereas penetration of the endothelium can 
be rapid (within a few minutes), migration through the perivascular BM and pericyte 
sheath to the interstitial tissue takes much longer (~30 minutes) (Woodfin et al., 
2011; Ley et al., 2007). The venular BM is a dense layer (50-300 nm thick) with a 
pore size of ~50 nm. It consists of a complex network of macromolecules such as 
proteins, glycoproteins and proteoglycans (Rowe and Weiss, 2008). Predominant 
components of venular BM involve filamentary proteins such as laminins and 
collagens interconnected to themselves and other extracellular matrix proteins 
(Figure 1.10). Both proteins are heterotrimeric glycoproteins composed of several 
chains, creating distinct isoforms. Laminin α, β and γ chains can form 16 different 
isoforms. The two main isoforms found in vascular BM are laminin 8 (composed of 
laminin α4, β1 and γ1 chains; also known as LN-411) and laminin 10 (composed of 
laminin α5, β1 and γ1 chains; also known as LN-511). Collagen IV is the main 
collagen type and consists of six different α chains and exists in three different 
isoforms (Rowe and Weiss, 2008). Different components of the BM are proposed to 
have biophysically and biochemically different properties to transmigrating 
leukocytes. As such the degree of covalently cross-linked collagen IV oligomers and 
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laminin networks might regulate penetration of the BM.(Rowe and Weiss, 2008) In 
addition, laminin 511 has been suggested to be anti-migratory, whereas laminin 411 
is proposed to promote migration as shown in studies analysing neutrophil 
(Wondimu et al., 2004a) and T-cell migration (Wu et al., 2009). Besides adhesive 
support for transmigrating leukocytes, the venular BM acts as a depot for matrix-
bound regulatory proteins (e.g. growth factors, enzymes, chemokines and 
thrombotic factors) that might further regulate migration of leukocytes through this 
structure (Rowe and Weiss, 2008).  
 
 
Figure 1.10: Molecular structure and components of basement membranes. Basement 
membranes are composed of complex network of laminins, collagen and other glycoproteins 
such as perlecans and nidogens, connected through specific interactions (A). Collagen IV, 
laminins and perlecans can bind to themselves and can also assembly with other 
extracellular matrix proteins, whereas nidogens only bind to collagen IV and laminin as 
indicated by arrows (B). (Figure from (Alberts B et al., 2002)). 
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There is evidence that leukocyte-EC interaction during TEM triggers signals 
involved in subsequent migration through the BM. This includes phenotypic changes 
in leukocytes such as upregulation of molecules that are needed for the latter step 
of breaching the BM (Dangerfield et al., 2002) (Figure 1.11). PECAM-1 has been 
shown to mediate the expression of members of the β1-, β2-, and β3 integrin families 
(Newman and Newman, 2003), which might support the passage of leukocytes 
through the BM by acting as interaction partners for components of the BM. Indeed, 
PECAM-1-mediated mobilisation of α6β1-integrin (VLA-6; receptor for laminin) from 
intracellular stores to the cell surface of transmigrating neutrophils allows 
neutrophils to interact with extracellular matrix in IL-1β-induced inflammation in 
murine models (Dangerfield et al., 2005; Dangerfield et al., 2002). These molecular 
interactions, however, are stimulus-dependent (they were not involved in TNF-
induced inflammation), indicating the existence of other additional pathways of 
leukocyte extravasation.  
 
             
Figure 1.11: Transmigration through BM and the pericyte sheath. Leukocyte migration 
through the pericyte sheath and vascular BM might be mediated by a chemokine gradient 
and under certain inflammatory conditions can occur in a β1-integrin- and protease-
dependent manner.(Figure from (Ley et al., 2007)). 
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Leukocyte transmigration through the vascular BM is associated with a transient 
increase in vascular permeability to macromolecules and reduced barrier function of 
the BM in vitro and in vivo (Hurley J.V., 1964; Huber and Weiss, 1989b).  Our group 
recently identified the presence of matrix protein low expression regions (LER) 
within the BM, sites that are co-localised with gaps between adjacent pericytes 
(Wang et al., 2006).  LERs are defined as areas within the venular BM with lower 
expression of certain matrix proteins (e.g. collagen type IV, laminin-8, laminin-10, 
nidogen, but not perlecan) than the average venular level. Although both neutrophils 
and monocytes have been shown to use these regions to breach the BM, the 
mechanisms involved seem to differ between the two leukocyte subsets (Voisin et 
al., 2009). Whereas monocytes squeeze through LERs, neutrophil transmigration 
through this layer is associated with BM remodelling. During neutrophil 
transmigration LERs undergo a transient enlargement and decrease in protein 
content in numerous inflammatory conditions, such as cytokine-, and 
chemoattractant-induced inflammation and pathological conditions such as I/R injury 
(Reichel et al., 2008; Reichel et al., 2009; Reichel et al., 2011; Voisin et al., 2009; 
Voisin et al., 2010; Wang et al., 2006). These regions provide higher 
permissiveness due to lower protein densities within the extracellular matrix. It is 
hypothesised that reduced barrier function for leukocytes and at the same time 
increased permeability to chemoattractants might facilitate leukocyte migration into 
the interstitial tissue via permissive sites. The underlying mechanism in this 
transient loss of BM integrity remains unclear. Several in vitro and in vivo studies 
suggest a role for proteases (such as matrix metallo proteinases (MMPs) or 
neutrophil elastase (NE)) in remodelling of BM proteins (Delclaux et al., 1996; 
Okada et al., 1997),(Voisin et al., 2009). Indeed, transendothelial migration of 
neutrophils triggers the release of proteases that are stored in intracellular granules 
and expressed on the surface of leukocytes (Cepinskas et al., 1999; Wang et al., 
2005). The hypothesis of subtle disassembly of the BM during leukocyte penetration 
is further supported by a study from our group, showing fragments of BM (laminin) 
on the surface of tissue-extravasated neutrophils (Voisin et al., 2009).  It is also 
possible that proteases act as supportive instruments by exposing potential 
interaction sites for leukocytes or activate chemotactic stimuli within the extracellular 
matrix (Adair-Kirk et al., 2003; Mydel et al., 2008). However, the involvement of 
proteases in the process of neutrophil breaching of the BM is controversial (Huber 
and Weiss, 1989c) and does not seem to be necessary for all leukocyte sub-types 
(Voisin et al., 2009). Collectively, the precise mechanism of how leukocytes 
penetrate this tightly packed structure is still under investigation. 
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1.3.4 Breaching the pericyte layer and potential roles of pericytes during 
inflammation 
In recent years, more insight has been gained into how leukocytes interact with and 
transmigrate though the EC layer (Ley et al., 2007; Muller, 2009), however, the 
latter step of leukocyte transmigration - penetrating the pericyte sheath - has been 
largely neglected and little is known about the role of pericytes during inflammation. 
This is largely due to difficulties in isolating primary pericytes and their 
heterogeneous morphology and phenotype in vivo. 
Following transendothelial migration, leukocytes migrate below the endothelial layer 
before finally breaching the pericyte sheath. Since LERs are closely associated with 
gaps between adjacent pericytes we hypothesised that these gaps could be 
preferred sites of leukocyte emigration through this cellular barrier and that pericytes 
actively facilitate leukocyte transmigration. This possibility is supported by data from 
our group (Voisin et al., 2009; Voisin et al., 2010; Wang et al., 2006). Although 
transcellular pericyte breaching of neutrophils through guinea-pig skin venules in 
response to fMLP was reported previously as quantified by electron microscopy 
(Feng et al., 1998), our group has recently shown that neutrophils primarily breach 
the pericyte layer in mouse cremasteric venules in response to TNF and IL-1β via 
the paracellular route (Proebstl et al., 2012; Wang et al., 2006; Wang et al., 2012). 
This suggests tissue- and/or stimulus-specific mechanisms for leukocyte breaching 
of the pericyte sheath.  
Although relatively little is known about the biological activities of pericytes during 
inflammation, intriguing evidence exist that pericytes are immunoactive and thus, 
able to modulate inflammatory events. In this context, the ability of pericytes to 
produce a number of immunoregulatory cytokines, including IL-1β, IL-6, 
granulocyte-macrophage colony-stimulatory factor (GM-CSF) and TNF has been 
shown in numerous in vitro studies using primary pericytes from several tissues and 
species (e.g. human, rat and mouse brains, bovine retinas and rat lungs) (Alcendor 
et al., 2012; Kovac et al., 2011; Kowluru et al., 2010; Fabry et al., 1993; Edelman et 
al., 2007). Primary pericytes isolated from rat brain or human placenta were further 
demonstrated to express adhesion molecules such as ICAM-1 and VCAM-1, and 
major histocompatibility complex (MHC) class I and II molecules on their surface 
that can be regulated by inflammatory mediators and through which they might 
interact with immune cells (Balabanov et al., 1999; Maier and Pober, 2011). MHC 
molecule expression suggests potential antigen-presenting functions for 
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lymphocytes. Reports have indeed implicated a role for pericytes in T cell exit from 
the thymus (Zachariah and Cyster, 2010) and in neuroinflammatory processes in 
vitro (Balabanov et al., 1999; Verbeek et al., 1995). In another study, T-cell 
responses were negatively regulated by human placental pericytes in vitro (Maier 
and Pober, 2011), results that might demonstrate the heterogeneous nature of 
pericytes in different organs. 
More recently, direct interaction of pericytes with cells of the innate immune system 
(neutrophils and monocytes) and the potential role of pericytes in facilitating 
transmigration of these cells has been demonstrated in vivo (Proebstl et al., 2012; 
Stark et al., 2013). Using a genetically modified mouse with fluorescent αSMA-
positive cells (pericytes and vSMCs) and myeloid leukocytes (e.g. neutrophils), 
together with intravital confocal microscopy our group was able to analyse pericyte-
leukocyte interactions during inflammation in real time in vivo (Proebstl et al., 2012). 
In this study, neutrophils crawled along pericyte processes for approximately 20 min 
and a distance of ~60 µm before exiting the vessel wall through specific gaps 
between adjacent pericytes.  
ICAM-1 (on pericytes) has been suggested to play a role in this abluminal crawling 
binding to Mac-1 and LFA-1 on neutrophils in TNF- and IL-1β-induced inflammation. 
Furthermore, it was shown that pericyte gaps transiently enlarge in response to 
these pro-inflammatory cytokines (Proebstl et al., 2012; Voisin et al., 2010; Wang et 
al., 2006) and that neutrophils preferentially employ enlarged pericyte gaps for 
transmigration. In another study by Wang et al using the mouse cremaster muscle 
model and primary mouse retina pericytes in vitro, TNF- and IL-1β-induced pericyte 
gap opening was associated with direct pericyte-neutrophil contact (Wang et al., 
2012). In this context, neutrophil engagement with primary pericytes in vitro induced 
pericyte relaxation by inhibition of the RhoA/ Rho Kinase ROCK signalling pathway 
and suppression of actomyosin-based contractility. Inducing cell relaxation in vivo 
by topical application of Tolazoline increased the number of extravasated 
neutrophils in the murine cremaster muscle, suggesting a supportive role for 
pericyte gap enlargement in leukocyte transmigration. However, these results are 
discordant with data obtained from our group where pericyte gaps enlarged even in 
the absence of neutrophils (using neutrophil-depleted mice) in response to both 
TNF and IL-1β (Proebstl et al., 2012). Furthermore, Tolazoline applied topically to 
the tissue affects every tissue cell type and thus, the combined response of all cells 
might influence leukocyte transmigration, rather than pericyte relaxation on its own. 
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Hence, the underlying mechanisms of pericyte gap opening and its relevance during 
different inflammatory reactions is unclear, issues that have been addressed as part 
of this project.  
In addition to facilitating neutrophil transmigration through the pericyte sheath, a 
distinct population of capillary and arteriolar pericytes (NG-2+) facilitate leukocyte 
migration within the interstitial tissue to the site of inflammation (Stark et al., 2013). 
Stark et al. found that human placental pericytes are able to sense DAMPs through 
PRRs expressed on their surface (including TLR2, TLR4, NLR family, pyrin-
containing domain 3 (NLRP3) and N-formyl peptide receptor 2 (FPR2)). When 
treated with TNF or PRP ligands, ICAM-1 and chemoattractants (CXCL1, CXCL8, 
macrophage inhibitory factor (MIF), CCL2 and IL-6) became upregulated on these 
cells, suggesting a role for pericytes in leukocyte attraction. Indeed, in a model of 
sterile skin injury in the mouse ear in vivo, after extravasation from the blood, 
neutrophils and macrophages showed fast directional migration along capillary and 
arteriolar pericytes toward the site of inflammation. This event was mediated by 
pericyte-expressed ICAM-1 and MIF as showed by blocking antibodies against 
ICAM-1 and a locally introduced MIF inhibitor. Collectively, this study provides 
evidence for the ability of capillary and arteriolar pericytes to facilitate efficient target 
finding by leukocytes within the interstitial space and hence, suggests distinct roles 
for different pericyte subsets. 
Collectively, these studies strongly suggest an active role for pericytes in mediating 
immune modulation and leukocyte transmigration during inflammation. Specifically 
pericytes might facilitate leukocyte transmigration by secretion and presentation of 
pro-inflammatory mediators and direct interaction with migrating cells, a topic that is 
further explored as part of this thesis. 
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1.4 Aims of this study 
To reach the site of infections or injury, leukocytes migrating through venular walls 
have to penetrate both the endothelial cell layer and the pericyte layer embedded 
within the BM. A key hypothesis of this study was that pericytes are able to actively 
participate in the regulation of the inflammation process via direct interaction with 
leukocytes and its environment, altered morphology and/or regulating the 
generation of extracellular BM. The present project has addressed several aspects 
of pericyte biology, collectively aimed at enhancing our understanding of the role of 
pericytes in inflammation. Specific aims of the project were:  
 
1. Analysis of expression and regulation of expression of pericyte cell surface 
molecules capable of supporting an inflammatory response. To address this 
objective, the expression of key adhesion molecules on pericyte-like cells 
(C3H/10T1/2 cells) was characterised in vitro under basal and inflammatory 
conditions using flow cytometry and confocal microscopy. Furthermore the 
expression of receptors for potent pro-inflammatory cytokines was investigated on 
primary murine lung pericytes to analyse whether pericytes are able to directly 
respond to these stimuli. 
 
2. Investigation of pericyte shape change in response to different inflammatory 
stimuli. Leukocytes have previously been shown to preferentially migrate through 
gaps between adjacent pericytes, gaps that were shown to enlarge in response to 
TNF and IL-1β. To extend these findings to a wider range of inflammatory 
mediators, in the present project the impact of multiple chemoattractants (e.g. LTB4, 
KC, C5a and fMLP) on pericyte shape change was investigated in vivo using 
confocal microscopy of immunofluorescently labelled murine cremaster muscles. 
 
3. Analysis of the mechanism of chemoattractant-induced pericyte shape 
change. The involvement of neutrophils mediating pericyte gap enlargement in 
response to neutrophil chemoattractants was analysed in neutrophil-depleted mice. 
Using antagonists, knockout mice or scavengers of molecules that are vasoactive 
on perivascular cells, potential secondary mediators involved in chemoattractant-
induced pericyte shape change were elucidated in vivo. 
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4. Analysis of the functional consequence of pericyte shape change during 
inflammation. By using confocal microscopy the role of pericyte shape change was 
investigated in relation to neutrophil transmigration. In addition, an association of 
BM remodelling to pericyte shape change in inflammation was analysed by 
elucidating the remodelling and restoration of BM proteins at different stages of 
inflammatory reactions in parallel with changes in pericyte morphology. As pericytes 
have been associated with regulating the barrier function of vessel wall to vascular 
leakage, the role of pericyte shape change in vascular permeability as occurs during 
inflammation was further analysed. To address this objective, the Miles assay was 
used and leakage to intravenously injected Evans Blue dye was analysed in 
response to locally injected chemoattractants. 
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CHAPTER 2: METHODS AND MATERIALS 
 
2.1 List of reagents 
2.1.1 General reagents 
Cell culture reagents 
Reagent Details and Source 
Dimethyl sulfoxide (DMSO): Sigma-Aldrich (Poole, Dorset, UK) 
Dulbecco’s Modified Eagle’s Medium (DMEM):   High glucose, GIBCO (Paisley, UK) 
Endothelial growth factor (EGF): Prepotech (London, UK) 
Ethylene diamine tetraacetic acid (EDTA): Sigma-Aldrich (Poole, Dorset, UK) 
Fetal bovine serum (FBS): Gibco (Paisley, UK) 
Fibroblast growth factor (FGF): bFGF, eBioscience (Hatfield, UK) 
Hank's Balanced Salt Solution (HBSS): Gibco (Paisley, UK) 
MCDB-131 medium: Invitrogen (Paisley, UK) 
L-Glutamine: c= 200 mM (100 x), Gibco (Paisley, UK) 
Penicillin/Streptomycin: 
10 000 units of penicillin and 10 mg/ml 
streptomycin, Gibco (Paisley, UK) 
Phosphate buffered saline (PBS): 1x PBS, pH 7.2, Gibco (Paisley, UK) 
Platelet-derived growth factor BB (PDGF-BB): Peprotech (London, UK) 
Trypan blue: Gibco (Paisley, UK) 
Trypsin/EDTA: 
1x solution (0.025% Trypsin and 0.01% 
EDTA, Cascade Biologics, Invitrogen 
(Paisley, UK) 
 
Anaesthetics 
 
Reagent Details and Source 
Ketamin: 
Ketaset
®
 Injection, c= 100 mg/ml, Fort 
Dodge Animal Health Ltd (Southampton, 
UK) 
Xylazine: 
Rompun
®
 2%, c= 20 mg/ml, Bayer plc. 
(Newbury, UK) 
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Enzymes 
Reagent Details and Source 
Catalase:  Sigma-Aldrich (Poole, Dorset, UK) 
Collagenase II:   Invitrogen (Paisley, UK) 
DNAse I: Sigma-Aldrich (Poole, Dorset, UK) 
Myeloperoxidase (MPO): Sigma-Aldrich (Poole, Dorset, UK) 
Proteinase K: Roche (Burgess Hill, UK) 
Superoxide dismutase (SOD): Sigma-Aldrich (Poole, Dorset, UK) 
Trypsin: Sigma-Aldrich (Poole, Dorset, UK) 
TAQ polymerase: 
Biotaq DNA polymerase, c= 5u/ μl, 
Bioline Reagents Ltd. (London, UK) 
 
 
Other reagents 
Reagent Details and Source 
7-Aminoactinomycin D (7-AAD): 
Approximately 97%, Sigma (Poole, 
Dorset, UK) 
Actinomycin-D (actD): 
From streptomyces species, 
approximately 97%, Sigma (Poole, 
Dorset, UK) 
Amonium Cloride (NH4Cl): Sigma-Aldrich (Poole, Dorset, UK) 
Agarose: Invitrogen (Paisley, UK) 
BD Cytofix/Cytoperm
TM
 Kit: 
Fixation and permeabilisation kit, BD 
Biosciences (Oxford, UK) 
BD Fc Block
TM
: Clone 2.4.G2, Pharmingen (Oxford, UK) 
Bovine serum albumin (BSA): New England Biolabs (Hitchin, UK) 
Bromophenol Blue: Sigma-Aldrich (Poole, Dorset, UK) 
Deoxynucleotide triphosphates (dNTPs): Bioline Reagents Ltd. (London, UK) 
DNA Ladder: 
SmartLadder SF, Eurogentec 
(Southampton, UK) 
Draq5: 
Draq5
TM
 nuclear dye, c= 5 mM, 
Biostatus limited (Shepshed, UK) 
Enhanced K-Blue
®
 TMB Substrate: Oxford Biosystems (Oxford, UK) 
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Ethanol: VWR (Soulbury, UK) 
Evans Blue dye: VWR (Soulbury, UK) 
Formamide: VWR (Soulbury, UK) 
GelRed: 
Biotum, via Cambridge BioScience 
(Cambridge UK) 
Goat serum (GS): 
Normal GS, AbD Serotec (Kidlingdon, 
UK) 
Isopropanol: VWR, (Soulbury, UK) 
Magnesium chloride (MgCl2): Bioline Reagents Ltd. (London, UK) 
Molecular biology grade water: Sigma-Aldrich (Poole, Dorset, UK) 
Methanol: VWR (Soulbury, UK) 
Paraformaldehyde (PFA): VWR (Soulbury, UK) 
Rabbit serum (RS): 
Normal rabbit serum AbD Serotec 
(Kidlingdon, UK) 
Saline: 
Sodium chloride, 0.9% w/v, Baxter 
Healthcare (Northampton, UK) 
Saponin Sigma-Aldrich (Poole, Dorset, UK) 
Sodium Chloride (NaCl): 
Fluka BioChemica, Sigma-Aldrich 
(Poole, Dorset, UK) 
Sodium dodecyl sulphate (SDS): 
10% SDS solution, Severn Biotech Ltd. 
(Kidderminister, UK) 
Sucrose: BDH AnalaR
®
, VWR (Soulbury, UK) 
Tris-Acetate-EDTA (TAE) buffer: 
UltraPure
TM
 10x TAE buffer Invitrogen 
(Paisley, UK) 
Tris-HCl: 
1 M Tris-HCl solution, pH 8.5, Severn 
Biotech Ltd. (Kidderminister, UK) 
Triton X-100: Sigma-Aldrich (Poole, Dorset, UK) 
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2.1.2 List of antibodies  
Primary antibodies 
Antigen Details and source 
αSMA: Monoclonal mouse anti-mouse αSMA-Cy3, clone 1A4, Sigma (St. 
Louis, USA), working conc.: 6.5 μg/ml (confocal microscopy of 
tissue) 
Purified monoclonal mouse anti-mouse α-SMA, clone 1A4, Sigma 
(St. Louis, USA), (directly conjugated to Alexa-488 using the 
Molecular Probes
TM
 Alexa Fluor
® 
488 Antibody labelling kit from 
Invitrogen), working concentration: 10 μg/ml (confocal microscopy of 
tissue) 
CD45: Monoclonal rat anti-mouse CD45-APC, clone 30-F11, Biolegend. 
working concentration: 5 μg/ml (confocal microscopy of tissue and 
flow cytometry) 
Collagen type IV: Purified polyclonal rabbit anti-mouse collagen IV, Abcam 
(Cambridge UK), working concentration: 5 μg/ml (confocal 
microscopy) 
E-Selectin: Purified rat anti-mouse E-Selectin, kind gift from Prof. Dorian 
Haskard (Cardiovascular Sciences, National Heart and Lung 
Institute, Faculty of Medicine, Hammersmith Campus, Imperial 
College Academic Health Sciences Centre, Imperial College 
London, London, UK), working concentration: 2 μg/ml (flow 
cytometry) 
GR-1: Purified monoclonal rat anti-mouse Ly-6G and Ly-6C (GR1), clone 
RB6-8C5, BD Pharmingen (Oxford, UK), working concentration: 100 
μg/ml or 25 μg/ml (neutrophil depletion), 5 μg/ml (flow cytometry) 
ICAM-1: Purified monoclonal hamster anti-mouse CD54, clone 3E2, BD 
Pharmingen (Oxford, UK), working concentration: 2 μg/ml (flow 
cytometry), 5 μg/ml (confocal microscopy of tissue) 
ICAM-2: Purified monoclonal rat anti-mouse CD102, clone 3C4 (mIC2/4), no 
azide/low endotoxin (NA/LE), BD Pharmingen (Oxford, UK), working 
concentration: 2 μg/ml (flow cytometry) 
IL-1R I: Purified goat anti-mouse IL-1RI, R&D Systems (Abingdon, UK), 
working conc.: 10 μg/ml (flow cytometry) 
Integrin α1 (CD49a): Purified monoclonal Armenian hamster anti-mouse CD49a, clone 
HMα1, BioLegend (San Diego, USA), working concentration: 1 
μg/ml (flow cytometry), 10 μg/ml (confocal microscopy of cultured 
cells) 
Integrin α2 (CD49b): Monoclonal Armenian hamster anti-mouse CD49b-PE, clone HMα2, 
BD Pharmingen (Oxford, UK), working concentration: 1 μg/ml (flow 
cytometry) 
Purified monoclonal Armenian hamster anti-mouse CD49b, clone 
HMα2, BioLegend (San Diego, USA), working concentration: 10 
μg/ml (confocal microscopy of cultured cells) 
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Integrin α4 (CD49d): Monoclonal fisher rat anti-mouse CD49d-PE, clone R1-2, BD 
Pharmingen (Oxford, UK), working concentration: 2 μg/ml (flow 
cytometry) 
Integrin α5 (CD49e): Monoclonal Armenian hamster anti-mouse CD49e-PE, clone HMa5-
1, eBiosciences (Hatfield, UK), working concentration: 1 μg/ml (flow 
cytometry) 
Purified monoclonal Lewis rat anti-mouse CD49e, clone 5H10-27, 
BD Pharmingen (Oxford, UK), working concentration: 10 μg/ml 
(confocal microscopy of cultured cells) 
Integrin α6 (CD49f): Monoclonal rat anti-mouse CD49f-PE, clone GoH3, eBioscience 
(Hatfield, UK), working concentration: 2 μg/ml (flow cytometry) 
Monoclonal rat anti-mouse CD49f-A488, clone GoH3, BioLegend 
(San Diego, USA), working concentration: 10 μg/ml (confocal 
microscopy of cultured cells) 
Integrin β1 (CD29): Monoclonal Armenian hamster anti-mouse CD29-PE, clone HMb1-
1, BioLegend (San Diego, USA), working concentration: 1 μg/ml 
(flow cytometry) 
Purified monoclonal rat anti-mouse CD29, clone MB1.2, Millipore 
(Watford, UK), working concentration: 10 μg/ml (confocal 
microscopy of cultured cells) 
Integrin β3 (CD61): Purified NA/LE monoclonal Armenian hamster anti-mouse CD61, 
clone 2C9.G2, BD Pharmingen (Oxford, UK), working concentration: 
10 μg/ml (flow, cytometry, confocal microscopy of cultured cells) 
Integrin β4 (CD104): Purified monoclonal fisher rat anti-mouse CD104, clone 346-11A, 
BD Pharmingen (Oxford, UK), working concentration: 10 μg/ml (flow 
cytometry) 
JAM-A: Purified monoclonal rat anti-mouse JAM-A, clone BV-II, kind gift 
from Prof Elisabetta Dejana (Department of Biomolecular Sciences 
and Biotechnologies, School of Sciences, University of Milan, Italy) 
generated as previously described (Martin-Padura et al., 1998; 
Vecchi et al., 1994), working concentration: 2 μg/ml (flow cytometry) 
JAM-B: Purified rat anti-mouse JAM-B, kind gift from Prof Beat Imhof 
(Department of Pathology and Immunology, Centre Médical 
Universitaire, Geneva , Switzerland), working concentration: 2 μg/ml 
(flow cytometry) 
JAM-C: Purified monoclonal rat anti-mouse JAM-C, clone H33, Millipore 
(Hoddeston Hets, UK), working concentration: 2 μg/ml (flow 
cytometry) 
 Laminin: Purified polyclonal rabbit anti-mouse pan-laminin, Sigma-Aldrich 
(Poole, Dorset, UK), working concentration: 2.5 μg/ml (confocal 
microscopy of tissue) 
MRP-14: Purified monoclonal rat anti-mouse MRP-14, clone 2B10, kind gift 
from Dr. Nancy Hogg (Leukocyte Adhesion Laboratory, Cancer 
Research UK, London Research Institute, Lincoln’s Inn Fields 
Laboratories, London, UK), working concentration: 7 μg/ml (confocal 
microscopy of tissue) 
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NG-2: Purified polyclonal rabbit anti-mouse NG-2, Chemicon (Billerica, MA 
01821, USA), working concentration: 3.3 μg/ml (flow cytometry), 5 
μg/ml (confocal microscopy of tissue) 
PDGFR-β: Purified polyclonal goat anti-mouse PDGFR-β, R&D Systems, 
working concentration: 2 μg/ml (flow cytometry), 5 μg/ml (confocal 
microscopy of tissue) 
PECAM-1 (CD31): Purified monoclonal rat anti-mouse CD31, clone 390, eBiosciences 
(Hatfield, UK), (directly conjugated to Alexa-647 using the Molecular 
Probes
TM
 Alexa Fluor
® 
647 antibody labelling kit from Invitrogen 
(Paisley, UK)), working concentration: 2 μg/400 μl saline i.s. 
(confocal microscopy of tissue) 
TNFR I: Purified goat anti-mouse TNFRI, R&D Systems (Abingdon, UK), 
working concentration: 10 μg/ml (flow cytometry) 
TNFR II: Purified goat anti-mouse TNFRII, R&D Systems (Abingdon, UK), 
working concentration: 10 μg/ml (flow cytometry) 
Smooth muscle 
protein α (SM22α): 
Purified polyclonal goat anti-mouse SM22α, abcam, working 
concentration: 5 μg/ml (confocal microscopy of tissue) 
Syndecan-2: Purified polyclonal rabbit anti-mouse Syndecan-2 (M-140), Santa 
Cruz Biotechnology, Inc. (Santa Cruz, USA), working concentration: 
10 μg/ml (flow cytometry) 
VCAM-1: Monoclonal rat anti-mouse CD106-Alexa 647, clone 492 
(MVCAM.A), BioLegend (San Diego, USA), working concentration: 5 
μg/ml (flow cytometry), 10 μg/ml (confocal microscopy of cultured 
cells) 
VE-Cadherin: Purified monoclonal rat anti-mouse CD144, clone eBioBV13 (BV13), 
eBiosciences (Hatfield, UK), working concentration: 2 μg/ml (flow 
cytometry) 
 
 
Isotype controls 
Isotype Details and source 
Armenian hamster IgG1: Purified, clone G235-2356, BD Pharmingen 
(Oxford, UK) 
Armenian hamster IgG: PE-conjugated, clone HTK888, BioLegend (San 
Diego, USA) 
Goat IgGs: Normal goat IgGs, R&D Systems (Abingdon, UK) 
Rabbit IgGs: Normal rabbit IgGs, Abcam (Cambridge, UK) 
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Rat IgG2a: 
 
PE-conjugated, clone R35-95, BD Pharmingen 
(Oxford UK) 
Purified, clone YTH71.3, AbD Serotec (Kidlingdon, 
UK) 
Alexa 647-conjugated, clone RTK2758, BioLegend 
(San Diego, USA) 
Rat IgG2b: Purified, clone LO-DNP-11, AbD Serotec 
(Kidlingdon, UK) 
 
Secondary antibodies and streptavidin conjugates 
 
Antigen Details and source 
Armenian hamster IgG: Goat anti-Armenian hamster IgG-biotin, Biolegend 
(San Diego, USA) 
Goat anti-Armenian hamster IgG-DyLight 649, 
BioLegend (San Diego, USA) 
Goat IgG: Rabbit anti-goat IgG-Alexa 488, Invitrogen 
(Paisley, UK) 
Rabbit anti-goat IgG-Alexa 633, Invitrogen 
(Paisley, UK) rabbit anti-goat IgG-Alexa 488, 
Invitrogen (Paisley, UK) 
Rabbit IgG: Goat anti-rabbit IgG-Alexa 488, Invitrogen (Paisley, 
UK) 
Goat anti-rabbit IgG-Alexa 555, Invitrogen (Paisley, 
UK) 
Goat anti-rabbit IgG-Alexa 647, Invitrogen (Paisley, 
UK) 
Sheep anti-rabbit IgG-PE, AbD Serotec 
(Kidlingdon, UK) 
Rat IgG: Chicken anti-rat IgG-Alexa 647, Invitrogen 
(Paisley, UK) 
Goat anti-rat IgG-Alexa 488, Invitrogen (Paisley, 
UK) 
 
 
Biotin-binding protein Details and source 
Streptavidin Streptavidin-Alexa 488, Invitrogen (Paisley, UK) 
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2.1.3 List of inflammatory stimuli  
Stimuli Details and source 
C5a: Recombinant mouse C5a, Cat. No.: 2150-
C5-025/CF, R&D Systems (Abingdon, UK) 
CXCL1/keratinocyte-derived chemokine 
(KC): 
Recombinant murine CXCL1, Cat. No.: 
PMP66, AbD serotec (Kidlington, UK) 
Formyl-Methionyl-Leucyl-Phenylalanine 
(fMLP): 
fMLP, Cat. No.: F3506, Sigma (St. Louis, 
MO, USA) 
Interleukin-1β (IL-1β): Mouse IL-1β, Cat. No.: 401-ML-005/CF, 
R&D Systems (Abingdon, UK) 
Leukotriene B4 (LTB4): LTB4, Cat. No.: 434625, Merck (Hoddeston 
Hets, UK) 
Platelet-activating factor (PAF): PAF-16, Cat. No.: 511075, Calbiochem, 
Merck Millipore (Hoddeston Hets, UK) 
Tumour necrosis factor-α (TNF-α): Mouse TNF-α, Cat. No.: 401-ML-010/CF, 
R&D Systems (Abingdon, UK) 
 
 
 
2.2 Cell Culture 
2.2.1 Cell lines 
The adherent murine fibroblast-like cell line C3H/10T1/2 (clone 8) was obtained 
from American Type Culture Collection (ATCC; Manassas, USA). These cells were 
originally isolated from mouse embryos of the C3H strain in 1973 as described by 
Reznikoff et al. (Reznikoff et al., 1973). In the present study C3H/10T1/2 cells were 
used due to their pericyte-like properties (Darland and D'Amore, 2001; Hirschi et al., 
1998; Proebstl et al., 2012; Walshe et al., 2009). 
 
Culture of C3H/10T1/2 cells 
C3H/10T1/2 cells were cultured according to the supplier’s protocol. Cells were 
maintained in DMSO supplemented with 10% heat-inactivated fetal bovine serum 
(FBS), 2mM L-glutamine, 1% Penicillin (10,000 u/ml)/ Streptomycin (10 mg/ml). 
Cultured cells were kept in a humidified 5% CO2
 atmosphere at 37°C. C3H/10T1/2 
cells were split twice a week when they reached a confluency of about 70 to 80% 
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and were used for experiments between passage 14 and 20. For harvesting or 
passaging, the culture medium was aspirated from the cell monolayer. Cells were 
washed with PBS and detached enzymatically using Trypsin/EDTA (0.025% Trypsin 
and 0.01% EDTA). 1/6 volume of the cell suspension was then sub-cultured (5x103 
cells per cm2). 
For storage, aliquots of 1x106 cells were suspended in 1 ml DMEM enriched with 
20% FBS and 10% DMSO and were frozen at -80°C over night. The following day 
the vials were transferred into a liquid nitrogen tank. 
For usage, cells were thawed at 37°C, suspended in 9 volumes medium and 
centrifuged at 200 g for 30 min at room temperature. Supernatant was removed and 
pelleted cells were resuspended in 5 ml medium for further cultivation in 25 cm2 cell 
culture flasks. The following day, cells were transferred into 75 cm2 cell culture 
flasks. 
 
2.2.2 Isolation and culture of primary murine lung perivascular cells 
Isolation of microvascular cells 
Cells were isolated from mice expressing green fluorescent protein (GFP) under an 
αSMA promoter. For this purpose, a slightly modified protocol as described 
previously for the isolation of perivascular cells from mouse embryos and meninges 
(Brachvogel et al., 2005) was used. The entire procedure was performed using 
sterilised instruments (autoclaved and/or sterilisation using 70% ethanol). In adult 
mice (5-6 weeks old) the lung was removed immediately after euthanizing the 
animal by cervical dislocation and rinsed with calcium- and magnesium-free PBS. 
Tissues were mechanically minced into small pieces with a scalpel and digested by 
incubation in 2 ml collagenase II (200u/ml) in HBSS at 37°C in a shaking bath for 1 
h. After initial dissociation, tissues were gently homogenised using successive 5, 1, 
and 0.2 ml pipettes to loosen microvessel fragments, followed by adding 2% 
Trypsin/ 100 units DNAse I to the suspension and further incubation at 37°C in a 
shaking bath for 30 min. To remove undigested tissue and large vessel segments 
the resulting suspension was subsequently passed through a 100 µm nylon mesh 
filter and washed with MCDB-131 medium containing 5% FCS. After centrifugation 
at 300 g for 5 min, the pellet containing microvessel segments and single cells was 
plated on gelatine-coated (0.05% gelatine) petri dishes in 10 ml proliferation 
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medium (MCDB131, 5% FCS, 2mM L-glutamine, 1% Penicillin (10 000u/ml)/ 
Streptomycin (10mg/ml), bFGF (2 ng/ml), PDGF-BB (5 ng/ml), EGF (10 ng/ml); cells 
obtained from one lung were split onto two 10 cm dishes. 
 
Culture of isolated cells 
On the day after cultivation, medium with floating cells (mainly red blood cells) and 
tissue debris was carefully aspirated and replaced with fresh proliferation medium.  
Cells were then left undisturbed for 3 days in a humidified 5% CO2
 atmosphere at 
37°C to allow cell attachment and pericyte outgrowth. Medium was changed 
thereafter every second day. Cultures were examined morphologically and by 
fluorescence for viability and contaminating cell types using an Olympus IX81 
motorised inverted microscope (Olympus Medical, Southend-on-Sea, UK). Cells 
derived from lungs of wild-type mice were used as negative control. Between culture 
days 5-7, GFP-positive cells started to proliferate and extensive outgrowth of 
colonies could be observed by microscopy by day 14-20. At this point, ~ 1x106 cells 
could be obtained from one lung, of which 50 to 70% were positive for αSMA-GFP.  
From this point, proliferation medium was replaced with MCDB131 medium without 
growth factors. Cells were split when they reached confluency of about 70-80% and 
were used for experiments between passages 1 to 5.  
Outgrowth cells were characterised for pericyte (αSMA, NG-2 and PDGFR-β), EC 
(CD31), SMC (SM22α) and leukocyte markers (CD45) as described 
previously(Maier et al., 2010) using flow cytometry or immunofluorescence staining 
as described below. 
 
2.2.3 Determination of cell number and viability  
Total cell number and viability was assessed by trypan blue exclusion assay. Cells 
were suspended 1:1 with a 0.4% trypan blue solution. After incubation for 1-3 min at 
room temperature total cell number and cell viability counts were determined using 
a Neubauer haematocytometer (VWR International, Leicestershire, UK) as 
recommended by the manufacturer. Cells that absorbed trypan blue were shown as 
distinctive blue colour under the microscope and were identified as dead. Whereas 
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live cells with an intact cell membrane did not take up the stain and were therefore 
uncoloured. 
 
2.2.4 Cell stimulation with inflammatory mediators 
To investigate the cells’ responsiveness to proinflammatory cytokines, C3H/10T1/2 
cells were seeded in 6-well culture plates at a density of 1 x 105 cells/ well 
maintained in complete medium. The day after cultivation, medium was removed 
and fresh medium containing the distinct stimulus was added.  Cells were treated 
with either 10 or 100 ng/ml TNFα, 1 or 10 ng/ml IL-1β and stimulated for 4 h at 
37°C. Inflammatory stimuli were then removed by washing the cells twice with cold 
PBS and expression of receptors and adhesion molecules were then analysed via 
flow cytometry upon staining with specific antibodies (see section 2.2.5).  
 
2.2.5 Analysis of cell surface molecules by flow cytometry  
For characterisation of surface expression of immune receptors, adhesion 
molecules and specific cell markers (for pericytes, ECs, leukocyte) on 10T1/2 cells 
and/or isolated primary cells a cytometric assay was used as described before 
(Proebstl et al., 2012). Untreated cells or cells stimulated with different inflammatory 
mediators were analysed. Cells were harvested with 1 mM EDTA on ice. 
Subsequently cells were washed twice with ice-cold PBS containing 1% FCS 
followed by centrifugation for 5 min at 300 g and 4°C. In some experiments murine 
whole-blood leukocytes isolated by cardiac puncture or via the tail vein were 
stained. 5 × 105 detached cells or 50 µl whole blood in 10 µl 0.5M EDTA were 
transferred into 96-well plates. Cells were then incubated in 50 µl 5 μg/ml mouse BD 
Fc BlockTM in PBS/ 1% FCS or the respective serum (25% in PBS/ 1% FCS) for 10 
min on ice to block unspecific binding. After the blocking step, 50 µl of primary 
antibody in PBS/FCS was added. Cells were immunostained for cell-surface 
receptors (IL-1R I, TNFR I or TNFR II), adhesion molecules (integrin subunits α1, α2, 
α4, α5, α6, β1, β3, β4, JAM-A, JAM-B, JAM-C, ICAM-1, ICAM-2, VCAM-1, E-Selectin, 
VE-Cadherin or Syndecan-2), pericyte markers (NG-2 or PDGFR-β), for the EC 
marker CD31 (PECAM-1), leukocyte markers (CD45, Lys6G and Lys6M) or 
appropriate control antibody (detailed information about antibodies used in this 
study including concentrations are listed in section 2.1.2). Incubation was performed 
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for 30 min on ice in the dark. Subsequently stained cells were washed twice with 
PBS/FCS by centrifugation for 5 min at 300 g. In case of directly conjugated primary 
antibodies with a fluorochrome, labelled cells were diluted in 300 µl PBS/FCS. If an 
unconjugated primary antibody was used, cells were further incubated with a 
fluorescently labelled secondary antibody for 30 min on ice in the dark.  Labelled 
cells were washed twice with PBS/FCS. Red blood cell lysis of whole blood samples 
was performed following antibody staining. Cells were resuspended in 300 μl ACK 
lysis buffer (8.024 mg/l NH4Cl, 1.001 mg/l KHCO3, 3.722 mg/l EDTA, pH 7.3) and 
incubated at room temperature for 5 min or until solution was clear red. 
Subsequently cells were pelleted by centrifugation for 5 min at 300 g and 4°C and 
washed 2 times with PBS/FCS.  For flow cytometric analysis, cells were diluted in 
300 µl PBS/FCS. To exclude dead cells in the later analysis, 5 µl of 25 μg/ml 7-AAD 
in PBS was added to all samples. 
Samples were acquired on a FACSCalibur flow cytometer (BD Biosciences, 
Mountain View, CA, USA) using CellQuest acquisition software (BD Biosciences) 
and analysed using FlowJo software (Tree Star Inc., Ashland, OR, USA). Flow 
cytometry data are presented as the relative fluorescence intensity (RFI) calculated 
as the ratio of expression compared to a negative control. Unstained cells and cells 
incubated with an isotype control antibody were used as negative controls.  
 
2.2.6 Confocal microscopy of immunofluorescently labelled cells 
Confocal microscopy of cells was performed in order to analyse the localisation and 
expression profile of certain molecules expressed by C3H/10T1/2 cells. For this 
purpose, cells were cultured on 4-well chamber slides at a density of 1.6 x 104 cells/ 
well in 900 µl complete medium. 24h after culture, cells were washed twice with cold 
PBS containing 1% FCS. Cells were then fixed and permeabilised with 200 µl/well 
of fixation/permeabilisation solution (BD Cytofix/CytopermTM Kit) for 20 min on ice. 
Fixed cells were washed twice with BD permeabilisation/washing (perm/wash) 
buffer and incubated with 200 µl primary antibody in perm/wash buffer for 30 min on 
ice in the dark. Cells were immunostained for adhesion molecules (integrin subunits 
α1, α5, α6, β1 and β3, and VCAM-1) or appropriate control antibody and the pericyte 
marker αSMA. After 3 washing steps, if necessary a specific fluorescently labelled 
secondary antibody (diluted in perm/wash buffer) was applied, as determined by the 
combination of primary antibody used in the respective experiment. Cells were 
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incubated for 30 min on ice in the dark followed by 3 washing steps. Cell nuclei 
were counterstained with Draq5TM (1:1000 in 200 µl perm/wash) for one min and 
washed again 3 times with perm/wash buffer. Subsequently 200 µl 4% PFA was 
applied per well to fix the cells for 10 min on ice. Fixed cells were washed 3 times 
with PBS and mounted with Prolong®Gold antifade reagent at room temperature 
over night.  
Protein expression of immunofluorescently labelled cells seeded on chamber slides 
was analysed using a Zeiss LSM 5 PASCAL confocal laser-scanning microscope 
(Carl Zeiss Ltd, Welwyn Garden City, UK) and a 20 x water-dipping Achroplan 
objective (numerical aperture 0.5 W, PH2), 40 x water-dipping Achroplan objective 
(numerical aperture 0.8 and resolution 0.37 µm), or a 63 x oil-dipping Plan-
APOCHROMAT objective (numerical aperture 1.4, oil). As negative controls, cells 
were stained using the respective isotype-matched control antibody. The results 
were corrected for the background readings of the negative control.  
 
2.3 In vivo analyses 
2.3.1 Mice 
C57BL/6 WT mice from either sex were purchased from Harlan–Olac (Bicester, 
UK).  
αSMA-GFP mice were a gift from Prof. Clare Isacke (Breakthrough Breast Cancer 
Research Centre, The Institute of Cancer Research, London, UK) with authorisation 
of Prof. Sanai Sato (Department of Medicine, University of Oklahoma, Health 
Science Center, Oklahoma City, USA). These mice express GFP under the control 
of the αSMA promoter and have been described elsewhere (Yokota et al., 2006). 
This mouse strain was backcrossed at least 8 times onto the C57BL/6 background. 
Tumour necrosis factor receptor (TNFR) double knockout mice (TNFR-/-) lacking 
both genes TNFrsf1a (p55) and TNFrsf1b (p75) were purchased from The Jackson 
Laboratory (stock number: 003243). This strain was generated by intercrossing 
singly homozygotes for the TNFrsf1atm1Imx targeted mutation with homozygotes for 
the TNFrsf1btm1Imx mutation. Double homozygous mice are viable and fertile. TNFR-/- 
mice displayed the C57BL/6 background. 
63 
 
Neutrophil-elastase deficient mice (NE-/-) were a gift from Prof. Steven Saphiro, MD 
(Department of Medicine, University of Pittsburgh, Pittsburgh, USA ) and were 
generated by targeted disruption of the NE gene (Belaaouaj et al., 1998). 
Homozygous mice are viable, fertile and phenotypically normal under physiological 
(non-inflammatory) conditions.  NE-/- mice used were on a C57BL/6 background. 
CX3CR1
GFP/+ mice were obtained from the European Mutant Mouse Archive (EMMA, 
Orleans, France) and generated by targeted gene disruption as previously 
described (Jung et al., 2000). 
All mice were used at an age between 6-12 weeks at an average weight of 25g. As 
appropriate, age-matched control mice were litter mates or commercially purchased 
C57BL/6 mice. All experiments were approved by the United Kingdom Home Office 
according to the Animals Scientific Procedures Act 1986 (ASPA). 
 
2.3.2 Phenotyping and genotyping 
Phenotyping of αSMA-GFP mice 
To assess the phenotype of αSMA-GFP mice, ear notches were taken using a 
puncher at weaning age and analysed by fluorescence microscopy. For this 
purpose, the skin from ear notch samples was carefully separated from cartilage 
using fine forceps. The subcutaneous tissue was then mounted onto a glass slide 
and examined using a fluorescence microscope. Animals were considered positive 
for the GFP transgene, if GFP-positive perivascular cells (PVC) were observed 
(Figure 2.1). 
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Figure 2.1: Phenotyping of αSMA-GFP mice. Representative 3D-reconstructed confocal 
images of ear skin from mice expressing GFP under the promoter of αSMA. A, arteriole; C, 
capillary; PVC, postcapillary venule. Bars, 20 μm. 
 
  
65 
 
Genotyping of TNFR double knockout and NE knockout mice 
Polymerase chain reaction (PCR) was used to confirm the genotype of TNFR-/- and 
NE-/- mice used in this study. Ear notch samples or tail biopsies were digested by 4 
h incubation in 200 μl lysis buffer (100 mM Tris-HCl, pH8.5; 5 mM EDTA; 0.2% 
SDS, 200 mM NaCl) containing 10 μg/ml proteinase K at 55°C. To purify the DNA, 
samples were gently shaken and cooled down for 5 min at room temperature. After 
5 min centrifugation at 20,000 g, supernatants were transferred into fresh tubes 
containing 200 μl isopropanol and mixed well. Subsequently the suspension was 
centrifuged at 20,000 g for 5 min at room temperature and the resulting supernatant 
was discarded. 300 μl 70% (v/v) Ethanol was added, followed by centrifugation at 
20,000 g for 5 min at room temperature. After removal of supernatants, pellets were 
air dried for approximately 10 min and resuspended in 50 μl molecular biology 
grade water. For short-term storage (up to a week) samples were stored at 4°C, or 
at -20°C if stored for a longer time. 
For the PCR, 23 µl mastermix per sample containing distinct primers for each 
reaction (see Table 2.1) was prepared (Table 2.2, 2.4, 2.3 respectively) and mixed 
with 2 µl purified DNA. TNFR I (TNFrsf1a) and TNFR II (TNFrsf1b) in TNFR double 
knockout mice were detected in separate PCRs. 
DNA fragments were amplified in a thermal cycler (DNAEngine® Peltier Thermal 
cycler, Bio-Rad, Hemel Hempstead, UK) using varying reaction times depending on 
the primers used (Tables 2.3, 2.5, 2.7, respectively).  
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PCR Primer Primer sequence 
oIMRo834 (TNFR I WT) 5’-GGA TTG TCA CGG TGC CGT TGA AG-3’ 
oIMRo835 (TNFR I WT) 5’-TGA CAA GGA CAC GGT GTG TGG C-3’ 
oIMRo836 (mutant) 5’-TGC TGA TGG GGA TAC ATC CAT C-3’ 
oIMRo837 (mutant) 5’-CCG GTG GAT GTG GAA TGT GTG-3’ 
oIMRo838 (common) 5’-AGA GCT CCA GGC ACA AGG GC-3’ 
oIMRo839 (TNFR II WT) 5’-AAC GGG CCA GAC CTC GGG T-3’ 
WT NE forward primer 5’-GAG AAC ACA GCC CAC CAT G-3’ 
WT NE reverse primer 5’-GGG CCT GAG AAC ACA CAA AG-3’ 
Neo forward primer 5’-GAC AAT CGG CTG CTC TGA TG-3’ 
Neo reverse primer 5’-ATA CTT TCT CGG CAG GAG CAA-3’ 
Table 2.1: Primers used for genotyping TNFR
-/-
 and NE
-/-
 mice. 
 
Reagent Volume per sample Final concentration 
Primer 1: oIMRo834 (100 pmol/µl) 0.12 µl 0.5 µM 
Primer 2: oIMRo835 (100 pmol/µl) 0.12 µl 0.5 µM 
OR   
Primer 3: oIMRo836 (100 pmol/µl) 0.12 µl 0.5 µM 
Primer 4: oIMRo837 (100 pmol/µl) 0.12 µl 0.5 µM 
dNTPs (10 mM) 0.5 µl 0.2 mM 
MgCl2 (50 mM) 1 µl 2 mM 
NH4
+
 buffer (10x) 2.5 µl 1 x 
TAQ polymerase (5 U/µl) 0.15 µl 0.03 U/ml 
dH2O (molecular biology grade) 18.61 µl  
Total 23 µl  
Table 2.2: PCR master mix to amplify either the TNFR I WT or mutant allele. 
 
Initial denaturation 94°C for 3 min x 1 
Denaturation 94°C for 30 sec 
35 cycles Annealing 68°C for 1 min 
Elongation 72°C for 1 min 
Final elongation 72°C for 2 min x 1 
Table 2.3: PCR program for amplifying the TNFR I WT or mutant allele 
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Reagent Volume per sample Final concentration 
Primer 1: oIMRo837 (100 pmol/µl) 0.13 µl 0.5 µM 
Primer 2: oIMRo838 (100 pmol/µl) 0.26 µl 1 µM 
Primer 3: oIMRo839 (100 pmol/µl) 0.13 µl 0.5 µM 
dNTPs (10 mM) 0.5 µl 0.2 mM 
MgCl2 (50 mM) 1 µl 2 mM 
NH4
+
 buffer (10x) 2.5 µl 1 x 
TAQ polymerase (5 U/µl) 0.15 µl 0.03 U/ml 
dH2O (molecular biology grade) 18.33 µl  
Total 23 µl  
Table 2.4: PCR master mix to amplify both the TNFR II WT and mutant allele. 
 
Initial denaturation 94°C for 3 min x 1 
Denaturation 94°C for 30 sec 
35 cycles Annealing 69°C for 1 min 
Elongation 72°C for 1 min 
Final elongation 72°C for 2 min x 1 
Table 2.5: PCR program for amplifying the TNFR II WT and mutant allele 
 
Reagent Volume per sample Final concentration 
Primer 1: WT NE forward primer 0.25 µl 1 µM 
Primer 2: WT NE reverse primer 0.25 µl 1 µM 
OR   
Primer 1: Neo forward primer 0.25 µl 1 µM 
Primer 2: Neo reverse primer 0.25 µl 1 µM 
dNTPs (10 mM) 0.5 µl 0.2 mM 
MgCl2 (50 mM) 0.75 µl 1.5 mM 
NH4
+
 buffer (10x) 2.5 µl 1 x 
TAQ polymerase (5 U/µl) 0.1 µl 0.005 U/ml 
dH2O (molecular biology grade) 18.65 µl  
Total 23 µl  
Table 2.6: PCR master mix to amplify either the NE WT or the mutant allele. 
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Initial denaturation 94°C for 5 min x 1 
Denaturation 94°C for 30 sec 
35 cycles Annealing 60°C for 30 sec 
Elongation 72°C for 30 sec 
Final elongation 72°C for 10 min x 1 
Table 2.7: PCR program for amplifying the NE WT and mutant allele 
 
Amplified DNA samples (15 µl of each reaction product) were mixed with 2 µl blue 
agarose gel electrophoresis loading buffer (25 mg bromophenol Blue, 4 g sucrose, 
10 ml molecular biology grade water) and separated on a 1% (w/v) agarose gel (in 
TAE buffer) supplemented with 2 µl GelRed. Samples were run together with a 100-
1,000 bp DNA ladder as a marker in an electrophoresis chamber (Mupid® -One 
electrophoresis system, Eurogentec) at 90 V. Reaction products were visualised 
and photographed under ultraviolet light on a UV White Darkroom BioImaging 
system (UVP, Cambridge, UK). The WT TNFR I gene was denoted by a 120 bp 
fragment, mutant TNFR I gene by a 155 bp, WT TNFR II gene by a 257 bp, TNFR II 
mutant by a 160 bp, WT NE gene by a 400 bp and mutant NE gene by a 500 bp 
fragment.  
 
Phenotyping of CX3CR1
GFP/+ mice 
Litters of this colony were phenotyped by my colleague Dr. Martina Beyrau using 
flow cytometry analysis of blood monocytes. Mice heterozygous for CX3CR1-GFP 
were distinguished from homozygous mice by the lower fluorescence intensity of 
specific monocyte subsets. 
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2.3.3 Neutrophil depletion 
Pure WT C57BL/6 mice were depleted of their circulating neutrophils by 
intraperitoneal (i.p.) injection of 100 μg anti-GR1 antibody in 500 µl saline as 
previously described (Wang et al., 2006). Injection was performed 24 h prior to 
inducing inflammatory responses. Control mice received the same concentration of 
rat IgG2bκ isotype-matched control antibody. Blood samples taken from the tail vein 
before and after antibody injection were used to determine the level of neutrophils 
by Kimura staining (11 ml 0.05% Toluidine Blue, 0.8 ml 0.03% Light green, 0.5 ml 
saturated saponin in 50% ethanol, 5 ml 1/15M phosphate buffer pH 6.4). This 
protocol depleted circulating neutrophils by 90% but likely also reduced monocyte 
levels. 
Neutrophil-only depletion was induced in WT C57BL/6 and CX3CR1
EGFP/+ mice by 
serial i.p. injections of a lower dose of anti-GR1 antibody as previously described 
(Voisin et al., 2009). 25 µg antibody in 500 µl saline per day was given for 3 days in 
a row. IgG2bκ isotype control antibody was injected in control animals. The level of 
neutrophils and monocytes was determined in blood samples taken from the tail 
vein before and after 3 days of antibody treatment using Kimura staining and/or flow 
cytometry (GR1+, GR1+/CX3CR1-GFP
+ cells, respectively). Mice treated with 3 
doses of the anti-GR1 antibody typically showed a depletion of their circulating 
neutrophils of more than 85%. Of importance, this protocol had no effect on the 
proportion of blood CX3CR1-GFP
+ GR1+ monocytes. 
 
2.3.4 Inhibition of ROS Signalling 
In some experiments the role of reactive oxygen species (ROS) molecules on 
pericyte shape change was analysed using superoxide dismutase (SOD) and 
catalase as described previously (Woodfin et al., 2011) to scavenge O2- free 
radicals, hydrogen peroxide, respectively. Male mice were anaesthetised by i.m. 
injection of 1 ml/kg ketamin (40 mg) and xylazine (2 mg) in saline. SOD (2,000 U/kg) 
together with catalase (50,000 U/kg) were injected intravenously (i.v.) into the tail 
vein of male pure WT C57BL/6 mice immediately prior to induction of inflammation. 
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2.3.5 Inhibition of PAF-induced responses 
Male mice were anaesthetised by i.m. injection of 1 ml/kg ketamin (40 mg) and 
xylazine (2 mg) in saline. To block PAF-induced responses, male WT C57BL/6 mice 
were pre-treated with the PAF-antagonist UK 74,505. 150 μl UK 74,505 (0.5 mg/kg 
bodyweight in saline) was administered i.v. into the tail vein 10 min prior to induction 
of inflammation as described previously (Young et al., 2002). Control mice received 
0.6 mM HCl in saline (vehicle). 
 
2.3.6 Induction of inflammatory reactions in murine tissues 
Induction of inflammation in the cremaster muscle 
To induce inflammatory responses in the cremaster muscle, inflammatory mediators 
were injected via the intrascrotal route following sedation. Male mice were 
anaesthetised by i.m. injection of 1 ml/kg ketamin (40 mg) and xylazine (2 mg) in 
saline. TNF (300 ng), IL-1β (50 ng), LTB4 (30 ng), KC (500 ng), C5a (300 ng) or 
fMLP (5 µg) in 300 μl PBS were administered intrascrotally (i.s.). As a vehicle 
control 300 μl PBS was injected i.s. alone. Mice were treated for 2, 3, 4, 6, 8, 24, 48 
or 72 h as indicated for each experiment. At the end of each in vivo test period, mice 
were sacrificed by cervical dislocation and the cremaster muscle was surgically 
dissected away, flattened on dental wax and fixed for subsequent ex vivo 
immunofluorescent staining and confocal analysis (see section 2.3.7). 
 
Induction of inflammation in the dorsal skin and ear skin 
Mice were anaesthetised by injecting 1 ml/kg ketamine (40 mg) and xylazine (2mg) 
in saline i.m. Inflammation in the ear skin or dorsal skin was induced via intradermal 
(i.d.) injection of 30 ng LTB4, 300 ng TNF, 500 ng KC, 300 ng C5a, 5 µg fMLP or 50 
ng PAF in 30 µl, 50 μl PBS, respectively. As a vehicle control mice received PBS 
alone. For injections of the compounds into dorsal skin, the dorsal fur was removed 
using an electric razor beforehand. Agents under test were injected according to a 
randomised site injection plan and not more than 8 dorsal sites were injected per 
mouse (Figure 2.2). At the end of experiments, mice were sacrificed by cervical 
dislocation. Dorsal skin was removed and injected sites were cut out as circular 
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patches using a metal puncher (~8 mm in diameter) and ears were cut off using 
surgical scissors for further analysis. 
 
 
 
Figure 2.2: Site injection plan of inflammatory mediators in the mouse dorsal skin 
inflammation model. Mice were anaesthetised and dorsal fur was removed using an 
electric razor. Inflammatory mediators were injected i.d. in 50 µl PBS at balanced sites as 
separated by the dotted lines shown in this figure. Not more than eight sites were injected 
per mouse. 
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2.3.7 Preparation of lung sections for immunofluorescence labelling 
To investigate expression of pericyte markers in the murine lung, lungs were 
harvested from C57BL/6 WT and αSMA-GFP mice as previously described (Uyechi 
et al., 2001). For this purpose, initially lungs were inflated as follows to avoid 
collapsing of the organ. Mice were killed by cervical dislocation and the thoracic 
cavity was opened exposing the lungs and heart. Warm PBS was perfused into the 
right heart ventricle to wash out the blood from the vessels for 30 seconds, followed 
by 4% PFA for 30 seconds. Warmed PBS (42°C) was used as lavage in the open 
chest cavity to keep subsequent injected agarose solution flowing through the whole 
lung. After exposing and intubation of the trachea, 800 μl pre-warmed (to 42°C) 3% 
low-melting point agarose was injected. Subsequently the trachea was quickly 
closed by making a tight knot with a fine thread. To solidify the agarose, ice-cold 
PBS was administered around the lungs. Lungs together with the trachea were then 
removed, fixed over night in 4% PFA at 4°C and stored in PBS at 4°C until tissue 
sectioning. Lung lobes were dissected and sectioned at 200 μm using a VT12005 
vibratome (Leica) at an amplitude set at 1.8 mm and speed of 0.1 mm/s-0.5 mm/s. 
Sections were then blocked and permeabilised in PBS supplemented with 25% of 
the respective serum (10% normal goat serum, 10% FCS and 5% normal mouse 
serum or 1% normal rabbit serum, 10% FCS and 5% normal mouse serum, 
depending on the antibody) and 3.75% Triton-X 100 for 7 h at room temperature 
under agitation. Tissues were stained with fluorescently labelled antibodies followed 
by image acquisition by confocal microscopy (as described in section 2.3.8). 
 
2.3.8 Immunofluorescent labelling and confocal microscopy 
Immunofluorescent labelling of untreated tissues or after stimulation (as described 
in section 2.3.6) was performed as previously described (Proebstl et al., 2012; 
Voisin et al., 2009; Voisin et al., 2010; Wang et al., 2006). Following dissection, 
tissues were fixed immediately in cold 100% methanol or 4% PFA for 30 min at 4°C. 
After washing in PBS, fixed whole-mounted tissues were blocked and permeabilised 
in PBS supplemented with 25% of the respective serum (10% normal goat serum, 
10% FCS and 5% normal mouse serum or 1% normal rabbit serum, 10% FCS and 
5% normal mouse serum, depending on the antibodies used) and 1% Triton-X 100 
for 3 h at room temperature while shaking. Tissues were then immunostained for 
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neutrophils (anti-MRP14), pericytes (anti-αSMA, anti-NG2, anti-PDGFRβ, anti-
SM22α), and/or ECs (anti-CD31) and BM components type IV collagen and pan-
laminin, or appropriate control antibodies. After incubation with primary antibodies in 
PBS containing 10% serum (FCS, GS or RS) at 4°C over night or longer, tissues 
were washed 3 times for 15-30 min in PBS. If necessary, tissues were further 
incubated with specific fluorescently-conjugated secondary antibodies, as 
determined by the combination of primary antibody used in the respective 
experiment. Incubation was performed at 4°C for 3 h in PBS containing 10% serum 
(FCS, GS or RS). Following 3 washing steps in PBS for 15-30 min, tissues were 
stored at 4°C in PBS in the dark until analysed using a confocal microscope. 
Immunofluorescently labelled tissues were analysed using a Zeiss LSM 5 PASCAL 
confocal laser-scanning microscope incorporating a x 40 water-dipping objective 
lens (numerical aperture 0.8 and resolution 0.37 µm), and a 10 x Plan NEOFLUOR 
objective (numerical aperture 0.3), or with a Leica SP5 confocal microscope (Leica 
Microsystems, Milton Keynes, UK) incorporating a x 20 water-dipping objective 
(numerical aperture 1.0 and resolution 0.28 µm). Z-stack images of half post-
capillary venules (20-45 µm in diameter) were captured using the multiple track 
scanning mode at a resolution of 800 x 800 pixels in the x x y plane. Results were 
corrected for the background readings of the negative control (tissues stained with 
the respective isotype matched antibody). Images were analysed for leukocyte 
transmigration, pericyte gaps and BM LERs as described below 
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Quantification of leukocyte transmigration 
Confocal images were analysed for the level of inflammation (number of 
extravasated leukocytes in the tissue) using the image processing software IMARIS 
(Bitplane, Zurich, Switzerland) as previously described (Proebstl et al., 2012). 
Three-dimensional reconstruction of Z-stack images of post-capillary venules (20-45 
µm in diameter) were used for analysis. MRP-14 positive neutrophils and/or 
CX3CR1-GFP positive monocytes were counted across 200 µm vessel segments 
and within 50 µm away from the vessel (above and below of vessel) (Figure 2.3a). 
The number of transmigrated neutrophils was determined for each vessel segment. 
At least 3 vessel segments per cremaster muscle (6 per mouse) were quantified 
and data plotted as mean number of transmigrated cells per mouse.   
 
Quantification of gaps between adjacent pericytes 
The image analysing software ImageJ (National Institute of Healths, Bethesda, 
Maryland, USA) was used to quantify the size (area) and density (average number 
of gaps per defined vessel area) of gaps between pericytes surrounding post-
capillary venules (20-45 µm in diameter). 3D-reconstructed confocal images of half 
vessels (vessels were split along the longitudinal axis) were artificially displayed on 
a 2D surface (z-projection, maximum intensity) and converted into 8-bit greyscale 
projections. Gaps between adjacent pericytes, defined as αSMA-negative regions, 
were either manually encircled across 200 µm vessel segments (Figure 2.3b) and 
their area was measured in µm2 as previously described (Proebstl et al., 2012; 
Voisin et al., 2010; Wang et al., 2006), or automatically quantified by ImageJ. For 
automatic analysis, regions of interest (gaps between adjacent pericytes) were 
defined in binary images (positive/negative in contrast to intensity plots) by creating 
greyscale cut-off points: To display only pericyte gaps (background) rather than 
aSMA-positive regions the lower threshold level was set to 0 and the upper 
threshold level was adjusted so that only areas with low intensities (in terms of pixel) 
were included (i.e. pericyte gaps). Areas of regions of interest (set between 1-500 
µm2) were measured automatically by ImageJ using the “Analyze Particles” 
command. The above automatic analysis was developed as part of the present 
project. 
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For both, manual and automatic analysis, the values of all ROI areas per vessel 
segment were totalled. Mean gap size and gap density was determined for each 
vessel segment. At least 4 vessel segments per mouse were quantified and plotted 
as mean gap size per mouse, or number of gaps per defined vessel area (1 mm2) 
per mouse, respectively. 
 
Quantification of basement membrane low expression regions 
As previously described (Voisin et al., 2009; Voisin et al., 2010; Wang et al., 2006; 
Wang et al., 2012), size and density of venular matrix LERs were determined in 3D 
images of semi-vessels captured and quantified on a 2D surface using ImageJ. 
Images were converted into gray scale intensity projection to indicate intensities of 
pixels from high to low.  Regions with less than 60% of average fluorescence 
intensity as compared with average intensity of the entire vessel segment (200 µm) 
were defined as LERs (described in (Wang et al., 2006)). These regions were 
encircled manually and their size, density and fluorescence intensity was measured 
in at least 4 vessel segments per mouse (Figure 2.3c). Data were plotted as mean 
LER size per mouse, or number of LERs per defined vessel area (1 mm2) per 
mouse, respectively. 
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Figure 2.3: Schematic diagram of vasculature and tissue analysis. 200 μm vessel 
segments of post-capillary venules with a diameter between 25-45 μm were quantified for 
neutrophil transmigration, gaps between adjacent pericytes and LERs. MRP-14-positive 
cells were counted across these vessel segments within 50 μm away from the vessel (a). 
Gaps between adjacent pericytes (b) and matrix protein LERs (c) were analysed on grey 
scale intensity projections of the images to quantify their size and density. 
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2.3.9 In vivo vascular permeability assay 
Vascular leakage was assessed by measuring the accumulation of plasma-protein-
bound Evans Blue dye in the dorsal skin, ear skin and cremaster muscles of 
animals stimulated with locally injected inflammatory mediators or PBS alone. As 
previously described (Colom et al., 2012), anaesthetised animals received Evans 
Blue dye (0.5% in PBS, 5 µl per g bodyweight) i.v. through the tail vein before or 
after administering the stimulating agents under test as indicated in section 2.3.6. At 
the end of the experiment animals were sacrificed by cervical dislocation. Sites of 
injections were removed and incubated in 250 µl formamide at 56°C for 24 h to 
extract Evans Blue dye from the tissues. The amount of accumulated Evans Blue 
dye was quantified by spectroscopy at 620 nm using a Spectra MR spectrometer 
(Dynex technologies Ltd., West Sussex, UK). Results are presented as the optical 
density at 620 nm (OD620) per mg tissue and per mouse. 
In some experiments, mice were pre-treated with one dose of anti-GR1 antibody 
(100 µg/ 500 µl saline) injected i.p. 24 h before (to deplete circulating neutrophils). 
 
2.3.10 MPO Assay 
A myeloperoxidase (MPO) assay was used to quantify neutrophil infiltration in 
mouse skin samples as previously described (Colom et al., 2012). Freshly dissected 
dorsal skin samples, or samples rapidly frozen in liquid nitrogen and stored at -
80°C, were transferred to in-beaded tubes containing 500 μl homogenizer buffer 
(600 mM NaCl, 0.5% HTAB, 600 mM KH2PO4, 66 mM Na2HPO4 in H2O). Samples 
were then homogenized using a Precellys homogenizer (Bertin technologies, 
Montigny-le-Betonneux, France) for 3 cycles at 6500 rpm for 20 second durations 
and 30 second pauses. After freezing the homogenate with liquid nitrogen and 
adding further 500 μl homogenizer buffer, the samples were homogenized once 
more under the same conditions as before. Subsequently the final homogenate was 
transferred into 1.5 ml tubes and centrifuged at 13,000 g for 10 min at 4°C. 
Supernatants were either stored at -80°C or used immediately to determine the 
MPO activity by enzymatic assay.  
To assess the MPO activity, tissue extracts were diluted 1:2 in homogenizer buffer. 
Furthermore a standard curve was set up for each assay using partially purified 
MPO diluted in PBS (3, 2.5, 2, 1.5, 1, 0.5 and 0 u/ml). 25 μl assay buffer (6.6 mM 
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Na2HPO4, 60 mM KH2PO4, 0.5% HTAB; pH 6) was added to 96-well plate and 
mixed with 25 μl of sample or standard. Wells with 100 μl assay buffer served as 
negative control (blanks). 100 μl MPO substrate was then added to each well. 
Enzymatic activity was immediately measured by continually monitoring the change 
in absorbance at 650 nm for 20 min using a Spectra MR spectrometer (Dynex 
technologies Ltd., West Sussex, UK). Results are presented as MPO activity (units) 
per ml tissue lysate. 
 
2.4 Statistical Analysis 
Data management and analysis was performed using GraphPad Prism® 4. Data are 
presented as means ± standard deviation (SD) or standard error of the mean 
(SEM). Differences between two groups (e.g. untreated versus treated) were 
analysed for statistical significance using a Student’s t test. To analyse differences 
between multiple groups (e.g. different time points) one-way or two-way analysis of 
variance (ANOVA) followed by Newman-Keuls or Bonferroni multiple comparison 
test was used. P-values < 0.05 were considered to be statistically significant.  
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CHAPTER 3: EXPRESSION OF KEY ADHESION MOLECULES AND PRO-
INFLAMMATORY RECEPTORS ON PERICYTES IN VITRO 
 
3.1 INTRODUCTION 
Recruitment of leukocytes from the blood stream through the vessel wall to sites of 
infection is a crucial event in host defence during injury and infection. ECs and 
pericytes represent the two cellular components of postcapillary venular walls and 
together with the BM act as barriers for transmigrating leukocytes (Nourshargh et 
al., 2010). During inflammation the vessel wall becomes permeable to 
macromolecules and emigrating leukocytes. It is now well accepted that leukocyte 
transmigration is driven by interactions between adhesion molecules on immune 
cells and the endothelium or with the BM extracellular matrix (Hynes and Lander, 
1992; van der and Sonnenberg, 2001; Vestweber, 2002). However, mechanisms 
through which leukocytes interact with pericytes are unknown. This key issue was 
addressed as part of the present work.  
With respect to leukocyte-EC interaction, the importance of numerous adhesion 
molecules and their regulation during leukocyte transendothelial migration have 
been demonstrated recently (Ley et al., 2007). Pro-inflammatory mediators such as 
TNF and IL-1β are able to induce the expression, upregulation and/or re-localisation 
of endothelial adhesion molecules, a response which is known to stimulate 
leukocyte adhesion to venular ECs and regulate breaching of the EC barrier (Ley et 
al., 2007). Although the expression of adhesion molecules (such as ICAM-1 or 
VCAM-1) on primary pericytes in vitro has been demonstrated (Balabanov et al., 
1999; Maier and Pober, 2011; Verbeek et al., 1995), their regulation and role during 
inflammatory processes and leukocyte transmigration in vivo is less well studied. 
Work conduced in our laboratory has previously demonstrated that neutrophils 
preferentially transmigrate through gaps between adjacent pericytes, sites that are 
associated with regions of lower deposition of certain BM constituents (LERs) 
(Voisin et al., 2009; Voisin et al., 2010; Wang et al., 2006). Furthermore there is now 
evidence for the ability of neutrophils to crawl on capillary and arterial pericytes 
(Stark et al., 2013), but full details of the associated mechanism are unclear. One 
hypothesis addressed as part of the present work is that pericytes support leukocyte 
transmigration via the regulation of adhesion molecule expression on their surface, 
a response that supports leukocyte-pericyte interaction. In this chapter this 
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possibility was investigated in vitro, an approach that enabled the analysis of a wide 
range of molecules.  
Primary pericytes have been routinely obtained from bovine retinas, an organ where 
pericyte abundance is particularly high. However, emerging data indicate that 
pericytes are heterogeneous across different species and thus, might show species-
specific properties. Furthermore technical difficulties and the lack of specific 
markers for pericytes have hampered the isolation and culture of primary pericytes 
in the past. Therefore pericyte-like cell lines (e.g. C3H/10T1/2 cells) have been 
commonly used by some groups to analyse pericytes in vitro. Reznikoff et al. 
established the clonal cell line C3H/10T1/2, clone 8 from 14-to 17-day-old C3H 
mouse embryos in 1973 (Reznikoff et al., 1973). C3H/10T1/2 cells have been 
derived from whole embryos, so their tissue of origin is unknown. Due to functional 
similarities (they are able to differentiate into cells of myofibroblast or osteogenic cell 
lineages such as muscle, adipose, bone, or cartilage cells) (Pinney and Emerson, 
Jr., 1989), C3H/10T1/2 cells may represent mesenchymal stem cells. In most 
systems C3H/10T1/2 cells have been used as fibroblasts based on their functional 
and biochemical properties and morphology (Clemens et al., 2005; Thorsen et al., 
2003; Yauk et al., 2008). Cells from this cell line display a stellate fibroblast-like cell 
shape with several processes protruding from the body of the cell which remains 
stable for long periods in culture. However, C3H/10T1/2 cells also express markers 
for perivascular cells (e.g. αSMA and NG-2) and were shown to exhibit similar 
properties to those obtained from primary perivascular cells (Brachvogel et al., 
2007). Previous work from our group further demonstrated the ability of C3H/10T1/2 
cells to contract in response to inflammatory stimuli (TNF and IL-1β) similar to 
pericytes in vivo (Proebstl Doris, 2011). Therefore there is reason to propose that 
this cell line represents pericyte-/smooth muscle cell-like cells and as such have 
been used in this context in EC co-culture and vascular maturation studies (Darland 
and D'Amore, 2001; Hirschi et al., 1998; Walshe et al., 2009). 
Although C3H/10T1/2 cells may not represent “real” pericytes, this cell line provides 
a useful opportunity for the analysis of perivascular cell responses in vitro and 
circumvents significant limitations associated with most primary cells (e.g. difficulties 
in isolation, limited cell survival and differentiation in culture). Hence, C3H/10T1/2 
cells were used as pericyte-like cells in this chapter to investigate the expression 
and regulation of inflammatory relevant surface molecules on these cells. As part of 
this thesis, a new protocol was also established to isolate and select primary 
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pericytes from murine tissues and cells isolated with this method were analysed in 
preliminary works.  
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3.2 RESULTS 
3.2.1 Expression profile of receptors for pro-inflammatory mediators on 
C3H/10T1/2 cells 
Recent findings obtained within our laboratory have shown that TNF and IL-1β can 
activate blood vessels not only by stimulating ECs but also by acting on pericytes 
(Proebstl Doris, 2011). Specifically it was shown that post-capillary pericytes in vivo 
and C3H/10T1/2 cells in vitro exhibit shape-change in response to TNF and IL-1β. 
Evidence was obtained within our laboratory for the expression of TNF and IL-1 
receptors on pericytes in vivo (Proebstl et al., 2012). To extend this work, in 
preliminary experiments, the expression of TNFR I, TNFR II and IL-1R I was 
analysed on C3H/10T1/2 cells by flow cytometry. These experiments confirmed 
previous results obtained from our group (Proebstl Doris, 2011). 
C3H/10T1/2 cells were harvested from cell culture using EDTA. Cells in suspension 
were then fluorescently immunostained for TNFR I, TNFR II and IL-1R I and 
analysed by flow cytometry. Non-specific background staining was determined by 
staining cells with an isotype-matched goat IgG antibody. The results from both the 
specific mAbs and control antibodies were used to present immunoreactive antigen 
expression by relative fluorescent intensity (RFI). Flow cytometric analysis of at 
least 6 independent experiments revealed the expression of TNFR I, II and IL-1R I 
on the cell surface of C3H/10T1/2 cells (Figure 3.1). Mean RFI levels for IL-1R I 
were relatively low (1.8 ± 0.18), but significantly different when compared to isotype 
controls (goat IgG) (Figure 3.1b). Specificity of the anti IL-1RI antibody was further 
verified by Dr. Doris Proebstl using IL-1 receptor antagonist (IL-1ra) in the staining 
solution, which abolished IL-1RI receptor staining completely (Proebstl Doris, 2011). 
TNFR I and II, showed comparable RFI levels (5.6 ± 0.6, 5.6 ± 0.6, respectively).   
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Figure 3.1: C3H/10T1/2 cells express receptors for TNF and IL-1β. Cell-surface 
expression of IL-1R I, TNFR I and TNFR II on C3H/10T1/2 cells were analysed by flow 
cytometry. (a) Representative histogram plots show overlays of cells stained with anti-TNFR 
I, -TNFR II, or –IL1R I, respectively (green), and cells stained with an isotype-matched 
control antibody (red). These plots illustrate the number of events as percentage of the 
maximum number over a spectrum of increasing fluorescence intensity. (b) Data are 
presented as the relative fluorescence intensity (RFI) normalized to the isotype control. 
Therefore the dotted line illustrates the isotype control with an RFI of 1 by definition. Bars for 
IL-1R I, TNFR I and TNFR II, respectively, represent the mean ±SD of at least 6 
independent experiments per group. Significant expression levels as compared to the 
isotype control were determined using Student’s t-test. (**: p < 0.01; ***: p < 0.001) 
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3.2.2 Effects of TNF and IL-1β on expression of key adhesion molecules on 
C3H/10T1/2 cells 
TNF and IL-1β are well known to promote leukocyte transmigration by activating 
leukocytes and/or inducing the upregulation of adhesion molecules on ECs (e.g. 
ICAM-1, VCAM-1, E-Selectin). Having demonstrated in this chapter (section 3.2.1) 
and by Dr. Doris Proebstl (Proebstl Doris, 2011) that C3H/10T1/2 cells express 
receptors for these cytokines, the potential effect of TNF and IL-1β on adhesion 
molecule expression on this pericyte-like cells was next investigated.  
Initial studies were performed to assess the basal expression levels of certain 
adhesion molecules, including integrins, junctional adhesion molecule (JAMs) and 
cellular adhesion molecules (CAMs), on the surface of C3H/10T1/2 cells. In order to 
do this, C3H/10T1/2 cells were harvested from cell culture flasks using EDTA, 
fluorescently immunostained and analysed by flow cytometry. As negative control, 
cells were stained using the respective isotype control antibodies. Immunoreactive 
antigen expression was assessed in at least 3 independent experiments and 
presented as RFI. Flow cytometry analysis of resting C3H/10T1/2 cells showed 
significant expression of integrin subunits α1, α5, α6, β1 and β3, as well as JAM-A, -
B, -C, ICAM-1 and VCAM-1 under basal conditions. In contrast, no detectable levels 
of integrin subunits α2, α4 and β4, or ICAM-2, E-Selectin and VE-Cadherin could be 
quantified on these cells (Figure 3.2).  
To analyse the regulation of these adhesion molecules by pro-inflammatory 
cytokines, cells seeded in 6-well plates were treated with different concentrations of 
TNF (10 ng/ml and 100 ng/ml in PBS), IL-1β (1 ng/ml and 10 ng/ml in PBS) or PBS 
alone for 4 h. Cells were then washed with cold PBS and analysed by flow 
cytometry as described in the previous paragraph. Whereas the expression levels of 
the analysed integrins and JAMs remained unchanged following TNF or IL-1β 
stimulation of cells for 4 h (Figure 3.3a), ICAM-1 and VCAM-1 expressions were 
significantly up-regulated in response to the cytokines in a dose-dependent manner 
(Figure 3.3b).  
For a selection of molecules, the expression and distribution of adhesion molecules 
on C3H/10T1/2 cells was also analysed by immunofluorescent staining and confocal 
microscopy. For this purpose, C3H/10T1/2 cells were grown on 4-well chamber 
slides, fixed and co-stained with antibodies against adhesion molecules under 
investigation and the pericyte marker αSMA. To analyse also intracellular 
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expression of the proteins cells were permeabilised before staining. As a negative 
control, cells were stained using the respective isotype control antibody. The 
nucleus was visualized using the nuclear dye Draq5. Confocal microscopy of 
immunofluorescently labelled cells further confirmed the expression of integrin 
subunits α5, α6, β1 and β3, and VCAM-1 on unstimulated cells (Figure 3.4). In 
addition, focal adhesions could be observed for at least α5- and β1-integrin subunits 
(Figure 3.5), suggesting a functional implication of these molecules in binding to 
extracellular matrix proteins. 
In summary, these data demonstrate that C3H/10T1/2 cells are able to respond to 
the pro-inflammatory cytokines TNF and IL-1β. Furthermore, as the findings are in 
line with the limited level of in vivo data available (Proebstl et al., 2012), these 
studies also suggest that C3H/10T1/2 cells act as a useful tool to investigate a wider 
range of molecular pathways involved in pericyte responses in vitro. 
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Figure 3.2: Expression of key adhesion molecules on C3H/10T1/2 cells. Cell-surface 
expression of a diverse range of adhesion molecules on C3H/10T1/2 cells were analysed by 
flow cytometry. (a) Representative histogram overlays show the expression of integrin 
subunits α1, α5, α6, β1, β3, as well as JAM-A, JAM-B, JAM-C, ICAM-1 and VCAM-1, but not 
integrin subunits α2, α4, β4, and ICAM-2, E-Selectin and VE-Cadherin on pericyte-like cells 
in vitro. Specific staining is shown by the green line; isotype-matched control staining is 
shown by the red line. (b) Data are presented as the decimal logarithm of the RFI 
normalized to the isotype control. They represent the mean ±SD of at least 3 independent 
experiments per group. Significant expression levels as compared to the isotype control 
were determined using Student’s t-test. (*: p < 0.05; **: p < 0.01; ***: p < 0.001). ND, not 
detected. 
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 Figure 3.3: Regulation of expression of adhesion molecules on C3H/10T1/2 cells.  
Cells were cultured in the absence of inflammatory stimuli or treated with 1 or 10 ng/ml 
IL-1β or 10 or 100 ng/ml TNF for 4 h. Expression levels of adhesion molecules were 
assessed by flow cytometry analysis. (a) C3H/10T1/2 cells showed similar expression 
levels of integrin subunits α1, α2, α4, α5, α6, β1, β3, β4, and JAM-A, JAM-B, JAM-C, 
ICAM-2, VE-Cadherin and E-Selectin in PBS, IL-1β- or TNF-treated cells. (b) ICAM-1 
and VCAM-1 expression were upregulated on C3H/10T1/2 cells following IL-1β and TNF 
stimulation as compared to PBS controls. Data are presented as the RFI normalized to 
the isotype control and are displayed on a log (a) or linear (b) scale. They represent the 
mean ±SD of at least 3 independent experiments. Significant expression levels as 
compared to the isotype control (marked with asterisks) and differences between PBS 
control vs. TNF, IL-1β stimulation, respectively (marked with hashes) were determined 
using Student’s t-test. (* and #: p < 0.05; **: p < 0.01; ***: p < 0.001). 
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Figure 3.4: Expression pattern of adhesion molecules by C3H/10T1/2 cells. Cells were 
seeded on 4-well chamber slides, fixed, permeabilised and stained with antibodies against 
the pericyte marker αSMA (red), the nuclear dye Draq5 (blue) and specific antibodies against 
indicated adhesion molecules or matched isotype controls (green). Representative confocal 
images from 3 independent experiments are shown. Bars, 50 µm 
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Figure 3.5: Assembly of integrin adhesion structures in cultured C3H/10T1/2 cells. Cells 
were seeded on 4-well chamber slides, fixed, permeabilised and stained with antibodies 
against indicated adhesion molecules (green). Integrin clustering leads to assembly of 
adhesion structures (marked with arrowheads). Representative confocal images out of 3 
independent experiments are shown and are the same as shown in Figure 3.4. Bars, 50 µm 
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3.2.3 Isolation of primary pericytes 
To extend the results obtained with the pericyte-like cell line C3H/10T1/2 to a more 
physiological scenario, studies aimed at using primary pericytes were also initiated. 
For this purpose a new protocol was established to isolate pericytes from murine 
lung tissues.  
Characterisation of pericyte marker expression in different murine tissues 
Prior to isolation, the expression profile of different protein markers reported for 
pericytes was analysed in immunofluorescently labelled murine tissues (i.e. lung 
sections in comparison to whole-mount cremaster muscles) using confocal 
microscopy. The characterisation of marker expression on different pericyte subsets 
is important to be able to identify and sort isolated primary cells in a later step. For 
these experiments the lung was selected for investigation based on its high 
vascularisation and hence high abundance of pericytes.  
Lungs from WT animals were inflated by injecting low-melting point agarose via the 
trachea into the lung immediately after cervical dislocation. This was important to 
preserve the structure of the vasculature. Organs were fixed after removal from the 
thoracic cavity and sectioned at 200 μm using a vibratome. Subsequently, sections 
were co-stained using an anti-αSMA antibody together with antibodies against other 
pericyte markers. Whole mounted cremaster muscles removed from WT animals 
were used in parallel for comparative analysis. Confocal images were taken from 
different vessel types (e.g. arteries, venules, capillaries) that were identified using a 
number of criteria including vessel diameter and morphology of ECs and 
perivascular cells along the vasculature.  
αSMA is a commonly used marker to identify perivascular cells such as pericytes 
and SMCs (Armulik et al., 2011). This protein is a major constituent of the 
cytoskeleton and is involved in regulating cell motility, structure and integrity. 
Immunofluorescence staining of whole mounted murine cremaster muscles (Figure 
3.6) and lung sections (Figure 3.7) revealed a high intensity staining on SMCs 
surrounding arteries, arterioles, pre-capillary arterioles and large veins as 
characterised by a tightly wrapped perivascular morphology. High expression of 
αSMA was further detected on postcapillary and collecting venules, defined as 
vessels with a diameter between 25-50 µm and >50 μm, respectively and exhibiting 
notable gaps between adjacent pericytes. In contrast, pericytes on capillaries 
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showed hardly any αSMA staining. These results obtained with murine lung and 
cremaster muscle are in line with published reports by others, demonstrating the 
same expression pattern in multiple human organs and murine pancreatic tissues 
(Morikawa et al., 2002b; Nehls and Drenckhahn, 1991).  
Postcapillary pericytes were positively stained for PDGFR-β, as well as pericytes 
surrounding collecting venules and capillaries, and to a lesser extend SMCs of 
arterioles. The expression profile of PDGFR-β was similar in both cremaster muscle 
(Figure 3.6b) and lung tissues (Figure 3.7b). PDGFR-β has been shown to be 
expressed broadly by developing SMCs and pericytes in almost all organs (except 
the liver) (Hellstrom et al., 1999), and plays a crucial role in pericyte recruitment to 
the vessel wall, especially during embryonic development and angiogenesis 
(Armulik et al., 2011).  
NG-2 is a membrane-spanning chondroitin sulphate proteoglycan and is considered 
as one of the most reliable markers for pericytes (Hughes and Chan-Ling, 2004). 
NG-2-positive perivascular cells were associated with cells in vessel walls of 
capillaries, arteries and arterioles, but not postcapillary venules in the cremaster 
muscle (Figure 3.6b) and in lung sections (Figure 3.7b). Furthermore NG-2 staining 
was observed on nerves along vessels in the interstitial space. The present findings 
are consistent with results from a previous study by Murfee et. al., showing an 
absence of NG-2 expression in pericytes along postcapillary venules in rat lungs 
(Murfee et al., 2005).  
The intracellular protein smooth muscle 22-α (SM22α) is a marker of early 
differentiated SMCs and is highly expressed by isolated human umbilical artery 
SMCs (Maier et al., 2010). It was considered to be absent on pericytes (Maier and 
Pober, 2011). However, in in the present work SM22α labelling covered all mural 
cells of arterioles, venules and capillaries in the cremaster muscle (Figure 3.6b) and 
lung tissue (Figure 3.7b). Tissues stained with isotype-matched control antibodies 
showed no staining, indicating a true positive staining for PDGFR-β, NG-2 and 
SM22α (Figure 3.6b and 3.7b). 
Based on these findings, postcapillary pericytes were characterised as αSMA-, 
PDGFR-β- and SM22α-positive, but NG-2-negative cells. These markers therefore 
provide a useful tool to identify pericytes derived from postcapillary venules after 
isolation and were employed as such as detailed below. 
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Figure 3.6: Expression profile of pericyte markers in the cremaster muscle. 
Representative 3D-reconstructed confocal images from independent experiments show 
different blood vessel types in the murine cremaster muscle. Whole-mount cremaster 
muscles from unstimulated WT C57BL/6 mice were  double-stained for  αSMA (red) and the 
isotype control (a), PDGFR-β, NG-2 or SM22α (green) (b). A, arteriole; C, capillary; N, 
nerve; PCV, postcapillary venule. Bars, 50 μm. 
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Figure 3.7: Expression profile of pericyte markers in the lung. Representative 3D-
reconstructed confocal images from 3 independent experiments show different blood vessel 
types in the murine lung. Lung vibratome sections from unstimulated WT C57BL/6 mice 
were  double-stained for  αSMA (red) and the isotype control (a), PDGFR-β, NG-2 or SM22α 
(green) (b). A, arteriole; AC, alveolar capillary; PCV, postcapillary venule. Bars, 50 μm. 
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Characterisation of isolated lung perivascular cells  
Primary cells were obtained from mice expressing GFP under the promoter of 
αSMA using collagenase and trypsin digestion of lungs. Following enzymatic 
digestion larger tissue fragments and undigested tissue were removed by sieving 
the resulting solution through a nylon mesh. The flow-through including single cells 
and microvessel fragments was cultured in medium containing growth factors to 
support pericyte proliferation. Cells were characterised for their pericyte nature 
based on their morphology and marker expressions (described above) as assessed 
by a combination of bright field and fluorescence microscopy, and flow cytometry.  
GFP-positive vessel fragments and single cells could be detected directly after 
digestion from αSMA-GFP as compared to WT cell suspensions (Figure 3.8a). 
Cultured cells started to attach and spread on gelatine-coated plates by day 2, 
where cells showing a pericyte-like morphology with highly irregular peripheries and 
several protrusions could be observed (Figure 3.8b). In some cultures small EC 
colonies, characterised by a tightly packed, cobble-stone morphology were also 
present, which were seen only in the first few days in culture and disappeared later 
(Figure 3.8b, right). Cells started to proliferate within 5 to 7 days and a confluency of 
about 80-90% was typically visible within 14-20 days (Figure 3.8c). 
Using flow cytometry, cells isolated from αSMA-GFP mice and expanded in culture 
were analysed for pericyte, endothelial cell and leukocyte markers. Dead cells were 
excluded by 7-Aminoactinomycin D (7-AAD) staining (Figure 3.9a, left panel). A 
population of usually more than 50% was revealed exhibiting a strong fluorescent 
signal for GFP (Figure 3.9a, right panel). These αSMA-GFP+ cells further expressed 
PDGFR-β and lacked markers for leukocytes (CD45) and endothelial cells (CD31). 
36% of the αSMA-GFP+ population were also positive for NG-2, likely representing 
SMC and pericytes surrounding vessel types other than postcapillary venules 
(Figure 3.9b). Based on analyses of pericyte marker expression in lung sections as 
described before, α-SMA-EGFP+, PDGFR- β+, NG-2- cells were considered as 
postcapillary pericytes.  
Morphology and marker expression was shown to be sustained for at least 5 
passages, indicating that serially passaged primary cells continued to express a 
pericytic phenotype within this time frame.   
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Altogether, these findings outline a valuable method for isolating and culturing 
murine perivascular cells from lung vasculature of fluorescent αSMA-GFP mouse 
strain. Primary pericytes (α-SMA-EGFP+, PDGFR- β+, NG-2-) acquired using this 
protocol were analysed for cell surface expression of cytokine receptors as detailed 
below. 
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Figure 3.8: Isolated primary lung pericytes in culture. Representative phase contrast and 
corresponding fluorescent images of cultured primary cells isolated from lungs of αSMA-GFP 
C57BL/6 mice are shown. (a) GFP-positive vessel fragments (left panel) and single cells 
(right panel) were visible immediately after enzymatic digestion and culture. Mainly 
erythrocytes could be observed in the phase contrast displays. (b) Several processes were 
extending from the cell bodies of GFP-positive cells in 2-day old cultures (left panels), 
indicating adhesion and spreading of cells. Also small cobble-stone shaped endothelial cell 
colonies could be detected in 2-day old cultures, which were negative for GFP (right panels). 
(c) Confluency was typically reached between culture days 14-20, as shown here by phase 
contrast (left) and fluorescent overlay images (right) of an 18-day old culture. Bars, 50 µm. 
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Figure 3.9: Characterisation of cultured primary cells isolated from murine lungs. 
Primary cells were obtained from αSMA-GFP mice using enzymatic digestion of lungs and 
cultured for at least seven days.  The expression of cell-specific markers on their surface 
was analysed over five passages using flow cytometry. Representative flow cytometry data 
from cells at subculture 1 are shown. (a) Living cells were gated in dot plots upon incubation 
with 7-AAD (left). GFP/ FSC-H dot plot shows 62.9% GFP-positive cells (right). (b) 
Histogram overlays of cells gated in (a) (living and GFP-positive cells) show the expression 
of the pericyte marker PDGFR-β on cultured primary cells. Within the αSMA-GFP
+
 
population an NG-2-positive population of 35.68% of total cells could be detected. αSMA-
GFP
+
 cells lacked markers for leukocytes (CD45) and ECs (CD31). Specific staining is 
shown by the green line; isotype-matched control staining is shown by the red line. Similar 
results were obtained in six independent experiments. 
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3.2.4 Expression of receptors for TNF and IL-1β on isolated primary murine 
lung pericytes 
To further characterise pericytes isolated from lung microvessels, the expression of 
cytokine receptors and thus, their ability to directly respond to pro-inflammatory 
mediators was examined. For this purpose, the expression of TNF and IL-1β 
receptors, namely TNFR I, TNFR II and IL-1R I, respectively, were analysed on 
mixed primary cells isolated from αSMA-GFP mice between passage 0 and 5.  Co-
staining for NG-2 allowed us to identify pericytes derived from postcapillary venules, 
the site where leukocyte transmigration normally occurs during inflammation. 
Indeed, αSMA-GFP+, NG-2- pericytes expressed significant levels of TNFR I, TNFR 
II and IL-1R I as shown by flow cytometry analysis (Figure 3.10).  
Together with the results obtained from the pericyte-like C3H/10T1/2 cell line, these 
data further support the concept that pericytes are direct cellular targets for TNF and 
IL-1β, suggesting a functional role for pericytes in inflammation. 
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Figure 3.10: Primary murine lung postcapillary pericytes express receptors for TNF 
and IL-1β. Primary cells were obtained from αSMA-GFP mice using enzymatic digestion of 
lungs.  Cell-surface expression of IL-1R I, TNFR I and TNFR II was analysed over five 
passages using flow cytometry. Representative flow cytometry data from cells at subculture 
3 are shown. (a) An αSMA-GFP
+
 NG-2
-
 population was considered to represent pericytes 
derived from postcapillary venules and were gated in αSMA-EGFP/ NG-2-A647 dot blots 
(left).  Representative histogram plots show overlays of αSMA-GFP
+
 NG-2
-
 cells stained with 
anti-TNFR I, -TNFR II, or –IL1R I, respectively (green), and cells stained with an isotype 
matched antibody (red) (right panels). These plots illustrate the number of events as 
percentage of the maximum number over a spectrum of increasing fluorescence intensity. 
(b) Data are presented as the relative fluorescence intensity (RFI) normalized to the isotype 
control. Therefore the dotted line illustrates the isotype control with an RFI of 1 by definition. 
Bars for IL-1R I, TNFR I and TNFR II, respectively, represent the mean ±SD of 3 
independent experiments. Significant expression levels as compared to the isotype control 
were determined using Student’s t-test. (*: p < 0.05; **: p < 0.01) 
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3.3 DISCUSSION 
Migration of circulating leukocytes through venular walls to sites of inflammation is a 
crucial component of host immune response against pathogens and tissue injury. 
Although there is at present much interest in deciphering the mechanisms of 
leukocyte transendothelial migration, little attention has been paid to the analysis of 
the role of pericytes during leukocyte transmigration. In this chapter, a possible role 
for pericytes in supporting and facilitating leukocyte transmigration during 
inflammation was investigated in vitro. To address this question, the expression of 
key pro-inflammatory surface molecules on pericytes (including cytokine receptors 
and adhesion molecules) and the regulation of these molecules upon cytokine 
stimulation were investigated. To enable investigation of a wider range of molecular 
pathways, in vitro models were used involving the pericyte-like cell line C3H/10T1/2 
and primary murine pericytes. C3H/10T1/2 cells are widely used for analysis of 
pericyte responses in vitro as they show similar morphologies and properties to 
those shown by primary pericytes. To study these cells, flow cytometry and confocal 
microscopy were employed to investigate the expression of molecules of interest. 
In preliminary experiments the expression of receptors for the pro-inflammatory 
cytokines TNF and IL-1β, namely TNFR I and II, and IL-1R I, respectively, on 
C3H/10T1/2 cells were analysed in parallel with Dr. Doris Proebstl (Proebstl Doris, 
2011). As has been shown for postcapillary pericytes in the murine cremaster 
muscle in vivo (Proebstl et al., 2012), all 3 receptors could be detected on 
C3H/10T1/2 cells in vitro. A recent study performed by Stark et al. further showed 
the upregulation of TNFR I mRNA expression in human placenta pericytes 
stimulated with TNF and LPS (Stark et al., 2013). Biological functions of cytokines, 
chemokines and chemoattractants are mediated by receptors on the cell’s surface. 
ECs are known to express both TNFRs and IL1-R1 and to respond to TNF and IL-
1β. However, very little is known about the potential effects of these cytokines on 
pericytes. Recent data acquired from our group has shown that C3H/10T1/2 cells as 
well as mouse cremaster muscle pericytes of postcapillary venules in vivo exhibit 
shape change in response to TNF and IL-1β (Proebstl Doris, 2011). In these 
experiments, pericyte-shape change in vivo occurred even in the absence of 
neutrophils and evidence was presented for expressions of TNF and IL-1 receptors 
on pericytes. In line with these studies, data acquired in the present project 
confirmed the expression of cytokine receptors on C3H/10T1/2 cells, indicating that 
these cells have the potential to directly respond to TNF and IL-1β.  
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As a next step the expression and regulation of expression of key potential ligands 
for leukocytes on C3H/10T1/2 cells was investigated. To identify proteins with a role 
in inflammatory responses, changes in cell-surface expression of various adhesion 
molecules on the pericyte-like C3H/10T1/2 cells were investigated after TNF or IL-
1β stimulation. Cells were treated with different concentrations of either TNF (10 or 
100 ng/ml) or IL-1β (1 or 10 ng/ml) for the indicated length of time or were left 
untreated. Adhesion molecules that were analysed included integrins, junctional 
adhesion molecules (JAMs) and cellular adhesion molecules (CAMs). 
Immunoreactive antigen expression was assessed through quantifications of RFI or 
the percentage of positively stained cells. In this context, C3H/10T1/2 were found to 
express several integrins (α1, α5, α6, β1 and β3), JAMs (JAM-A, -B, -C) and cell 
adhesion molecules (ICAM-1 and VCAM-1) under basal conditions. In contrast, 
expression of integrin subunits α2, α4 and β4, as well as ICAM-2, E-Selectin and VE-
Cadherin could not be detected on C3H/10T1/2 cells.  
At present, few reports are published that demonstrate the expression of adhesion 
molecules on the surface of pericytes. In line with the present study, ICAM-1 
expression has been shown on murine post-capillary pericytes of the cremaster 
muscle (Proebstl et al., 2012) and capillary pericytes in the ear (Stark et al., 2013) in 
vivo, pericytes of brain tissue from multiple sclerosis patients ex vivo (Verbeek et al., 
1995) and primary pericytes isolated from rat brains (Balabanov et al., 1999), bovine 
retinas (Kowluru et al., 2010) and human placentas (Stark et al., 2013). VCAM-1 
expression on pericytes has been found on synovial tissue of patients with 
rheumatoid arthritis (Kriegsmann et al., 1995), brain tissues of multiple sclerosis 
patients (Verbeek et al., 1995), dermal tissue of patients with bullous pemphigoid 
(Dahlman-Ghozlan et al., 2004), primary rat (Balabanov et al., 1999) and human 
brain pericytes (Dahlman-Ghozlan et al., 2004). In contrast, cultured pericytes from 
human placentas did not express VCAM-1 under basal conditions or following 
stimulation with Interferon (IFN)-γ or TNF (Maier and Pober, 2011). In agreement 
with the present results using C3H/10T1/2 cells, E-Selectin expression could also 
not be detected in this study (Maier and Pober, 2011).  
Using an EC-pericyte coculture model α1, α3 and α6 integrin mRNA has been 
demonstrated to be expressed on bovine retinal pericytes in vitro, whereas 
expression of α2 and α4 could not be detected (Stratman et al., 2009). These 
findings support the data obtained in the present study. Adhesion molecules on 
pericytes represent possible interaction partners for ECs, adjacent pericytes, BM 
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components and transmigrating leukocytes. In this context, α1β1 integrin and α6β1 
integrin are known as collagen-, laminin-binding integrins, respectively (Humphries 
et al., 2006). α5β1 and αVβ3 integrins bind RGD (arginine-glycine-aspartic acid)-
containing soluble and ECM molecules (e.g. fibronectin, vitronectin, fibrinogen, 
thrombospondin, osteopontin and laminins) (Ruoslahti, 1996). Members of the JAM 
family have a role in leukocyte transmigration and are involved in EC junction 
assembly (Bazzoni, 2003). Hence, JAMs on pericytes might possess similar 
function by binding to ligands in a homophilic (JAMs expressed by adjacent 
pericytes and/or ECs), and heterophilic way (LFA-1, αLβ2 integrin; VLA-4, α4β1 
integrin; Mac-1; αMβ2 integrin expressed on leukocytes), as has been shown for 
JAMs on ECs (Bazzoni, 2003; Bradfield et al., 2007).  Pericytes might also interact 
with leukocytes through their expressions of ICAM-1 and VCAM-1, and adhesion 
molecules on leukocytes that bind ICAM-1 or VCAM-1 are LFA-1 and Mac-1, or 
VLA-4 (Ley et al., 2007).  
The overall role of adhesion molecules on pericytes, however, is not well 
understood. A key hypothesis of this study was that pro-inflammatory cytokines 
such as TNF and IL-1β stimulate the expression of proteins necessary for leukocyte 
interaction on pericytes and that this  may mediate leukocyte adhesion and 
transmigration through gaps between adjacent pericytes. Interestingly, whilst the 
expression levels of integrins and JAMs did not change following TNF or IL-1β 
stimulation, ICAM-1 and VCAM-1 were highly up-regulated in response to the 
cytokines. These results are in agreement with results by others showing the 
upregulation of both molecules by pericytes following stimulation with inflammatory 
mediators such as TNF or IFN-γ (Balabanov et al., 1999; Maier and Pober, 2011; 
Verbeek et al., 1995; Stark et al., 2013). ICAM-1 appears to facilitate neutrophil 
intravascular crawling through interaction with leukocyte Mac-1 (Phillipson et al., 
2006). Thus, pericytic ICAM-1 might have a potential role during transmigration of 
leukocytes through the pericyte sheath. Indeed, confocal IVM experiments 
conducted within our group indicate that after transendothelial migration neutrophils 
crawl along pericyte processes in an ICAM-1 dependent-manner (Proebstl et al., 
2012). Blocking antibodies against ICAM-1 diminish abluminal crawling of 
leukocytes to preferred sites of transmigration through pericyte gaps. However, the 
inhibitory effect of ICAM-1 blocking antibodies was not absolute, indicating a role for 
other pericyte-associated adhesion molecules in facilitating neutrophil sub-
endothelial transmigration. Although  VCAM-1 on pericytes has been suggested to 
have a role in facilitating T-cell adhesion and migration during multiple sclerosis as 
103 
 
demonstrated in a study using human brain perictytes in vitro (Verbeek et al., 1995), 
at present nothing is known about the role of pericyte VCAM-1 in vivo or a role for 
pericyte VCAM-1 in innate immune responses.  In addition to guiding leukocytes to 
exit sites in venular walls, ICAM-1 on capillary and arteriolar pericytes in the mouse 
ear has recently been shown to navigate interstitial leukocyte migration to sites of 
sterile inflammation (Stark et al., 2013). Hence, in line with the well accepted roles 
of ICAM-1 and VCAM-1 in supporting leukocyte adhesion, these findings suggest an 
active participation of pericytes in leukocyte migration in inflammation in vivo.  
At this point, however, it needs to be emphasised that C3H/10T1/2 cells, being 
isolated from mouse embryos (Reznikoff et al., 1973), may not represent “real” 
pericytes, but rather mesenchymal stem cells. Hence, these cells might behave 
differently than pericytes and data obtained with C3H/10T1/2 cells need to be 
interpreted with caution. As such, to complement the results obtained with these 
cells with a more physiological approach, as part of this work a protocol was 
established for the isolation and culture of primary mouse pericytes.  
Pericytes have to date been isolated from different species (bovine, mouse, rat, 
human) and tissues (brain, retina, lung, placenta) (Brachvogel et al., 2005; Doherty 
and Canfield, 1999; Khoury and Langleben, 1996; Maier et al., 2010; Schor et al., 
1995). However, technical difficulties in isolation and characterisation of pericytes 
due to a lack of a universal specific pericyte marker has made isolation of primary 
pericytes difficult. Several pericyte markers have been reported in the literature, 
including αSMA, NG-2, PDGFR-β and desmin. However, the expression of these 
molecular markers is not necessarily cell-type specific and are not specific to all 
pericytes. For example NG-2, has been shown to be expressed by capillary 
pericytes but not by postcapillary pericytes (Murfee et al., 2005). Furthermore NG-2 
is also expressed on vSMCs and neuronal cells (Grako and Stallcup, 1995; Levine 
and Nishiyama, 1996; Murfee et al., 2005) suggesting that NG-2 alone is not a 
reliable pericyte marker as previously suggested (Hughes and Chan-Ling, 2004). 
Furthermore, pericytic expression of these markers varies depending on the type of 
vessels, tissue and changes under different pathological conditions (Chan-Ling et 
al., 2004; Gerhardt et al., 2000; Hughes and Chan-Ling, 2004). In previous studies, 
the employed methods of pericyte purification have mostly relied on selective 
adherence properties and morphological characteristics of the cell populations 
isolated from pericyte-rich tissues. Thus, the nature of the specific cell type isolated 
was unclear and likely represented a mixture of perivascular cells including SMCs 
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and other mesenchymal cells. Therefore the understanding of the expression profile 
of pericyte markers within the microvascular network in relation to location and 
morphology of the cells is critical to identify pericytes and isolate them.  
In the present study a detailed marker analysis of perivascular cells in the lung and 
cremaster muscle was carried out prior to isolation. Murine lungs were chosen as a 
source of pericytes based on their relatively high pericyte density. Although tissues 
of the blood-brain-barrier (i.e. brain, retina) are generally regarded as the sites of 
highest pericyte abundance (Mathiisen et al., 2010; Sims, 1986), cells from these 
organs are likely to exhibit organo-specific properties due to the specialised function 
of the central nervous system. 
The expression profile of pericyte markers was analysed on immunofluorescently 
labelled lung sections and whole-mounted cremaster muscles using confocal 
microscopy. Pericytes surrounding postcapillary venules and collecting venules as 
well as SMCs surrounding arterioles, arteries and veins were highly positive for 
αSMA, whereas capillary pericytes showed hardly any αSMA staining. These results 
were in line with previous studies using bovine retina, rat mesentery and mouse 
pancreas (Nehls and Drenckhahn, 1991). Other perivascular cell markers include 
PDGFR-β and SM22α, which were both expressed in cremasteric postcapillary 
venular pericytes, whilst NG-2 was only present on capillary pericytes and SMCs, 
and not on postcapillary pericytes, as previously described in rat tissues (Murfee et 
al., 2005). The expression profile of the analysed pericyte markers was similar in 
lung and cremaster tissues. Hence, primary postcapillary pericytes in a mixed 
population of isolated lung cells were identified as αSMA+, PDGFR-β+, SM22α+, NG-
2- cells. Primary cells were isolated by enzymatic digestion of murine lungs and 
expanded in culture for up to five passages. Indeed, phenotypic characterisation of 
these cells in vitro by flow cytometry revealed a postcapillary pericyte-like population 
that lacked markers for ECs (CD31) and leukocytes (CD45). Furthermore, isolated 
primary pericytes expressed receptors for the pro-inflammatory cytokines TNF and 
IL-1β as shown by immunofluorescence staining for TNFR I, II and IL1R I and flow 
cytometry analysis.  
The similarities of protein marker expression of the isolated cells cultured in vitro 
and pericytes in vivo strongly indicate that these cells retain a pericyte-like 
phenotype in culture for at least five passages and therefore represent a unique and 
relatively simple tool for studies of these cells in vitro. However, it needs to be 
considered that pericytes might differentiate with increasing passage number and 
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significantly change their phenotype, a phenomenon that has been shown for many 
other primary cells, such as SMCs (Orlidge and D'Amore, 1986). Another concern of 
this method is the presence of contaminating cell populations, especially SMCs and 
fibroblasts. It is therefore necessary to positively and negatively sort these cells from 
primary tissue digests or serially propagated cultures (with magnetic beads or flow 
cytometry cell sorting) prior to their use in assays. Furthermore, it is important to 
understand that pericytes derived from different tissues –similar to many other cell 
types- might exhibit organo-typic properties and thus behave differently in culture 
and different research models. Nevertheless, the method described here provides a 
novel and relatively simple way to identify postcapillary pericytes from a mixed 
culture of isolated cells. The use of NG-2 to distinguish between SMCs and 
postcapillary venular pericytes represents a novel and useful approach to gain a 
clean pericyte population and study these cells in vitro.  
In summary, the results presented in this chapter suggest that IL-1β and TNF can 
act directly on pericytes as shown by the expression of IL-1R I, TNFR I and TNFR II 
by pericyte-like cells and primary pericytes in vitro. Indeed, receptor expression for 
these cytokines has also been found on pericytes in vivo (Proebstl et al., 2012; 
Stark et al., 2013). Furthermore, the present findings show that pericytes express 
adhesion molecules in vitro that can be upregulated by pro-inflammatory cytokines, 
suggesting an active participation of pericytes in the regulation of an inflammatory 
response. In vivo evidence has been obtained for the ability of TNF to induce 
expression of ICAM-1 and chemokines on pericytes, responses that facilitate 
neutrophil transmigration (Proebstl et al., 2012; Stark et al., 2013). Furthermore, 
cytokines such as TNF and IL-1β have been reported to induce pericyte shape 
change in vitro (Proebstl et al., 2012) and in vivo (Proebstl et al., 2012; Wang et al., 
2012). Hence, pericytes are able to actively respond to TNF and IL-1β in a number 
of models. This represents a novel mechanism through which these cytokines could 
exert their pro-inflammatory effects. To extend these findings to other types of 
inflammatory stimuli, the next chapter focused on the impact of neutrophil 
chemoattractants on pericyte morphology and function. 
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CHAPTER 4: CHEMOATTRACTANT-INDUCED PERICYTE SHAPE 
CHANGE IN VIVO 
 
4.1 INTRODUCTION 
Despite our improved understanding of transendothelial migration of leukocytes, the 
mechanism whereby immune cells breach the pericyte sheath in vivo remains 
elusive. Studies showing the expression of adhesion molecules such as ICAM-1 
and VCAM-1 on pericytes (Balabanov et al., 1999; Dahlman-Ghozlan et al., 2004; 
Kowluru et al., 2010; Kriegsmann et al., 1995; Maier and Pober, 2011; Proebstl et 
al., 2012; Stark et al., 2013; Verbeek et al., 1995) (discussed in chapter 3) strongly 
suggest the participation of these mural cells in the recruitment of leukocytes. In 
addition, in vivo 3D data obtained within our laboratory has been shown that 
neutrophils preferentially breach the pericyte sheath through gaps between adjacent 
cells (Wang et al., 2006).  More recently, these sites have been shown to transiently 
enlarge in response to TNF and IL-1β (Proebstl et al., 2012; Wang et al., 2012). 
Hence, we hypothesise that pericyte shape change might facilitate leukocyte 
transmigration through a yet unknown mechanism.  
TNF- and IL-1β-induced pericyte gap enlargement in postcapillary venules of the 
cremaster muscle, as induced by local injection of the cytokines, is independent of 
the presence of neutrophils (Proebstl Doris, 2011; Proebstl et al., 2012). The aim of 
this chapter was to extent these findings to different types of inflammatory 
mediators. In the present study, pericyte shape change was analysed in conditions 
when inflammation was induced by potent neutrophil chemoattractants, namely 
LTB4, KC, C5a and fMLP. In contrast to cytokines, which are well known to act 
directly on vessel wall components such as ECs (Dinarello, 2000), the primary 
target of chemoattractants is leukocytes (Adams and Lloyd, 1997). In fact, 
chemoattractants provide directional cues for these cells and hence, allow 
leukocytes to rapidly migrate towards the site of inflammation. Chemoattractant 
signals are released endogenously by cells of the immune system and tissue cells 
upon activation or derived directly from bacterial sources. They are associated with 
the ability to stimulate specific leukocyte subtypes via primarily G-protein coupled 
receptors (GPCRs) (Adams and Lloyd, 1997). The main neutrophil 
chemoattractants include “intermediate” chemoattractants including endogenous 
lipids such as leukotriene B4 (LTB4), and CXC chemokines such as 
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CXCL1/keratinocyte-derived chemokine (KC) and CXCL2/monocyte-inhibitory 
protein-2 (MIP-2) and “end-target” chemoattractants such as bacterial peptides (e.g. 
formyl-methionyl-leucyl-phenylalanine (fMLP)) and components of the complement 
cascade (such as C5a) (Phillipson and Kubes, 2011). These different types of 
chemoattractants provide a multistep hierarchy of directional cues, with endothelial- 
and immune-derived intermediate chemoattractants as the first molecular guidance 
signals regulating directional neutrophil crawling, followed by a prioritised gradient of 
short-range cues secreted by pathogens (i.e. end-target chemoattractants). 
Chemoattractants act through their respective receptor on target cells, which are all 
related to the large family of seven-transmembrane-domain rhodopsin-like G 
protein-coupled receptors (Murphy, 1994). Besides broadly overlapping roles in 
inducing chemotaxis and adhesion of leukocytes, chemoattractants may have 
specialised functions in regulating inflammatory responses by stimulating leukocyte 
degranulation. 
In the present chapter, the effect of the neutrophil chemoattractants LTB4, KC, C5a 
and fMLP on pericyte morphology was analysed in vivo. For this purpose, the 
murine cremaster muscle was used. Tissue infiltration of neutrophils and pericyte 
shape change were analysed ex vivo by wholemount immunostaining using specific 
markers for neutrophils and pericytes (MRP-14 and αSMA, respectively), and 
viewed by confocal microscopy. 
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4.2 RESULTS 
4.2.1 Effect of neutrophil chemoattractants on pericyte morphology in 
cremasteric postcapillary venules 
To analyse the effect of LTB4, KC, C5a and fMLP on pericyte morphology, 
cremaster muscles were stimulated locally by i.s. injection. Initial experiments were 
performed to establish optimal experimental conditions including doses of the 
respective chemoattractant and/or duration of cremaster muscle stimulation.  
The initial doses used for LTB4, KC, and fMLP in this study were selected based on 
previous experiments from our group at which significant leukocyte transmigration is 
elicited in the murine cremaster muscle. In preliminary experiments, the in vivo test 
period for these chemoattractants was established in which a significant change in 
pericyte morphology could be observed. To induce local inflammation in the 
cremaster muscle, 30 ng LTB4, 500 ng KC, or 5 μg fMLP in 300 μl PBS were 
injected into WT C57BL/6 mice by i.s. injection. 300 μl PBS alone was used as 
control. After an in vivo test period of 2 or 4 h, cremaster muscles were dissected 
away from the mice, fixed in 4% PFA and immunostained for pericytes and 
leukocytes using specific markers (αSMA, MRP-14, respectively). Whole-mounted 
immunofluorescently labelled tissues were then analysed for neutrophil infiltration 
and pericyte-shape change using confocal microscopy and ImageJ, IMARIS, 
respectively (as described in section 2.3.8). Some tissues treated with KC for 4 h 
were prepared by Dr. Mathieu Benoit-Voisin and Amar Ladwa. Independent 
experiments were performed at least 4 times.  
Local injection of LTB4, KC, and fMLP induced neutrophil transmigration responses 
that were very low and/or absent in PBS-treated controls (Figure 4.1). Significant 
LTB4-induced neutrophil extravasation could be detected 4 h post injection (Figure 
4.1b, left). Both, KC and fMLP elicitated neutrophil transmigration within 2 h of 
stimulation, which was sustained up to 4 h post injection (Figure 4.1b, middle and 
right). 3D-reconstruced confocal images of postcapillary venules further showed that 
this response was associated with a change in pericyte morphology as seen 
through enlargement of gaps between adjacent pericytes (Figure 4.2a, 4.3a and 
4.4a). LTB4 and fMLP stimulation induced significant increase in mean gap size by 4 
h post injection as compared to control samples (Figure 4.2b, 4.4b, respectively). 
Mean gap size under control conditions (PBS) was 7.2 ± 0.26 µm2. Local injection of 
LTB4 and fMLP (both for 4 h) resulted in a mean gap size between adjacent 
109 
 
postcapillary pericytes of 13 ± 0.32 µm2, 12.54 ± 0.96 µm2, respectively. In contrast, 
gap enlargement between adjacent pericytes induced by KC occurred at an earlier 
time point as a significant increase could be detected 2 h after injection (mean gap 
size: 12.47 ± 0.6 µm2; Figure 4.3b). Furthermore the effect of these 
chemoattractants on the gap density of adjacent pericytes was assessed as defined 
by the average number of gaps per vessel area (per 1 mm2). The average gap 
density of PBS-treated cremaster muscles was 6.649 ± 1.979 gaps/mm2 and did not 
significantly change upon stimulation with LTB4, KC, and fMLP at all time points 
investigated (Figure 4.2b, 4.3b and 4.4b).  
As no reference point for C5a was available in this model, a dose-response curve 
for C5a to elicit leukocyte transmigration was established. WT C57BL/6 mice 
received either 100, 300 or 1000 ng C5a in 300 µl PBS or 300 µl PBS alone i.s. 4 h 
after injection, cremaster muscles were dissected away from the mice, fixed and 
whole mount tissues were used for immunofluorescence labelling and confocal 
microscopy as described above. Significant increases in neutrophil transmigration 
were detected with 300 and 1000 ng C5a, but not 100 ng (Figure 4.5), thus the dose 
of 300 ng/ 300 μl PBS was used for quantifications of pericyte gaps. As seen in 3D-
reconstruced confocal images of postcapillary venules this dose also provoked a 
significant enlargement of gaps between adjacent pericytes with a mean gap size of 
13.64 ± 0.52 µm2 at 4 h post injection (Figure 4.6). As seen with LTB4, KC and 
fMLP, local injection of C5a had no effect on pericyte gap density in this model 
(Figure 4.6b, right). 
In summary, all tested chemoattractants induced pericyte shape change resulting in 
significant increases in gap size between adjacent cells with an average of 80% as 
compared to control animals. In contrast, but in agreement with our previous 
results(Proebstl et al., 2012; Voisin et al., 2010), the average gap density did not 
significantly change in stimulated tissues (~6600 gaps per mm2 of vessel surface). 
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Figure 4.1: LTB4-, KC- and fMLP-induced neutrophil transmigration. Cremaster muscles 
of WT C57BL/6 mice were treated with LTB4 (30ng), KC (500 ng), fMLP (5 µg) or PBS and 
were dissected away 2 or 4 h after i.s. injections. Tissues were fixed, immunostained for 
pericytes (αSMA, red) and neutrophils (MRP-14, blue) and analysed for transmigrated 
neutrophils by confocal microscopy and IMARIS. (a) Representative 3D-reconstructed 
confocal images of post-capillary venules in PBS-, LTB4-, KC- and fMLP-stimulated 
cremaster muscles illustrating neutrophil responses are shown. Bars, 20 μm. (b) The number 
of extravasated neutrophils adjacent to 200 μm vessel segments and within 50 μm away 
from the vessel (0.02 mm
2
 area) was quantified in images of 2 or 4 h treated tissues. White 
Bars represent control samples (PBS, 2 and 4 h pooled together) and grey bars correspond 
to stimulated tissues (LTB4, KC or fMLP, for 2 or 4 h). At least 6 vessel segments per mouse 
(3 per cremaster) were analysed and plotted as mean per mouse. Data are represented as 
the mean ±SEM of at least 4 mice per condition. Significant differences between groups 
were determined using one-way ANOVA and Neuman-Keuls multiple comparison test. 
Differences compared to PBS control are indicated by * (p < 0.05), ** (p < 0.01) and *** (p < 
0.001). 
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Figure 4.2: LTB4-induced changes in pericyte gaps. Changes in pericyte gap size and 
density were quantified in 3D-reconstruced confocal images of cremaster muscles stimulated 
with LTB4 or PBS for 2 or 4 h using ImageJ. Images used for analysis were the same as 
analysed for Figure 4.1. (a) Representative 3D-reconstructed confocal images of post-
capillary venules in PBS- or LTB4 (30 ng)-stimulated cremaster muscles illustrate neutrophils 
(blue) and pericytes (red) with gaps between adjacent cells. The right panels show 
magnifications of the αSMA channel of the region outlined in the left panels. Bars, 20 μm. (b) 
Pericyte gaps were quantified for their size (left graph) and density (right graph) in 200 μm 
vessel segments of 2 and 4 h treated tissues. White Bars represent control samples (PBS, 2 
and 4 h pooled together) and grey bars correspond to LTB4- stimulated tissues. At least 6 
vessel segments per mouse (3 per cremaster) were analysed and plotted as mean per 
mouse. Data are represented as the mean ±SEM of at least 4 mice per condition. Significant 
differences between groups were determined using one-way ANOVA and Neuman-Keuls 
multiple comparison test. Differences compared to PBS control are marked with asterisks. 
Differences between time points were marked with hashes. (*** and  ###: p < 0.001) 
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Figure 4.3: KC-induced changes in pericyte gaps. Changes in pericyte gap size and 
density were quantified in 3D-reconstruced confocal images of cremaster muscles stimulated 
with KC (500 ng) or PBS for 2 or 4 h using ImageJ. Images used for analysis were the same 
as analysed for Figure 4.1. (a) Representative 3D-reconstructed confocal images of post-
capillary venules in PBS- or KC-stimulated cremaster muscles illustrate neutrophils (blue) 
and pericytes (red) with gaps between adjacent cells. The right panels show magnifications 
of the αSMA channel of the region outlined in the left panels. Bars, 20 μm. (b) Pericyte gaps 
were quantified for their size (left graph) and density (right graph) in 200 μm vessel segments 
of 2 and 4 h treated tissues. White Bars represent control samples (PBS, 2 and 4 h pooled 
together) and grey bars correspond to KC- stimulated tissues. At least 6 vessel segments per 
mouse (3 per cremaster) were analysed and plotted as mean per mouse. Data are 
represented as the mean ±SEM of at least 4 mice per condition. Significant differences 
between groups were determined using one-way ANOVA and Neuman-Keuls multiple 
comparison test. Differences compared to PBS control are marked with asterisks. 
Differences between time points were marked with hashes. (*: p < 0.05; *** and  ###: p < 
0.001) 
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Figure 4.4: fMLP-induced changes in pericyte gaps. Changes in pericyte gap size and 
density were quantified in 3D-reconstruced confocal images of cremaster muscles stimulated 
with fMLP (5 µg) or PBS for 2 or 4 h using ImageJ. Images used for analysis were the same 
as analysed for Figure 4.1. (a) Representative 3D-reconstructed confocal images of post-
capillary venules in PBS- or fMLP-stimulated cremaster muscles illustrate neutrophils (blue) 
and pericytes (red) with gaps between adjacent cells. The right panels show magnifications 
of the αSMA channel of the region outlined in the left panels. Bars, 20 μm. (b) Pericyte gaps 
were quantified for their size (left graph) and density (right graph) in 200 μm vessel segments 
of 2 and 4 h treated tissues. White Bars represent control samples (PBS, 2 and 4 h pooled 
together) and grey bars correspond to fMLP- stimulated tissues. At least 6 vessel segments 
per mouse (3 per cremaster) were analysed and plotted as mean per mouse. Data are 
represented as the mean ±SEM of at least 4 mice per condition. Significant differences 
between groups were determined using one-way ANOVA and Neuman-Keuls multiple 
comparison test. Differences compared to PBS control are marked with asterisks. 
Differences between time points were marked with hashes. (##: p < 0.01; ***: p < 0.001) 
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Figure 4.5: C5a-induced neutrophil transmigration. Cremaster muscles of WT C57BL/6 
mice were treated with 100, 300, or 1000 ng C5a in 300 μl PBS or PBS alone and dissected 
4 h after i.s. injections. Tissues were fixed, immunostained for pericytes (αSMA, red) and 
neutrophils (MRP-14, blue) and analysed for neutrophil transmigration by confocal 
microscopy and IMARIS. (a) Representative 3D-reconstructed confocal images of post-
capillary venules in PBS- and 300 ng C5a- treated cremaster muscles illustrating neutrophil 
responses are shown. Bars, 20 μm. (b) The number of extravasated neutrophils adjacent to 
200 μm vessel segments and within 50 μm away from the vessel (0.02 mm
2
 area) was 
quantified using images of tissues treated with PBS or 100, 300, or 1000 ng C5a for 4 h. A 
dose-response curve is shown. At least 6 vessel segments per mouse (3 per cremaster) 
were analysed and plotted as mean per mouse. Data are represented as the mean ±SEM of 
3 mice per condition. Significant differences between groups were determined using one-way 
ANOVA and Neuman-Keuls multiple comparison test. Differences compared to PBS control 
are indicated by *** (p < 0.001). 
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Figure 4.6: C5a-induced changes in pericyte gaps. Changes in pericyte gap size and 
density were quantified in 3D-reconstruced confocal images of cremaster muscles stimulated 
with 300 ng C5a or PBS for 4 h using ImageJ. Images used for analysis were the same as 
analysed for Figure 4.5. (a) Representative 3D-reconstructed confocal images of post-
capillary venules in PBS- or C5a-stimulated cremaster illustrate neutrophils (blue) and 
pericytes (red) with gaps between adjacent cells. The right panels show magnifications of the 
αSMA channel of the region outlined in the left panels. Bars, 20 μm. (b) Pericyte gaps were 
quantified for their size (left graph) and density (right graph) in 200 μm vessel segments of 4 
h treated tissues. White Bars represent control samples (PBS) and grey bars correspond to 
C5a- stimulated tissues. At least 6 vessel segments per mouse (3 per cremaster) were 
analysed and plotted as mean per mouse. Data are represented as the mean ±SEM of 3 
mice per condition. Significant differences between groups were determined using one-way 
ANOVA and Neuman-Keuls multiple comparison test. Differences compared to PBS control 
are indicated by *** (p < 0.001) 
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4.2.2 Time course of LTB4-induced changes in pericyte morphology  
To characterise the effect of chemoattractants on pericytes in more detail, time 
course experiments of LTB4-induced pericyte shape change was analysed. 
Inflammation was induced locally by intrascrotal injection of 30ng LTB4 in 300 μl 
PBS for 2, 3, 4, 6, 8, 24, 48 and 72 h. Control mice received 300 μl PBS alone. 
Pericyte shape change was analysed ex vivo by wholemount immunostaining and 
confocal microscopy as described before. At least 3 independent experiments were 
performed for each treatment. 
LTB4 stimulation led to a gradual and time-dependent increase in mean gap size 
between 2-8 h after injection of the stimulus as compared to control samples (Figure 
4.7, left). Although not significant, a change in pericyte gap size was already noted 
at 2 h post LTB4 injection (p > 0.05), resulting in a mean gap size of 8.95 ± 0.62 μm
2 
and a 24% increase as compared to PBS-injected control tissues. Maximum gap 
size was achieved within 4 h of LTB4 treatment (13 ± 0.32 μm
2 and 80% increase as 
compared to controls). This response was transient and time points beyond 4 h 
indicated a time-dependent decrease of the size of αSMA-negative areas. Pericyte 
gap size returned to basal levels by 48 h of LTB4 stimulation (6.03 ± 0.82 μm
2). The 
average gap density of PBS-treated cremaster muscles was 7,649 ± 1,979 
gaps/mm2 and did not significantly change upon LTB4 stimulation at all time points 
investigated (Figure 4.7, right). 
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Figure 4.7: LTB4 induces a time-dependent change in pericyte gap size. Changes in 
pericyte morphology were quantified in 3D-reconstruced confocal images of cremaster 
muscles stimulated with LTB4 (30 ng) or PBS for the indicated in vivo test period using 
ImageJ. Pericyte gaps were quantified for their size (left graph) and density (right graph) in 
200 μm vessel segments. White Bars represent control samples (PBS, 2-72h pooled 
together) and grey bars correspond to LTB4-stimulated tissues. At least 4 vessel segments 
per mouse were analysed and plotted as mean per mouse. Data are represented as the 
mean ±SEM of at least 3 mice per time point. Significant differences between groups were 
determined using one-way ANOVA and Neuman-Keuls multiple comparison test. 
Differences compared to PBS control are marked with asterisks. Differences between time 
points were marked with hashes. (**: p < 0.01, ***: p < 0.001, #: p < 0.05, ##: p < 0.01, ###: 
p < 0.001) 
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4.2.3 Profile of neutrophil transmigration in relation to pericyte gap 
enlargement 
Notably, increased pericyte gap size was associated with an increase in neutrophil 
transmigration. To compare the time course of neutrophil transmigration in relation 
to pericyte gap size in more detail, the same confocal images of post-capillary 
venules as analysed in the previous section (section 4.2.2) were also analysed for 
extravasated neutrophils (MRP-14 positive cells).  
At base line conditions (PBS treatment), only few MRP-14-positive cells were found 
within the tissue (Figure 4.8, left). Similar to pericyte gap enlargement, i.s. injection 
of 30 ng LTB4 elicited neutrophil infiltration in a time-dependent manner starting 
within 2 h and a peak at 4 h post injection. Time points beyond 4 h indicated a 
gradual decrease in the neutrophil transmigration response. Although not 
statistically significant (likely because of a high variability and relatively low n-
number), it appears that neutrophils are present within the tissue up to 24 h. Data 
presented here demonstrate that both, pericyte gap opening and neutrophil 
transmigration peaked at similar time points (4 h post injection of LTB4) before 
returning back to basal levels by 48 h (Figure 4.8). The comparable time frames of 
these responses suggest a correlation between neutrophil recruitment and pericyte 
shape change. Thus, the contribution of neutrophils to chemoattractant-induced 
morphological changes of cremaster muscle venular pericytes was analysed as 
detailed in the following chapter (chapter 5). 
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                 Neutrophil transmigration               Pericyte gap size 
 
Figure 4.8: Time course of LTB4-induced neutrophil transmigration and pericyte shape 
change. Neutrophil and pericyte responses were quantified in 3D-reconstruced confocal 
images of cremaster muscles stimulated with LTB4 (30 ng) or PBS for the indicated in vivo 
test period using ImageJ. Images used for analysis were the same as those analysed for 
Figure 4.7. The number of extravasated neutrophils was quantified adjacent to 200 μm 
vessel segments and within 50 μm away from the vessel (0.02 mm
2
 area) (left). White Bars 
represent control samples (PBS, 2-72 h pooled together) and grey bars correspond to LTB4-
stimulated tissues. At least 4 vessel segments per mouse were analysed and plotted as 
mean per mouse. Data are represented as the mean ±SEM of at least 3 mice per time point. 
Significant differences between groups were determined using one-way ANOVA and 
Neuman-Keuls multiple comparison test. Differences compared to PBS control are marked 
with asterisks. Differences between time points were marked with hashes. (**: p < 0.01, ***: p 
< 0.001, #: p < 0.05, ##: p < 0.01, ###: p < 0.001) 
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4.3 DISCUSSION 
Data acquired in chapter 3 demonstrated that pericyte-like cells are able to respond 
to pro-inflammatory cytokines (TNF and IL-1β) by inducing the upregulation of 
adhesion molecules on their surface. This result suggests that pericytes might be 
able to directly interact with transmigrating leukocytes and thereby facilitate their 
penetration of the pericyte sheath. Supporting this idea, leukocytes have been 
shown to migrate on the abluminal side of ECs along pericyte processes for a 
significant amount of time in an ICAM-1-dependent manner, before breaching the 
pericyte layer through gaps between adjacent pericytes (Proebstl et al., 2012). Of 
interest, these gaps increase in size in response to TNF and IL-1β and 
transmigrating neutrophils appear to preferentially use enlarged pericyte gaps 
(Proebstl et al., 2012; Wang et al., 2012). Hence, in addition to direct interaction 
with leukocytes, pericytes may guide transmigrating leukocytes through the pericyte 
layer via altered pericyte morphology. When using TNF and IL-1β as inflammatory 
stimuli, pericyte shape change occurred in a neutrophil-independent manner, and 
together with the expression of TNFRs and IL-1R on pericytes, this indicates a 
direct effect of these cytokines on pericytes. To extend these findings to other types 
of inflammatory mediators, here the impact of a wide range of neutrophil 
chemoattractants (LTB4, KC, C5a and fMLP) on pericyte morphology was 
investigated.  
The model employed was that of the mouse cremaster muscle which through its thin 
and transparent nature enables high resolution analysis of changes in vascular 
morphology as observed and quantified by immunofluorescent staining and confocal 
microscopy (Proebstl et al., 2012; Voisin et al., 2009; Voisin et al., 2010; Wang et 
al., 2006). The findings presented in this chapter show for the first time that 
chemoattractants (i.e. LTB4, KC, C5a and fMLP) can induce pericyte gap 
enlargement. However, the average gap density did not significantly change upon 
stimulation (~6600 gaps per mm2 of vessel surface) as previously noted for other 
stimuli (Voisin et al., 2010). This finding indicates that the increase in area likely 
represents a true enlargement of pre-existing gaps rather than aggregation of 
several gaps or the generation of new permissive regions.  
Cell contraction was the first function suggested for pericytes and described some 
100 years earlier by the French scientist and discoverer of pericytes Charles-Marie 
Benjamin Rouget. With evolving imaging techniques, pericyte contractility could be 
analysed in more detail and has to date been demonstrated in response to several 
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vasoactive factors and neurotransmitters (Attwell et al., 2010; Hamilton et al., 2010). 
Molecular analyses led to the discovery of the activation of kinases with a role in the 
regulation of vasoconstriction within pericytes (Joyce et al., 1984; Joyce et al., 
1985). These kinases include actin, myosin, tropomyosin and cyclic GMP-
dependent protein kinase. Of interest, shape change (contractility/relaxation) of 
pericytes in inflammatory scenarios (i.e. stimulation with TNF, IL-1β and LPS) has 
already been demonstrated for rat lung pericytes in vitro (Kerkar et al., 2006; Khoury 
and Langleben, 1998; Speyer et al., 2000). There is also evidence to suggest that 
pericyte contractility might be regulated by members of the Rho family of small 
GTPases (Bryan and D'Amore, 2007; Kutcher and Herman, 2009). More 
specifically, a study using bovine retinal pericytes identified RhoA as a mediator of 
pericyte shape change through the disassembly of αSMA stress fibres and 
formation of non-muscle actin stress fibres. In contrast, other Rho GTPases (Ras-
related small GTPases Rac 1 and cdc42) do not seem to be involved in this process 
(Kolyada et al., 2003; Kutcher et al., 2007). Notably, cytokine-induced pericyte gap 
opening was recently associated with disassembly of stress fibres and focal 
adhesion sites and as such it has been suggested that pericyte shape change may 
occur as a result of cell relaxation rather than contraction (Wang et al., 2012). In this 
study inhibition of RhoA/Rho kinase (ROCK) signalling and suppression of 
actomyosin-based contractility upon leukocyte-pericyte interaction in vitro led to 
shape change of mouse primary pericytes. However, at present it is unclear whether 
the pericyte shape change noted in the mouse cremaster tissue is as a result of cell 
relaxation or contraction.  
In addition, although several studies have shown that pericytes generally exhibit the 
ability to undergo shape change during inflammatory conditions, the functional role 
of this phenomenon is yet unknown. Pericyte contraction has most notably been 
associated with capillary constriction, however, no convincing evidence has to date 
been found for a definitive role of pericyte shape change in regulating blood flow at 
the microvascular level (reviewed in (Armulik et al., 2011)). Pericyte shape change 
during inflammatory conditions might facilitate leukocyte transmigration through 
enhanced permissiveness to infiltrating cells, the establishment of a chemotactic 
gradient, regulation of blood flow or other unknown mechanisms.  
Although cytokines have previously been shown to induce pericyte shape change 
both in vitro (Kerkar et al., 2006) and in vivo (Proebstl et al., 2012; Wang et al., 
2012), this is the first report that demonstrates the ability of pericytes to respond to 
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chemoattractants. All analysed chemoattractants are potent neutrophil stimulators 
and several studies demonstrate the requirement of neutrophils to induce changes 
in the vessel wall (e.g. opening of EC junctions and BM remodelling) in response to 
chemoattractants such as LTB4 in vivo (Bjork et al., 1982; Wedmore and Williams, 
1981; Williams and Jose, 1981). Based on these studies, the role of neutrophils in 
pericyte shape change as mediated by these stimuli was investigated next. In time 
course experiments, the timeframe of LTB4-induced pericyte gap enlargement was 
compared with neutrophil transmigration in the same tissues. Post-capillary venules 
of the cremaster muscle showed a time-dependent increase in pericyte gap size 
following LTB4 stimulation, with a peak at 4 h post injection. Pericyte gap 
enlargement then gradually returned to basal levels between 4-24 h after LTB4 
treatment. These findings indicate that at sites of inflammation pericytes undergo a 
time-dependent and transient shape change which may account for their proposed 
role in regulating microvascular permeability under inflammatory conditions 
(Hellstrom et al., 2001; Leveen et al., 1994; Sims et al., 1990; Sims et al., 1994).  
As expected, local injection of LTB4 elicited neutrophil transmigration in a time-
dependent manner. Interestingly, time course analysis of LTB4-induced 
inflammation showed a direct correlation between tissue infiltration of neutrophils 
and pericyte gap opening, with both responses peaking at 4 h. This is in contrast to 
TNF-induced inflammation, where pericyte gap enlargement precedes neutrophil 
transmigration, as has been shown by our group (Proebstl et al., 2012). In addition, 
the onset and termination of pericyte gap opening has been shown to occur earlier 
in response to TNF as compared to LTB4 in the present work. As pericytes express 
receptors for TNF, the effect of this cytokine on changes in pericyte morphology are 
considered to be direct and hence possibly more rapid. Hence, these results 
suggest a role for neutrophils in chemoattractant-, but not cytokine-induced pericyte 
shape change.  
In summary, this chapter describes for the first time the ability of pericytes to 
respond to neutrophil chemoattractants as indicated by pericyte shape change in 
chemoattractant-stimulated tissues. The functional consequence of this response is 
at present unclear, but the observed changes in pericyte shape might contribute to 
the overall pro-inflammatory effects of certain stimuli. Time course experiments 
further provided indications for a role for neutrophils in this response, a possibility 
that was examined as part of the following chapter (chapter 5). However, the 
underlying mechanism remains to be elucidated, which is part of the next chapter. 
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CHAPTER 5: MECHANISM OF CHEMOATTRACTANT-INDUCED 
PERICYTE SHAPE CHANGE IN VIVO 
 
5.1 INTRODUCTION 
The findings described in chapter 4 showed the ability of neutrophil 
chemoattractants to act on pericytes by inducing pericyte shape change in vivo. In 
these experiments, pericyte shape change resulted in a marked increase in mean 
gap size between adjacent cells. The aim of the present chapter was to extend 
these results by dissecting the mechanism through which these factors induce the 
observed pericyte shape change. As neutrophils are the main target for the 
analysed chemoattractants (i.e. LTB4, KC, C5a and fMLP), here the role of 
neutrophils and neutrophil-derived factors in pericyte gap enlargement was 
investigated. 
Although there exists a wide range of structurally different neutrophil 
chemoattractants, biochemical and molecular analysis have demonstrated several 
similarities of functions and mechanisms of actions of chemoattractants on 
neutrophils (Murphy, 1994; Murphy, 1996). For instance, all of them bind to GPCRs 
of the 7 transmembrane spanning protein family (Murphy, 1994; Pierce et al., 2002). 
Members of these receptors include the formyl peptide receptor 1 (FPR1), 
chemokine receptors of the CCR and CXCR families, leukotriene receptors BLTs 
and C5aR that are all expressed on the surface of neutrophils. During acute 
inflammation, chemoattractants mediate rapid neutrophil accumulation in the 
vascular lumen and guide leukocyte migration through the vessel wall into the tissue 
(Fernandez et al., 1978; Ford-Hutchinson et al., 1980; Schiffmann et al., 1975). In 
addition, chemoattractants activate neutrophils by inducing degranulation and 
release of degrading enzymes, antimicrobial molecules, pro-inflammatory stimuli 
and production of oxygen-derived free radicals (Dahinden et al., 1983; Goetzl and 
Pickett, 1980; Showell et al., 1982; Sumimoto et al., 1984). Besides directly acting 
on neutrophils, chemoattractants can indirectly induce changes in vascular wall 
properties such as vasodilatation and reduced barrier function of vessels (Hurley 
J.V., 1964; Bjork et al., 1982; Wedmore and Williams, 1981). Specifically, 
chemoattractants have been shown to indirectly act on ECs by inducing the opening 
of EC junctions and impairing its barrier function to plasma fluid and 
macromolecules, an effect that occurred in a neutrophil-dependent manner (Bjork et 
al., 1982; Wedmore and Williams, 1981). In addition, a number of studies have 
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demonstrated the ability of chemoattractants to mediate vascular BM remodelling 
via neutrophil activation (Hurley J.V., 1964; Reichel et al., 2009; Voisin et al., 2010; 
Voisin et al., 2009). In this context, recent data from our group and others have 
shown that neutrophil transmigration as induced by a variety of stimuli is associated 
with enlargement of regions within the venular BM that exhibit lower protein 
expression (LERs) (Reichel et al., 2009; Voisin et al., 2010; Voisin et al., 2009). The 
findings of the present study for the first time reports on the impact of neutrophil 
chemoattractants on pericytes as demonstrated by pericyte shape change in vivo. 
Although neutrophils have been shown to play an important role in mediating 
changes in the vessel wall, i.e. in inducing vascular permeability and BM 
remodelling, the precise mechanisms through which these responses are mediated 
is less well understood. Work presented in the previous chapter gave indications for 
a temporal association between chemoattractant-induced neutrophil migration and 
pericyte gap opening. Hence, as part of this chapter the role of neutrophils in 
chemoattractant-induced pericyte gap opening and the potential role of neutrophil-
derived secondary mediators in this response was investigated. 
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5.2 RESULTS 
5.2.1 Role of neutrophils in chemoattractant-induced pericyte shape change  
To analyse the mechanism by which chemoattractants induce pericyte shape 
change, the role of neutrophils in this response was analysed in mice depleted of 
their circulating neutrophils. For this purpose, WT mice received a single dose of 
100 μg anti-GR1 antibody RB6-8C5 i.p. 24 h before inflammation was induced. 
Control mice received either rat IgG i.p. and PBS i.s., anti-GR1 i.p. and PBS i.s., or 
rat IgG i.p. and LTB4 i.s. Three independent experiments were performed.  
Pericyte gaps were quantified for their size and density 4 h post LTB4 injection by 
immunofluorescent staining and confocal microscopy as previously described 
(chapter 2, section 2.3.8). Furthermore, the amount of neutrophils within a blood 
sample taken before and after antibody treatment and the level of extravasated 
neutrophils in the tissue were assessed. As confirmed by Kimura staining and 
confocal microscopy, treatment with the anti-GR1 antibody depleted almost all 
neutrophils (> 80%) (Figure 5.1, left). In contrast, a high number of extravasated 
neutrophils were present when mice were treated with the IgG control in response 
to LTB4. Whilst mice treated with the control antibody showed an increase in 
pericyte gap size 4 h post LTB4 injection, this increase was absent in neutrophil-
depleted mice (Figure 5.1, right). These results indicate that neutrophils can 
mediate the enlargement of pericyte gaps following LTB4 stimulation.  
As the concentration of the GR1-antibody used for the experiments described above 
appeared to also deplete monocytes, based on these experiments the potential 
involvement of monocytes/macrophages in mediating pericyte shape change cannot 
be ruled out. Thus, a more specific protocol for analysis of the role of neutrophils in 
this response was next employed. To induce specific neutropenia, WT mice or mice 
exhibiting green monocytes (CX3CR1
GFP/+ mice) were injected with a lower dose of 
anti-GR1 antibody (25 µg) given i.p. over 3 days prior to induction of inflammatory 
reactions as previously described(Voisin et al., 2009). Treatment with the anti-GR1 
antibody depleted almost all circulating neutrophils (> 82%), but not monocytes as 
confirmed by flow cytometry in CX3CR1GFP/+ animals (Figure 5.2).  
Using this protocol, quantitative analysis using confocal microscopy of 
immunofluorescently stained cremaster muscles showed no neutrophil infiltration in 
mice depleted of their circulating neutrophils in response to LTB4 (4 h) as compared 
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to control IgG antibody-treated animals (Figure 5.3, left and 5.4 top). In contrast, 
monocyte transmigration in GR1-treated animals was similar to the response 
obtained in animals injected with an IgG control antibody and relatively low as 
compared to neutrophils in undepleted animals (Figure 5.3, right).  
Similar to the experiments described above (using the high dose of GR-1 antibody) 
the specific depletion of neutrophils also abolished LTB4-induced pericyte gap 
opening (Figure 5.4, bottom). Of interest, the same results were achieved when 
cremaster muscles were stimulated with KC or C5a (Figure 5.4, bottom). In contrast, 
when cremaster muscles were stimulated with the pro-inflammatory cytokine IL-1β, 
pericyte shape change was independent of neutrophils as the pericyte gap size 
increased at similar levels in both control IgG-treated and neutrophil-depleted 
animals. These results are in line with previous results showing the expression of IL-
1R on pericytes and the ability of IL-1β to directly induce pericyte shape change in 
vitro and in vivo in a neutrophil-independent manner (Proebstl et al., 2012).  
Altogether, these results suggest that pericyte shape change can occur in a 
neutrophil-dependent manner when inflammation is induced by neutrophil-specific 
chemoattractants.  
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                         Neutrophil Transmigration          Pericyte gap size 
 
Figure 5.1: LTB4-induced pericyte shape change in neutrophil-depleted mice. WT mice 
were depleted of their neutrophils by i.p. injection of 100 μg anti-GR1 antibody 24 h prior to 
LTB4 (30 ng) or PBS i.s. injection. Control mice received an isotype-matched control 
antibody i.p. Cremaster muscles were dissected away 4 h after LTB4 or PBS injection, fixed 
and immunostained for neutrophils (MRP-14) and pericytes (αSMA) for confocal analysis. 
Number of transmigrated neutrophils (left) and the size of gaps between adjacent pericytes 
(right) were quantified. White bars represent control samples (PBS, 4 h) and grey bars 
correspond to LTB4-stimulated tissues which received control antibody. Patterned bars 
correspond to mice depleted of their circulating neutrophils and treated with PBS (patterned 
white) or LTB4 (patterned grey). 3 vessel segments per cremaster muscle (6 per mouse) 
were analysed and plotted as mean per mouse. Data are presented as the mean ±SD of 3 
independent experiments. Significant differences between groups were determined using 
Student’s t-test. Differences between depleted and undepleted groups are marked with 
hashes (#: p < 0.05, ##: p < 0.01), differences to PBS-treatment are indicated by asterisks. 
(*: p < 0.05, **: p < 0.01) 
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Figure 5.2: Blood neutrophil and monocyte counts in mice treated with low 
concentrations of GR1 antibody. CX3CR1
GFP/+
 mice were depleted of their neutrophils by 3 
doses of 25 μg anti-GR1 antibody. Control mice received the same amount of isotype-
matched control antibody i.p. Blood samples were taken 24 h after the last injection and 
stained with an anti-GR1 antibody for flow cytometric analysis. (a) Dot plots show GR1
+
 
CX3CR1
-
 granulocytes (neutrophils), GR1
-
 CX3CR1
+
 resident monocytes and GR1
+
 CX3CR1
+
 
inflammatory monocytes of blood taken from control IgG (left) or GR1 antibody treated mice 
(right). Numbers within the outlined gates indicate the percentage of the respective leukocyte 
subset within the blood sample. (b) Graph represents the percentage of neutrophils and 
monocytes from blood samples taken from control IgG (white) or GR1 antibody treated mice 
(patterned) as analysed by flow cytometry. Data are presented as the mean ±SD of 3 
independent experiments. Significant differences between groups were determined using 
Student’s t-test. Differences between depleted and undepleted groups are marked with 
hashes (##: p < 0.01). 
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               Neutrophil transmigration                          Monocyte transmigration 
 
Figure 5.3: Neutrophil and monocyte transmigration in response to LTB4 in mice 
treated with low concentrations of GR1 antibody or.  CX3CR1
GFP/+
 mice were depleted of 
their neutrophils by 3 doses of 25 μg anti-GR1 antibody i.p. Control mice received the same 
amount of isotype-matched control antibody. LTB4 (30 ng) or PBS was given i.s. 24 h after 
the last dose. Cremaster muscles were dissected away 4 h after stimulus injection, fixed and 
immunostained for neutrophils (MRP-14) for confocal analysis. Number of transmigrated 
MRP-14 positive neutrophils (left) and CX3CR1-positive monocytes (right) were quantified. 
Filled bars represent mice which received control antibody; patterned bars correspond to 
mice depleted of their circulating neutrophils. 3 vessel segments per cremaster muscle (6 
per mouse) were analysed and plotted as mean per mouse. Data are presented as the mean 
±SD of 3 independent experiments. Significant differences between groups were determined 
using Student’s t-test. Differences between depleted and undepleted groups are marked with 
hashes (#: p), differences to PBS-treatment are indicated by asterisks. (*: p < 0.05). 
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Figure 5.4: Neutrophil chemoattractant-induced pericyte shape change in neutrophil-, 
but not monocyte-depleted mice. WT or CX3CR1
GFP/+
 mice were depleted of their 
neutrophils by 3 doses of 25 μg anti-GR1 antibody i.p. Control mice received the same 
amount of isotype-matched control antibody. LTB4 (30 ng), KC (500 ng), C5a (300 ng), IL-1β 
(50 ng) or PBS was given i.s. 24 h after the last dose. Cremaster muscles were dissected 
away 2 h (KC) or 4 h (LTB4, C5a, IL-1β) after stimuli injection or 2 and 4h post PBS 
injections (results pooled together). Tissues were fixed and immunostained for neutrophils 
(MRP-14) and pericytes (αSMA) for confocal analysis. Number of transmigrated neutrophils 
(top) and size of gaps between adjacent pericytes (bottom) were quantified. White bars 
represent control samples (PBS) and grey bars correspond to LTB4-stimulated tissues which 
received control antibody. Patterned bars correspond to mice depleted of their circulating 
neutrophils and treated with PBS (patterned white) or inflammatory stimuli (patterned grey). 
At least 4 vessel segments per mouse were analysed and plotted as mean per mouse. Data 
are presented as the mean ±SD of 3 independent experiments. Significant differences 
between groups were determined using Student’s t-test. Differences between depleted and 
undepleted groups are marked with hashes (#: p < 0.05, ##: p < 0.01, ###: p < 0.001), 
differences to PBS-treatment are indicated by asterisks. (*: p < 0.05, **: p < 0.01, ***: p < 
0.001). 
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5.2.2 Role of secondary mediators in regulating pericyte shape change 
The data so far suggest that, in contrast to cytokine-induced inflammation, 
neutrophil chemoattractants induce a neutrophil-dependent change in pericyte 
morphology leading to an increase in size of gaps between adjacent cells. It was 
hypothesised that in chemoattractant-induced inflammation, neutrophils rapidly 
release a secondary mediator that acts on pericytes. Hence, a number of neutrophil-
derived factors that have been shown to be vasoactive on SMCs were investigated 
for their ability to stimulate changes in pericyte morphology in response to LTB4. 
Independent experiments were performed at least 3 times for each condition. 
LTB4 stimulation of neutrophils leads to a rapid release of platelet-activating factor 
(PAF) (Tessner et al., 1989), a phospholipid that has been shown to stimulate SMC 
contraction (Soloviev and Braquet, 1991; Stimler et al., 1981). To elucidate the 
potential role of PAF in mediating LTB4-induced pericyte gap opening, mice were 
pre-treated with the PAF antagonist UK 74,505 before inducing inflammatory 
responses by i.s. injection of LTB4 for 4 h. Stimulated whole mount cremaster 
muscles were immunostained for MRP-14 (neutrophils) and αSMA (pericytes) and 
analysed for neutrophil transmigration and changes in pericyte morphology by 
confocal microscopy. Treatment of mice with UK 74,505 abolished PAF-induced 
neutrophil transmigration almost completely as confirmed by confocal microscopy of 
PAF-induced dermal inflammation in mouse ears (Figure 5.5a). In contrast, blocking 
PAF receptors had no effect on neutrophil transmigration or pericyte gap opening in 
response to LTB4 (Figure 5.5b). 
Activated neutrophils, e.g. upon stimulation with LTB4, also release tissue-
destructive oxygen-derived free radicals (Sumimoto et al., 1984), which in turn are 
able to augment contraction of SMCs (uch-Schwelk et al., 1989b). Thus, the role of 
reactive oxygen intermediates in mediating pericyte responses to LTB4 was 
analysed next using confocal microscopy and immunofluorescent staining. 
Neutrophil extravasation following 4 h LTB4 was prevented by combined treatment 
of mice with the ROS scavenger SOD and catalase as shown by the absence of 
neutrophils within tissues (Figure 5.6a and 5.b, left). Of interest, in assessing the 
site of arrest of neutrophils, in SOD and catalase treated mice almost no neutrophils 
could be detected within the vessel wall (Figure 5.6b, middle) but high number of 
neutrophils were seen within the vessel lumen (Figure 5.6a and 5.6b right). These 
results indicate that reactive oxygen intermediates contribute to the process of 
neutrophil transmigration at the level of the endothelium in response to LTB4. 
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However, ROS scavenging had no effect on LTB4-induced pericyte shape change 
(Figure 5.7). Similarly, NE (also released by LTB4-stimulated neutrophils (Young et 
al., 2007)) was not required for LTB4-induced pericyte gap opening as analysed in 
mice deficient for NE (Figure 5.8, left). NE-/- mice further showed similar neutrophil 
transmigration following 4 h LTB4 as compared to WT animals (Figure 5.8, left). 
Results obtained in this laboratory have previously demonstrated that the pro-
inflammatory cytokine TNF can directly act on pericytes to induce pericyte shape-
change both in vivo and in vitro (Proebstl et al., 2012). As this molecule can also be 
generated and released from neutrophils upon stimulation with mediators such as 
LTB4 or KC (Chou et al., 2010; Gaudreault and Gosselin, 2009; Saiwai et al., 2010; 
Vieira et al., 2009), the role of TNF was investigated in the context of neutrophil-
dependent pericyte shape-change. Stimulated whole mount cremaster muscles of 
WT and TNFR-/- mice were immunostained for MRP-14 (neutrophils) and αSMA 
(pericytes) and analysed for neutrophil transmigration and changes in pericyte 
morphology as before. In both, WT and TNFR-/- mice neutrophil transmigration 
responses into the tissue were similar upon stimulation with LTB4 (4 h; Figure 5.9 
and 5.10, top), KC (2 h) or C5a (4 h; Figure 5.10, top). Interestingly, quantification of 
pericyte gap size showed that in contrast to WT animals, chemoattractant-induced 
increase in pericyte gap size was absent in TNFR-deficient mice (Figure 5.9, and 
5.10, bottom).  
As a control, TNFR-/- were also stimulated with TNF. As expected, neutrophil 
transmigration and pericyte shape change in response to TNF were both abolished 
in these animals (Figure 5.11, left). When cremaster muscles were stimulated with 
the pro-inflammatory cytokine IL-1β, pericyte shape change was independent of 
TNFR signalling as both, WT and TNFR-deficient animals showed significant 
enlargement of gaps between adjacent pericytes (Figure 5.11, right). These results 
are in line with previous results showing the ability of IL-1β to directly induce 
pericyte shape change in vivo (Proebstl et al., 2012) and suggest that neutrophil-
dependent chemoattractant, but not cytokine-induced, changes in pericyte 
morphology are triggered through TNFR signalling. 
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Figure 5.5: Effect of PAF antagonist UK74, 505 on LTB4-induced pericyte shape 
change. LTB4 (30 ng) or PBS was injected i.s. 10 min after i.v. injection of UK74, 505 
or vehicle control. To test the efficiency of UK74, 505, PAF was injected i.d. into the 
ear skin of the same animals. Tissues were extracted 4 h after stimulation, fixed, 
permeabilised and stained for neutrophils (MRP-14) and pericytes (αSMA) for confocal 
analysis. Number of transmigrated neutrophils was quantified in ear skin stimulated 
with PAF (a) and cremaster muscles stimulated with LTB4 (b, left). Furthermore the 
size of gaps between adjacent pericytes was analysed in post-capillary venules of the 
cremaster muscle (b, right). White bars represent control samples (PBS) and grey 
bars correspond to PAF-, LTB4-stimulated tissues. Patterned bars correspond to mice 
injected with the PAF antagonist UK74, 505. 3 vessel segments per cremaster muscle 
(6 per mouse) were analysed and plotted as mean per mouse. Data are presented as 
the mean ±SD of at least 3 independent experiments. Significant differences between 
groups were determined using Student’s t-test. Differences to corresponding PBS 
controls are indicated by asterisks (*: p < 0.05, ***: p < 0.001) and differences between 
vehicle and UK74, 505 treated groups are marked with hashes (#: p < 0.05). 
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Figure 5.6: Effect of ROS scavengers on LTB4-induced neutrophil transmigration. LTB4 
or PBS was injected i.s. immediately after i.v. injection of catalase+SOD. Uninjected animals 
served as control. Tissues were extracted 4 h after stimulation, fixed, permeabilised and 
stained for neutrophils (MRP-14) and pericytes (αSMA) for confocal analysis. (a) 
Representative 3D-reconstructed confocal images of LTB4-treated postcapillary venules in 
the absence (left) or presence of cat/SOD. Bars, 50 µm (b) Number of neutrophils within the 
lumen (left), within the vessel wall (middle) and transmigrated neutrophils (right) were 
analysed. Patterned bars correspond to mice injected with the catalase/SOD cocktail and 
filled bars to control mice. 3 vessel segments per cremaster muscle (6 per mouse) were 
analysed and plotted as mean per mouse. Data are presented as the mean ±SD of at least 3 
independent experiments. Significant differences between groups were determined using 
Student’s t-test. Differences to corresponding PBS controls are indicated by asterisks (*: p < 
0.05, ***: p < 0.001) and differences between untreated and cat/SOD-treated groups are 
marked with hashes (#: p < 0.05). 
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Figure 5.7: Effect of ROS scavengers on LTB4-induced pericyte shape change. LTB4 
(30 ng) or PBS was injected i.s. immediately after i.v. injection of catalase+SOD. Uninjected 
animals served as control. Tissues were extracted 4 h after stimulation, fixed, permeabilised 
and stained for neutrophils (MRP-14) and pericytes (αSMA) for confocal analysis. Size of 
pericyte gaps was analysed in the same images used for Figure 5.6. Patterned bars 
correspond to mice injected with the catalase/SOD cocktail and filled bars to control mice. 3 
vessel segments per cremaster muscle (6 per mouse) were analysed and plotted as mean 
per mouse. Data are presented as the mean ±SD of at least 3 independent experiments. 
Significant differences between groups were determined using Student’s t-test. Differences 
to corresponding PBS controls are indicated by asterisks (**: p < 0.01, ***: p < 0.001). 
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Figure 5.8: Effect of NE-deficiency on LTB4-induced pericyte shape change. LTB4 (30 
ng) or PBS was injected i.s. into WT or NE
-/-
 mice. Tissues were extracted 4 h after 
stimulation, fixed, permeabilised and stained for neutrophils (MRP-14) and pericytes (αSMA) 
for confocal analysis. Number of transmigrated neutrophils (left) and the size of pericyte 
gaps (right) were analysed in the cremaster muscle. Patterned bars correspond to NE
-/-
 mice 
and filled bars to WT mice. 3 vessel segments per cremaster muscle (6 per mouse) were 
analysed and plotted as mean per mouse. Data are presented as the mean ±SD of at least 3 
independent experiments. Significant differences between groups were determined using 
Student’s t-test. Differences to corresponding PBS controls are indicated by asterisks (*: p < 
0.05, **: p < 0.01, ***: p < 0.001).  
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Figure 5.9: Effect of TNFR-deficiency on LTB4-induced pericyte shape change. LTB4 
(30 ng) was injected i.s. into WT and TNFR
-/-
 mice. Cremaster muscles were dissected away 
4 h after stimulation, fixed, permeabilised and stained for neutrophils (MRP-14) and 
pericytes (αSMA) for confocal analysis. Representative 3D-reconstructed confocal images of 
LTB4-treated cremasteric postcapillary venules of WT (top) and TNFR
-/-
 mice (bottom) 
illustrating neutrophils (blue) and pericytes (red) with gaps between adjacent cells. The right 
panels show magnifications of the αSMA channel of the region outlined in the left panels. 
Bars, 20 μm. 
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Figure 5.10: Effect of TNFR-deficiency on chemoattractant-induced pericyte shape 
change. LTB4 (30 ng), KC (500 ng), C5a (300 ng) or PBS was injected i.s. into WT or TNFR
-
/-
 mice. Tissues were extracted 2 h (KC) or 4 h (LTB4, C5a) after stimulation, fixed, 
permeabilised and stained for neutrophils (MRP-14) and pericytes (αSMA) for confocal 
analysis. Number of transmigrated neutrophils (top) and the size of pericyte gaps (bottom) 
were analysed in the cremaster muscle. Patterned bars correspond to TNFR
-/-
 mice and 
filled bars to WT mice. 3 vessel segments per cremaster muscle (6 per mouse) were 
analysed and plotted as mean per mouse. Data are presented as the mean ±SD of at least 3 
independent experiments. Significant differences between groups were determined using 
Student’s t-test. Differences to corresponding PBS controls are indicated by asterisks (*: p < 
0.05, **: p < 0.01, ***: p < 0.001). Differences between mouse strains are marked by hashes 
(###: p < 0.001). 
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Figure 5.11: Effect of TNFR-deficiency on TNF- and IL-1β-induced pericyte shape 
change. TNF (300 ng), IL-1β (50 ng) or PBS were injected i.s. into WT or TNFR
-/-
 mice. 
Tissues were extracted 2 h (TNF) or 4 h (IL-1β) after stimulation, fixed, permeabilised and 
stained for neutrophils (MRP-14) and pericytes (αSMA) for confocal analysis. Number of 
transmigrated neutrophils (left) and the size of pericyte gaps (right) were analysed in the 
cremaster muscle. Patterned bars correspond to TNFR
-/-
 mice and filled bars to WT animals. 
3 vessel segments per cremaster muscle (6 per mouse) were analysed and plotted as mean 
per mouse. Data are presented as the mean ±SD of at least 3 independent experiments. 
Significant differences between groups were determined using Student’s t-test. Differences 
to corresponding PBS controls are indicated by asterisks (**: p < 0.01, ***: p < 0.001). 
Differences between mouse strains are marked by hashes (##: p < 0.01). 
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5.3 DISCUSSION 
Post-capillary venules are composed of 2 cellular components, the ECs and the 
pericytes, and networks of tightly packed matrix proteins forming the venular BM. 
During inflammation, neutrophils have to interact and penetrate all 3 structures 
(Nourshargh et al., 2010). Gaps between adjacent pericytes are preferential exit 
points for neutrophils to penetrate the pericyte sheath, sites that have been shown 
to transiently enlarge in response to cytokines such as TNF and IL-1β (Proebstl et 
al., 2012). In addition, the present study demonstrates for the first time the ability of 
different types of neutrophil chemoattractants, namely “intermediate” 
chemoattractants (LTB4 and KC) and “end-target” chemoattractants (fMLP and C5a) 
to act on pericytes in vivo. Collectively, the results presented in this chapter shed 
further light onto the cellular and molecular mechanisms that mediate pericyte 
shape change in inflammation.  
Based on previous studies showing the importance of neutrophils in changes in 
different vessel wall components as induced by chemoattractants (Hurley J.V., 
1964; Voisin et al., 2010; Wedmore and Williams, 1981) and results presented in 
chapter 4, showing a temporal association between pericyte shape change and 
neutrophil transmigration, the role of neutrophils in this response was investigated. 
Indeed, using neutropenic mice (as induced by antibody-based depletion of 
neutrophils), pericyte gap opening in response to LTB4, KC, and C5a, was 
completely abolished. This provides direct evidence for the importance of 
neutrophils in mediating pericyte shape change. Previous studies have further 
demonstrated the ability of at least LTB4 and C5a to direct chemotaxis of monocytes 
and macrophages (Smith et al., 1980). However the involvement of these leukocyte 
subsets in pericyte shape change could be ruled out as the concentration of GR1-
antibody used in this study was sufficient to deplete circulating neutrophils, but not 
monocytes or macrophages. 
Using IL-1β as a stimulus, enlargement of pericyte gaps occurred independently of 
neutrophils, a phenomenon that was also previously shown for TNF (Proebstl et al., 
2012).  The same study also showed the expression of both TNFRs and IL-1R on 
pericytes, indicating the ability of pericytes to directly respond to these cytokines. 
LTB4 acts through the G-protein coupled membrane receptors BLT1 (a high affinity 
receptor) and BLT2 (a low affinity receptor) (Tager and Luster, 2003). BLT1 is mainly 
expressed by leukocytes, whereas BLT2 is also found in the tissue. Both receptors 
were recently found to be expressed on human endothelial cells in vitro (Qiu et al., 
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2006), however, their involvement in inflammatory responses remains unclear. 
There is so far no evidence of either the presence of LTB4 receptors or a direct 
biological effect of this chemoattractant on pericytes.  
Though elegant studies associated a link between chemoattractant-induced 
neutrophil migration and changes in vessel wall properties five decades ago (Hurley 
J.V., 1964), the molecular mechanisms of this phenomenon have remained 
unknown. Mediators such as LTB4, KC, or C5a are not only potent chemotactic 
molecules for neutrophils, but also activate these cells and induce the generation 
and/or release of numerous proinflammatory molecules such as proteases, 
cytokines, vasoactive factors and ROS that could affect pericyte morphology 
(Adams and Lloyd, 1997; Ford-Hutchinson et al., 1980). The present study thus 
investigated the impact of possible secondary mediators in neutrophil-dependent 
chemoattractant-induced pericyte shape-change. Blocking PAF- or ROS-induced 
signalling, representing two vasoactive mediators (Soloviev and Braquet, 1991; 
Stimler et al., 1981; uch-Schwelk et al., 1989a) that are released by neutrophils in 
chemoattractant-induced inflammation (Sumimoto et al., 1984; Tessner et al., 
1989), did not overcome pericyte shape-change in the present model. Similar 
results were observed in mice deficient in the serine protease NE. Notably, in mice 
pre-treated with ROS scavengers, neutrophil transmigration into tissues was 
inhibited at the level of the endothelium with neutrophils accumulating within the 
vascular lumen. As pericyte gaps still increased under these circumstances, these 
data suggest that transmigration itself is not essential for the occurrence of pericyte 
shape change.  
Of interest, altered pericyte morphology was completely abolished in TNFR-/- mice 
upon LTB4, KC or C5a stimulation, demonstrating that chemoattractant-induced 
changes in pericyte gaps are triggered by endogenously released TNF. This is 
supported by the fact that TNF can directly induce the enlargement of pericyte gaps 
since the cells express the receptors for this cytokine (Proebstl et al., 2012). 
Although monocytes are the primary source of TNF, neutrophils have also been 
shown to release TNF e.g. following LPS (Bazzoni et al., 1991; Dubravec et al., 
1990), GM-CSF (Lindemann et al., 1989), Y-IgG (Bazzoni et al., 1991) or upon 
exposure to Candida albicans (Djeu et al., 1990) in vitro. However, conflicting data 
exists in the literature concerning the endogenous generation of neutrophil-derived 
TNF in response to chemoattractants. TNF has been shown to be secreted by 
human and mouse neutrophils ex vivo in response to LTB4 (Gaudreault and 
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Gosselin, 2009). KC injected intraperitoneally into mice has also been demonstrated 
to induce a dose- and time-dependent increase in TNF protein expression, a 
response that occurred in parallel with recruitment of neutrophils (Vieira et al., 
2009). TNF mRNA was further detected in isolated neutrophils after in vivo spinal 
cord injury, a response that was absent in neutrophils isolated from BLT1-/- mice, 
indicating a role for LTB4 in mediating TNF expression (Saiwai et al., 2010). 
Furthermore, upregulated TNF mRNA levels downstream of LTB4- signalling have 
been demonstrated in a murine model of inflammatory arthritis (Chou et al., 2010). 
In contrast, using the same model, TNF was not detected in synovial tissue in a 
study performed a few years earlier (Kim et al., 2006). TNF mRNA expression was 
also not detected upon fMLP, C5a or LTB4 stimulation of cultured human 
neutrophils (Cassatella et al., 1997). The discrepancy between these studies might 
be partly due to different time points analysed, different concentrations of 
stimulating factors used, or differences between mRNA and protein expression. In 
addition, in our model we cannot exclude the possibility that the endogenous TNF 
comes from other sources than neutrophils. Pericytes themselves for example 
express low constitutive TNF in vitro that can be upregulated upon stimulation 
(Alcendor et al., 2012; Kovac et al., 2011; Kowluru et al., 2010). Although 
monocytes can also generate TNF in response to chemoattractants (Cavaillon et al., 
1990; Schindler et al., 1990), in our hands, the level of monocyte infiltration was 
minimal and only depletion of neutrophils, but not monocytes, led to inhibition of 
pericyte shape change. Another potential mechanism for endogenous TNF release 
could be through the interaction of neutrophils with endothelium via β2 integrins 
(CD11/CD18), which can be upregulation on the surface of neutrophils upon 
chemoattractant stimulation (Sanchez-Madrid et al., 1983; Wallis et al., 1986). 
Further studies, however, are needed to better understand the source of TNF and 
the underlying mechanism of its synthesis and release. 
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CHAPTER 6: ROLE OF TNF IN CHEMOATTRACTANT-INDUCED 
VASCULAR FUNCTION AND BM REMODELLING  
 
6.1 INTRODUCTION 
As demonstrated in chapters 4 and 5, chemoattractant-induced inflammation was 
associated with changes in pericyte morphology in a neutrophil- and TNF-
dependent manner. In addition, chemoattractants such as LTB4 are further linked 
with neutrophil-dependent changes in the vascular wall properties in vivo including 
reduced barrier function of vessels to plasma proteins (Bjork et al., 1982; Wedmore 
and Williams, 1981), and BM remodelling (Voisin et al., 2009; Voisin et al., 2010). 
However, the molecular mechanisms of these phenomena are not well understood. 
The aim of this chapter was to investigate the potential role of endogenous TNF in 
mediating chemoattractant-induced vascular permeability and changes in the BM 
structure, specifically BM deposition post inflammation. 
Inflammation is intimately associated with an increase in vascular permeability 
leading to leakage of plasma fluid, proteins and macromolecules into the 
extravascular tissue resulting in oedema. This can occur via a transcellular route 
through interendothelial junctions or paracellular through transcytosis (Komarova 
and Malik, 2010). The most common described mechanism of vascular leakage is 
leakage via EC junctions in postcapillary venules (20-60 µm in diameter) (Majno and 
Palade, 1961; Baluk et al., 1997; McDonald et al., 1999), structures tightly regulated 
by complexes of EC junctional molecules (e.g. components of adherence and tight 
junctions) (Dejana et al., 2009; Taddei et al., 2008). Stimuli directly able to induce 
rapid and transient increased vascular permeability are low molecular weight 
mediators such as histamine, serotonin, bradykinin and substance P (Baluk et al., 
1997; Di et al., 1971). In addition, activated neutrophils in response to chemical 
stimuli are able to regulate the barrier properties of venular walls to plasma proteins 
(Wedmore and Williams, 1981). In this context, Williams and Morley suggested a 
two mediator model for regulation of permeability, where the first mediator 
stimulates ECs to increase vascular permeability, and the second mediator (e.g. 
prostaglandins) acts in synergy to potentiate the response by increasing arteriolar 
vasodilation and thus, increased blood flow (Williams and Morley, 1973). Although it 
is well known that neutrophils can mediate vascular leakage in response to 
chemoattractants such as LTB4 and C5a (Bjork et al., 1982; Wedmore and Williams, 
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1981; Arfors et al., 1987; Kaslovsky et al., 1990a), the precise mechanism through 
which neutrophils can provoke reduced barrier function of venular walls is not 
known. 
Pericytes are embedded within vascular BM, representing an additional barrier for 
transmigrating cells and macromolecules. In a study performed by Hurley in 1964, 
carbon particles could only fully breach the vessel wall under conditions of EC 
permeability and leukocyte transmigration (Hurley J.V., 1964). In the absence of 
emigrating leukocytes the particles accumulated at the luminal side of the BM, 
suggesting a barrier function of this structure. In addition, early electron microscopy 
studies revealed a generally higher number of transmigrating neutrophils within the 
BM layer as compared to cells breaching the EC barrier, indicating a high resistance 
of the BM to emigrating cells and macromolecules (HURLEY, 1963). Hence, 
following transendothelial migration, leukocytes remain in the sub-endothelial space 
for a considerable amount of time before penetrating the pericyte sheath and the 
vascular BM. Neutrophils have been shown to breach these layers preferentially 
through regions of low matrix protein expression (LER), sites that are directly 
aligned with pericyte gaps. Similar to pericyte gaps, these LERs undergo a transient 
increase in size in response to a number of inflammatory stimuli (Reichel et al., 
2008; Reichel et al., 2009; Reichel et al., 2011; Voisin et al., 2009; Voisin et al., 
2010).  
Vascular BMs are composed of independent networks of laminin and collagen, 
which form molecular bridges involving other glycoproteins such as perlecan and 
nidogen (Rowe and Weiss, 2008). The venular BM envelops pericytes and provides 
structural support for the vessel wall and adhesive support for emigrating cells. Both 
pericytes and ECs contribute to the generation of venular BM; however, as pericyte 
gaps are aligned with so-called LERs, the existence of significant gaps between 
adjacent pericytes seems to account for the generation of these leukocyte-
permissive sites.  
Matrix protein LERs have been identified in the collagen IV, laminin-511, laminin-
411 and nidogen networks (Voisin et al., 2009; Voisin et al., 2010; Wang et al., 
2006). We and others demonstrated increased LERs in tissues stimulated with 
several inflammatory stimuli including TNF, IL-1β, CCL2, LTB4, MIP1a, CCL3, LPS 
and I/R (Reichel et al., 2009; Reichel et al., 2011; Voisin et al., 2009; Voisin et al., 
2010; Wang et al., 2006). The mechanisms involved in leukocyte breaching of this 
barrier in vivo are poorly understood, but leukocyte proteases have been implicated 
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in this process (Delclaux et al., 1996; Wang et al., 2006). Furthermore, the 
expression of integrins on leukocytes that function as receptors for laminins and 
collagen IV (e.g. α2β1 and α6β1) are upregulated during transmigration, indicating 
that adhesive contacts between leukocytes and BM components may play a role in 
this phase of leukocyte transmigration (Bohnsack, 1992; Frieser et al., 1996; Werr 
et al., 1998; Werr et al., 2000). Interestingly, different BM components have been 
shown to exhibit distinct adhesive properties for leukocytes and hence may play an 
active role in regulating neutrophil transmigration through this barrier (Sixt et al., 
2001). 
As data presented in the previous chapter (chapter 5) indicated a role for 
chemoattractant-induced TNF in regulation of pericyte morphology, the potential 
functional role of endogenous TNF in chemoattractant-induced vascular 
permeability and BM remodelling was analysed as part of the present chapter. 
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6.2 RESULTS 
6.2.1 Role of endogenous TNF in chemoattractant-induced vascular 
permeability 
Experiments were carried out to investigate the role of TNF in chemoattractant-
induced vascular permeability. For this purpose, chemoattractant-induced vascular 
leakage was assessed in different inflammatory models (dorsal skin, ear skin and 
cremaster muscle) using Evans Blue as a tracer. 
 
Role of neutrophils in chemoattractant-induced plasma leakage 
In preliminary studies, vascular leakage of i.v. injected Evans Blue in response to 
LTB4 was compared in neutrophil-depleted and undepleted mice using the dorsal 
skin and ear skin models. In line with previous studies (Bjork et al., 1982; Wedmore 
and Williams, 1981), vascular leakage as induced by local injection of LTB4 (5 
minutes after Evans Blue injection i.v.) and stimulation for 4 h was absent in 
neutrophil-depleted mice (treated with 100 μg GR1 antibody 24 h prior stimulation) 
as compared to mice treated with control antibody (Figure 6.1).  
  
147 
 
a                         Dorsal skin b                     Ear skin 
 
Figure 6.1: LTB4-induced vascular leakage of intravenous Evans Blue in neutrophil-
depleted mice. WT C57BL/6 mice were depleted of their circulating neutrophils by 100 μg 
GR1 antibody given 24 h before inducing the inflammatory reaction. Control mice received 
an isotype-matched control antibody. 5 min after i.v. injection of Evans Blue dye, LTB4 (30 
ng) or PBS were injected i.d. into the dorsal skin and ear skin. 4 h post induction of 
inflammation, dorsal skin and ear were removed and analysed for Evans Blue dye influx into 
the tissue as measured by the change in OD620 using a spectrometer. (a) dorsal skin, (b) ear 
skin, respectively. White bars represent control samples (PBS) and grey bars correspond to 
LTB4-stimulated tissues of undepleted (filled) or neutrophil-depleted mice (patterned). Data 
are represented as the mean ±SD of 3 independent experiments. Significant differences 
between groups were determined using Student’s t-test. Differences compared to PBS 
control are marked with asterisks. Differences between depleted and undepleted groups 
were marked with hashes. (*: p < 0.05, ***: p < 0.001, ##: p < 0.01) 
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LTB4-induced vascular permeability in WT and TNFR
-/- mice in different vascular 
beds 
To elucidate the mechanism of how neutrophils provoke reduced barrier function of 
venular walls in response to chemoattractants, the potential role of TNF as a 
secondary mediator was next analysed. WT and TNFR-/- mice were injected i.v. with 
Evans Blue as a tracer followed by i.d. injections of LTB4 or PBS into the dorsal 
skin. To analyse neutrophil transmigration, separate mice were treated with LTB4 or 
PBS only (without injecting Evans Blue) in parallel and MPO activity, as a marker for 
neutrophils, was measured. Independent experiments were performed 3 times. As 
expected, LTB4 induced vascular leakage within 4 h of treatment as seen by the 
extravasated dye at injection sites and assessed by spectrometry (Figure 6.2a). 
Interestingly, this response was absent in TNFR-/- mice, mice that exhibited similar 
neutrophil transmigration as compared to control mice (Figure 6.2b) and reduced 
pericyte gap opening. These results were confirmed in different vascular beds 
including the ear skin and cremaster muscles (Figures 6.3, 6.4, respectively).  
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a 
 
b 
Figure 6.2: LTB4-induced vascular leakage of intravenous Evans Blue in the dorsal 
skin of WT and TNFR
-/-
 mice. (a) WT C57BL/6 and TNFR
-/-
 mice received i.v. injections of 
Evans Blue dye 5 min prior to i.d. injection of LTB4 (30 ng) or PBS into the dorsal skin. 
Dorsal skin was removed 4 h post induction of inflammation (left) and analysed for Evans 
Blue influx into the tissue as measured by the change in OD620 using a spectrometer (right). 
(b) Neutrophil transmigration was analysed in terms of MPO activity in separate mice, which 
did not receive Evans blue, but were treated with LTB4 or PBS for 4 h in parallel. White bars 
represent control samples (PBS) and grey bars correspond to LTB4-stimulated tissues of WT 
(filled) or TNFR
-/-
 mice (patterned). Data are represented as the mean ±SD of 3 independent 
experiments. Significant differences between groups were determined using Student’s t-test. 
Differences compared to PBS control are marked with asterisks. Differences between WT 
and TNFR
-/-
 mice were marked with hashes. (*: p < 0.05, **: p < 0.01; ##: p < 0.01) 
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Figure 6.3: LTB4-induced vascular leakage of intravenous Evans Blue in the ear skin 
of WT and TNFR
-/-
 mice.  WT C57BL/6 and TNFR
-/-
 mice received i.v. injections of Evans 
Blue dye 5 min prior to i.d. injection of LTB4 (30 ng) or PBS into the ear skin (left). Ear skin 
was removed 4 h post induction of inflammation and analysed for Evans Blue influx into the 
tissue as measured by the change in OD620 using a spectrometer (right). White bars 
represent control samples (PBS) and grey bars correspond to LTB4-stimulated tissues of WT 
(filled) or TNFR
-/-
 mice (patterned). Data are represented as the mean ±SD of 3 independent 
experiments. Significant differences between groups were determined using Student’s t-test. 
Differences compared to PBS control are marked with asterisks. Differences between WT 
and TNFR
-/-
 mice were marked with hashes.  (**: p < 0.01; ##: p < 0.01) 
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Figure 6.4: LTB4-induced vascular leakage of intravenous Evans Blue in the cremaster 
muscle of WT and TNFR
-/-
 mice.  WT C57BL/6 and TNFR
-/-
 mice received i.v. injections of 
Evans Blue dye 5 min prior to i.s. injection of LTB4 930 ng) or PBS (left). Cremaster muscles 
were removed 4 h post induction of inflammation and analysed for Evans Blue influx into the 
tissue as measured by the change in OD620 using a spectrometer (right). White bars 
represent control samples (PBS) and grey bars correspond to LTB4-stimulated tissues of WT 
(filled) or TNFR
-/-
 mice (patterned). Data are represented as the mean ±SD of 3 independent 
experiments. Significant differences between groups were determined using Student’s t-test. 
Differences compared to PBS control are marked with asterisks. Differences between WT 
and TNFR
-/-
 mice were marked with hashes. (*: p < 0.05; # < 0.05) 
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Kinetics of chemoattractant-induced vascular permeability in WT and TNFR-/- mice 
To further investigate the role of TNF in chemoattractant-induced vascular 
permeability and the potential relationship of this response with pericyte gap 
opening, time course experiments were performed and the kinetics of vascular 
leakage as induced by LTB4, KC, and C5a were analysed in WT and TNFR
-/- mice 
using the dorsal skin model. To analyse the rate of vascular leakage over certain 
time windows (i.e. 0-30, 30-60, 90-120 and 210-240 min of the inflammatory 
response), inflammatory stimuli were injected i.d. at different time points prior to i.v. 
Evans Blue: 4, 2, 1 and 0.5 h before scarifying the animal. Evans Blue was injected 
for the last ~28 min.  
These experiments showed a rapid induction of vascular leakage within the first 30 
min for all the chemoattractants tested, responses that progressively declines at 
later time points (Figure 6.5). As shown before for LTB4 (Figure 6.2, 6.3 and 6.4), 
KC- and C5a-induced increase in vessel wall permeability was also dependent on 
the presence of TNF signalling, as mice deficient for both TNF receptors showed no 
(KC) or reduced vascular leakage (C5a) as compared to WT animals (Figure 6.5c 
and d). Furthermore, locally injected TNF also induced a rapid increase in vascular 
permeability (between 0-30 min) in the dorsal skin model (Figure 6.6). These data 
indicate for the first time a role of TNF as a secondary mediator of chemoattractant-
induced vascular permeability. 
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a b 
 
c d 
 
Figure 6.5: Kinetics of chemoattractant-induced vascular permeability in the dorsal 
skin of WT and TNFR
-/-
 mice. WT C57BL/6 and TNFR
-/-
 were injected with LTB4 (30 ng), 
KC (500 ng), C5a (300 ng) or PBS i.d. at 240, 120, 60 and 30 min before the end of the 
experiments. Evans Blue dye was injected i.v. immediately after the last stimuli injection (30 
min time point). At the end of the experiment, dorsal skin was removed and analysed for 
Evans Blue dye influx into the tissue as measured as the change in OD620 using a 
spectrometer. (a) Dorsal skin is shown after stimulation with LTB4 or PBS and extraction 
from WT (left) and TNFR
-/-
 mice (right) indicating vascular leakage in terms of blue dye 
within the tissue. (b-d) Kinetics of LTB4-, KC- and C5a-induced vascular leakage, 
respectively were analysed in WT and TNFR
-/-
 mice. Light grey lines represent control 
samples (PBS) and dark grey lines correspond to LTB4-stimulated tissues of WT (uniform) or 
TNFR
-/-
 mice (patterned). Data are represented as the mean ±SEM of 3 independent 
experiments. Significant differences between groups were determined using two-way 
ANOVA and Bonferroni’s test. Differences between stimulus and PBS control are marked 
with asterisks. Differences between strains (WT and TNFR
-/-
) are marked with hashes. (**: p 
< 0.01, ***: p < 0.001; ##: p < 0.01, ###: p < 0.001) 
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Figure 6.6: Kinetics of TNF-induced vascular permeability in the dorsal skin of WT and 
TNFR
-/-
 mice. WT C57BL/6 and TNFR
-/-
 were injected with TNF (300 ng) or PBS i.d. at 240, 
120, 60 and 30 min before the end of the experiments. Evans Blue dye was injected i.v. 
immediately after the last stimuli injection (30 min time point). At the end of experiment, 
dorsal skin was removed and analysed for Evans Blue influx into the tissue as measured as 
the change in OD620 using a spectrometer. Light grey lines represent control samples (PBS) 
and dark grey lines correspond to LTB4-stimulated tissues of WT (uniform) or TNFR
-/-
 mice 
(patterned). Data are represented as the mean ±SEM of 3 independent experiments. 
Significant differences between groups were determined using two-way ANOVA and 
Bonferroni’s test. Differences between stimuli and PBS control are marked with asterisks. 
Differences between strains (WT and TNFR
-/-
) are marked with hashes. (**: p < 0.01; #: p < 
0.05) 
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6.2.2 Role of TNF in regulating post-inflammatory BM remodelling  
Pericyte gaps are directly associated with sites of venular BM LERs, regions that 
are preferred exit points for transmigrating leukocytes and undergo a transient 
increase in size in response to a number of inflammatory stimuli, similar to pericyte 
gaps (Reichel et al., 2008; Reichel et al., 2009; Reichel et al., 2011; Voisin et al., 
2009; Voisin et al., 2010; Wang et al., 2006). The role of TNF in regulating 
chemoattractant-induced changes in BM composition was analysed next. For this 
purpose, the remodelling of LERs within the extracellular matrix of cremasteric post-
capillary venules in LTB4–stimulated tissues of WT and TNFR
-/- mice was 
investigated by immunofluorescence staining and confocal microscopy. 
 
Profile of LTB4-induced BM protein LER enlargement  
In initial experiments the time course of LTB4-induced LER remodelling was 
analysed. For this purpose, the size of LERs within the venular BM was quantified in 
tissues extracted 4, 24, 48 and 72 h after i.s. LTB4 injection as compared to PBS-
treated tissues using ImageJ as described in chapter 2, section 2.3.7. Collagen IV 
and laminin were chosen for this characterisation because they represent the major 
matrix components of the venular BM.  
As previously demonstrated (Wang et al., 2006; Voisin et al., 2009; Voisin et al., 
2010), staining of tissues with anti-collagen IV antibody revealed a heterogeneous 
expression of this BM protein and the presence of LERs which were aligned with 
pericyte gaps (Figure 6.7). Furthermore, LTB4 stimulation led to a gradual increase 
in mean size of collagen IV LERs in post-capillary venules of WT animals, a 
response that peaked at 4 h (Figure 6.7 and 6.8a). Similar results were obtained for 
the BM protein laminin using a pan-laminin antibody (Figure 6.8b). Whilst in 
unstimulated tissues the mean size of post-capillary venule collagen IV and laminin 
LERs were 6.45 ± 0.63 μm2, 5.54 ± 0.84μm2, respectively, these increased to 10.72 
± 0.44 μm2, 11.68 ± 1.95 μm2, respectively, in response to local LTB4 (4 h test 
period). Thus, a 4 h LTB4 reaction induced a 66% and 110% increase in collagen IV 
and laminin LER size, respectively, as compared to control tissues.  
LERs remained enlarged up to 24 h and returned to basal levels by 48 h post LTB4 
stimulation. No significant differences in the densities of collagen IV and laminin 
LERs could be observed. The number of LE sites per unit area was comparable 
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between laminin and collagen IV and ranged between 14281 - 9614 sites/mm2 and 
13929 - 10580 sites/mm2, respectively (Figure 6.8, right panels).  
   
Figure 6.7: Time-dependent change in collagen type IV LERs in response to LTB4. 
Cremaster muscles were treated with PBS or LTB4 (30 ng) for 4 h. Tissues were fixed, 
permeabilised and stained with antibodies against αSMA (pericytes) and collagen IV. 
Representative 3D-reconstructed single channel confocal images of PBS- or LTB4-treated 
post-capillary venules display the pericyte layer (red) and venular BM collagen type IV 
(green). Gaps between adjacent pericytes and BM LERs are shown (encircled). The 
corresponding intensity profiles of collagen IV with a spectrum colour code (blue indicating 
low-intensity-sites and red indicating high-intensity-sites) are also shown in a higher 
magnification (right). Scale bar, 20 μm 
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Figure 6.8: Time-dependent change in collagen type IV and laminin LERs in response 
to LTB4. Changes in venular BM morphology were quantified in 3D-reconstruced confocal 
images of cremaster muscles stimulated with LTB4 (30 ng) or PBS for the indicated length of 
time using ImageJ. Images used for analysis were the same as analysed for Figure 5.1 and 
5.3. Collagen Type IV (a) and laminin (b) LERs were quantified for their size (left) and 
density (right) in 200 μm vessel segments. White Bars represent control samples (PBS, 4-
72h pooled together) and grey bars correspond to LTB4-stimulated tissues. At least 4 vessel 
segments per mouse were analysed and plotted as mean per mouse. Data are represented 
as the mean ±SEM of at least 3 independent experiments. Significant differences between 
groups were determined using one-way ANOVA and Neuman-Keuls multiple comparison 
test. Differences between LTB4 and PBS control are marked with asterisks. Differences 
between time points were marked with hashes. (**: p < 0.01, ***: p < 0.001, #: p < 0.05, ##: p 
< 0.01, ###: p < 0.001) 
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Mechanisms of LTB4-induced alterations in BM composition 
Recent data obtained from our laboratory showed that emigrating neutrophils 
appear to preferentially use enlarged gaps between adjacent pericytes to exit the 
vessel wall, sites that are colocalised with BM LERs (Proebstl et al., 2012). It is 
hypothesised that the composition of the BM might regulate leukocyte 
transmigration as different matrix constituents exhibit different biochemical and 
biophysical properties (Wu et al., 2009; Wondimu et al., 2004b; Kenne et al., 2010; 
Hallmann et al., 2005; Rowe and Weiss, 2008). However, despite the fact that 
pericyte gap opening was absent in TNFR-/- mice, TNFR-deficiency had no impact 
on the number of transmigrated neutrophils in LTB4 stimulated tissues as described 
in chapter 5.  To analyse the effect of TNF on BM remodelling/regeneration and to 
directly compare the profile of neutrophil transmigration in TNFR-/- animals in 
relation to changes in pericyte and BM morphology, time course experiments were 
performed. For this purpose, the same tissues were used as described for pericyte 
shape change. Independent experiments were performed at least 3 times.  
LTB4 was injected i.s. into WT or TNFR
-/- mice and cremaster muscles were 
dissected away after different in vivo test periods, fixed and used whole mounted for 
immunofluorescent staining for confocal analysis. Neutrophils, pericytes and BM 
were visualised using an anti-MRP-14, anti-αSMA, and anti-collagen IV antibody, 
respectively. Both, WT and TNFR-/- mice showed a time-dependent increase in LER 
size post LTB4 stimulation of cremaster muscles in vivo, a response that peaked at 
4 h post inflammation (Figure 6.9 and 6.10). These results suggest that in contrast 
to pericyte shape change, TNFR deficiency has no effect on BM LER remodelling in 
response to LTB4. Interestingly however, whilst the size of collagen IV LERs was 
back to basal level by 48 h in WT mice, in TNFR deficient mice the LERs remained 
enlarged at 48 h post LTB4 and was back to basal level by 72 h. These results 
indicate that LTB4-induced TNF release might contribute to the regeneration of 
venular BM in vivo and hence post inflammation BM remodelling.  
Quantification of MRP-4 positive cells in these tissues showed that TNFR-deficient 
mice exhibited a similar onset of neutrophil transmigration following LTB4 as 
compared to WT animals (Figure 6.10). Although TNFR-/- mice showed collagen IV 
LER enlargement, a response that was previously reported to be neutrophil-
protease-dependent(Wang et al., 2006), pericyte shape change was absent in these 
mice throughout the whole time course. 24 h post LTB4 injection both groups still 
exhibited a significant level of transmigrated neutrophils within the tissue as 
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compared to PBS-treated cremaster muscles. Of note, although not significant, the 
number of neutrophils within the tissue at this time point seemed to be higher in 
TNFR-deficient mice as compared to WT animals.  
 
 
Figure 6.9: Profile of LTB4-induced BM deposition in WT and TNFR
-/-
 mice. WT 
C57BL/6 and TNFR
-/-
 mice received LTB4 (30 ng) or PBS as a control. Cremaster muscles 
were extracted 4 or 48 h post injection, fixed and immunostained for confocal analysis. 
Intensity profiles of collagen IV with a spectrum colour coding (blue indicating low-intensity-
sites and red indicating high-intensity sites) are shown of WT (top) and TNFR
-/-
 post-capillary 
venules (bottom) treated with PBS (4 h) or LTB4 for 4 or 48 h. Scale bar, 20 μm  
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Figure 6.10: Profile of LTB4-induced neutrophil transmigration in relation to pericyte 
shape change and BM deposition in WT and TNFR
-/-
 mice.  WT C57BL/6 and TNFR
-/-
 
mice received LTB4 (30 ng) or PBS as a control. Cremaster muscles were extracted at 
different time points, fixed and immune-stained for confocal analysis. Neutrophil 
transmigration (top), pericyte gap size (middle) and BM LER remodelling/deposition were 
quantified in 3D-reconstruced confocal images of 200 μm post-capillary vessel segments 
using ImageJ. Images of WT animals used for analysis were the same as analysed for 
Figure 6.8. White bars represent control samples (PBS, 2-72h pooled together) and grey 
bars correspond to LTB4-stimulated tissues of WT (filled) or TNFR
-/-
 mice (patterned). At 
least 4 vessel segments per mouse were analysed and plotted as mean per mouse. Data 
are represented as the mean ±SEM of at least 3 independent experiments. Significant 
differences between groups were determined using two-way ANOVA and Bonferroni multiple 
comparison test. Differences compared to PBS control are marked with asterisks. 
Differences between time points were marked with hashes. (*: p < 0.05, **: p < 0.01, ***: p < 
0.001, ##: p < 0.01, ###: p < 0.001) 
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6.3 DISCUSSION 
Inflammation induced by injury or infection is characterised by changes in vascular 
morphology, plasma protein and fluid leakage and leukocyte transmigration. In 
inflammation evoked by chemoattractants, these responses are dependent on 
neutrophil activation  (Hurley J.V., 1964; Wang et al., 2006; Wedmore and Williams, 
1981). As such, the presence and/or intact adhesive function of neutrophils has 
been shown to be required for the induction of vascular permeability (Arfors et al., 
1987; Wedmore and Williams, 1981), BM remodelling (Wang et al., 2006) and 
pericyte shape change (as shown in this study) in response to chemotactic stimuli. 
However, the underlying mechanisms by which neutrophils may control these 
events are less well understood. Chapter 5 demonstrated the pivotal role of 
endogenous TNF in chemoattractant-evoked pericyte shape change. Here the role 
of this cytokine as a secondary mediator in inducing vascular leakage and BM 
remodelling/deposition was investigated using TNFR-/- mice. In addition, the 
temporal association of changes in vascular morphology, pericyte shape change, 
LER enlargement, and neutrophil transmigration were studied in both WT and 
TNFR-deficient mice. 
To analyse the role of TNF in vascular leakage as induced by chemoattractants, 
permeability assays were performed in vivo using i.v. Evans Blue as a tracer. In line 
with experiments by others (Bjork et al., 1982; Wedmore and Williams, 1981), 
plasma protein leakage into the tissue was strictly neutrophil-dependent in our 
model as determined in studies with neutrophil-depleted mice. Furthermore, LTB4-, 
C5a- and KC-induced permeability was rapid and transient as infiltration of plasma 
fluid into the tissue could be observed within 30 min post tissue stimulation. Of 
interest, vascular leakage in response to LTB4, C5a and KC was absent in TNFR
-/- 
mice. This was confirmed in different vascular beds including the dorsal skin, ear 
skin and cremaster muscle models. Hence, our data demonstrate for the first time a 
pivotal role for TNF in vascular permeability in response to chemoattractants.  
Neutrophil chemoattractants (C5a des Arg, fMLP and LTB4), in contrast to IL-1β, 
have been shown to induce rapid plasma protein leakage, which is unaffected by 
local inhibition of protein synthesis (Rampart and Williams, 1988). This suggests a 
rapid release of preformed mediators and is in line with our findings that vascular 
leakage is dependent on endogenous TNF. A study performed by Wong et al 
showed that exogenously administered TNF and IFN-γ induces a redistribution of 
VE-cadherin from EC junctions and increased vascular permeability in the rat 
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(Wong et al., 1999). However, the exact mechanism through which TNF mediates 
chemoattractant-induced vascular permeability in our model (chemoattractant-
stimulated murine tissues) remains to be explored. LTB4-stimulated human 
neutrophils have been shown to induce rapid EC permeability in vitro via the release 
of heparin-binding protein (HBP) (Di et al., 2009). It is however unclear whether 
HBP is also involved in the mouse models used in the present study and if so 
whether it acts downstream or upstream of TNF. This and possible differences 
between species needs to be further investigated. 
The potential role of chemoattractant-induced TNF in regulation of vascular BM 
remodelling was also investigated. The vascular BM envelops pericytes and - 
similar to pericytes - undergoes morphological changes during inflammation as 
evoked by numerous inflammatory stimuli (Reichel et al., 2008; Reichel et al., 2009; 
Reichel et al., 2011; Voisin et al., 2009; Voisin et al., 2010; Wang et al., 2006). The 
BM layer is heterogeneous and sites of lower matrix protein expression (LERs) are 
preferably used by transmigrating leukocytes (Voisin et al., 2010; Wang et al., 
2006). In the present study, a time-dependent and transient enlargement of collagen 
IV and laminin LERs in response to LTB4 was demonstrated. In contrast to pericyte 
gap size, TNFR deficiency had no effect on LTB4-induced LER enlargement. This is 
in accordance with the concept that BM remodelling is strictly neutrophil-dependent 
and requires protease activity (Wang et al., 2006). However, in comparison to WT 
animals (LER size was back to basal levels by 48 h), LER enlargement was 
prolonged in TNFR-/- mice and returned to basal levels by 72 h, suggesting a role for 
TNF downstream of LTB4 in post-inflammatory BM deposition.  
As leukocyte transmigration through the vascular BM is associated with a transient 
increase in vascular permeability and reduced barrier function (Huber and Weiss, 
1989a; Hurley J.V., 1964), BM deposition post inflammation might regulate 
leukocyte transmigration by reconstituting the barrier function of the vessel wall. 
Indeed, TNFR-/- mice showed a trend towards higher levels of neutrophils within the 
tissue at later time points (24 h). This sustained neutrophil response might suggest 
a role for BM deposition in the termination of the neutrophil transmigration response. 
However, further studies are required to analyse a possible connection between 
these events. 
Due to the close association of collagen and laminin LERs with pericyte gaps, 
pericytes are hypothesised to regulate the heterogeneous morphology of the BM. 
By regulating the composition of the BM, pericytes might control their biochemical 
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and biophysical property. Pericytes have previously been shown to be a source of 
extracellular matrix proteins both in vitro and in vivo (Cohen et al., 1980; Fujiwara et 
al., 2010; Hallmann et al., 2005; Mandarino et al., 1993; Stratman et al., 2009; 
Canfield et al., 1990). Thus, these mural cells might be involved in regulating the re-
generation of extracellular BM post inflammation and hence, regulate the re-sealing 
of LERs towards basal levels during the resolution phase of inflammation. Post-
inflammatory BM generation by pericytes might involve similar mechanisms to that 
involved in wound healing, where growth factors such as TGF-β regulate the 
remodelling of wound tissues through collagen secretion by myofibroblasts 
(Dulmovits and Herman, 2012). Furthermore pericytes have been shown to produce 
extracellular matrix proteins during vasculogenesis, a response that was dependent 
on the pericyte-derived matrix metalloproteinase inhibitor TIMP-3 (Stratman et al., 
2009). However, generation of extracellular matrix proteins in the context of 
inflammation has not been shown yet. Thus, further studies are needed to analyse 
whether pericytes indeed stimulate de novo synthesis of matrix components in 
chemoattractant-driven inflammatory reactions and in response to TNF. In addition, 
the functional consequence of this phenomenon in relation to neutrophil 
transmigration response requires further investigations.  
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CHAPTER 7: GENERAL DISCUSSION  
 
7.1 Project overview 
The venular wall acts as a semi-permeable barrier at the interface between 
circulating blood and the interstitial tissue, controlling the passage of cells (such as 
leukocytes) and macromolecules in and out of the bloodstream. Leukocyte exit from 
the blood during inflammatory conditions occurs via highly regulated processes 
involving specific interactions with all 3 components of the vessel wall: i.e. the 
endothelium, the pericyte sheath and the venular BM (Nourshargh et al., 2010). 
Lack of regulation of leukocyte recruitment can, however, lead to severe 
pathological inflammatory diseases such as myocardial infarction, stroke, 
rheumatoid arthritis, acute respiratory distress syndrome and inflammatory bowel 
disease (Luster et al., 2005; Mackay, 2008).   
To understand the complex regulation of leukocyte transmigration in health and 
disease, the analysis of all components involved in this process including 
inflammatory cells, inflammatory mediators, ECs, BM and pericytes is required. This 
PhD thesis aimed to investigate the responses of pericytes in inflammatory 
conditions in relation to the key inflammatory responses of leukocyte transmigration 
and vascular permeability.  
The presented data demonstrate the ability of pericytes to directly and indirectly 
respond to different types of inflammatory mediators, including cytokines and 
chemoattractants. Furthermore, the findings discovered the cellular mechanisms 
that mediate pericyte shape change in chemoattractant-induced inflammation and 
identified endogenous TNF as a crucial mediator in chemoattractant-induced 
inflammation. Thus, the findings of the present study contribute to our 
understanding of pericyte biology in inflammation and have opened novel avenues 
for future research. The following discussion gives an overview of possible functions 
of pericytes in inflammation and discusses the potential role of TNF in 
chemoattractant-induced responses, including pericyte shape change, BM protein 
deposition and vascular permeability. 
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7.1.1 Pericytes are able to respond to inflammatory mediators 
Expression of inflammation modulating surface molecules on pericytes 
The recruitment and activation of neutrophils into inflamed tissue involves a tightly 
regulated and complex process of interactions of leukocytes with different 
components of the venular wall (Nourshargh et al., 2010). Although the role of 
adhesion molecules has been well documented in leukocyte-EC interactions, little is 
known about adhesion molecules on pericytes, not to mention their regulation 
during inflammatory scenarios. In this study, the pericyte-like cell line C3H/10T1/2 
was found to express several adhesion molecules (integrins, JAMs, CAMs), as 
investigated by confocal microscopy and flow cytometry. In addition, the expression 
of receptors for cytokines (TNFR I, TNFR II and IL-1R I) could be confirmed. This is 
in line with previous in vitro studies suggesting that pericytes generally express 
adhesion molecules at basal levels (Maier and Pober, 2011; Verbeek et al., 1995; 
Stratman et al., 2009; Balabanov et al., 1999). Low levels of constitutive ICAM-1 
(Balabanov et al., 1999; Maier and Pober, 2011; Verbeek et al., 1995), LFA-3 (Maier 
and Pober, 2011) and β1-integrins (Stratman et al., 2009) have previously been 
detected on unstimulated primary pericytes isolated from several species and 
organs (rat brain, human brain, human placenta and bovine retina). The overall role 
of these surface molecules on pericytes, however, is not well understood.  
Adhesion molecules expressed by pericytes might represent possible interaction 
partners for ECs, BM compounds and transmigrating leukocytes as has been shown 
for ECs (Figure 7.1) (Muller, 2003; van der and Sonnenberg, 2001; Vestweber, 
2002). Since C3H/10T1/2 cells expressed receptors for main BM components 
including the integrins α1β1 (collagen receptor), α6β1 (laminin receptor) and α5β1 
(fibronectin receptor), these adhesion molecules might be involved in pericyte-BM 
interactions and thus, might have a role in supporting the structure of the vessel wall 
and/or BM remodelling. The expression of JAMs on pericytes might regulate cell-cell 
interactions with adjacent cells via homophilic interactions. In addition, expression of 
JAMs on pericytes might enable these mural cells to associate with leukocytes as 
they bind β2 integrins LFA-1 and Mac-1 as well as with the β1 integrin α4β1 (Bazzoni, 
2003; Bradfield et al., 2007).  Pericytes might also regulate leukocyte interactions 
through ICAM-1 and VCAM-1, molecules that have been shown to be expressed on 
both C3H10/T1/2 cells and pericytes in vitro and in vivo.  
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Figure 7.1: Adhesion molecules on pericytes. Adhesion molecules expressed by 
pericytes such as integrins, members of the JAM family, ICAM-1 and VCAM-1 might 
represent possible interaction partners for transmigrating leukocytes, adjacent pericytes, 
ECs and BM components. (Figure modified from (Nourshargh et al., 2010)). 
 
 
Whereas all integrins and JAMs analysed in the present study showed no change in 
expression levels upon TNF and IL-1β stimulation of C3H/10T1/2 cells, ICAM-1 and 
VCAM-1 were both upregulated in response to these cytokines. Thus, these 
pericyte-like cells are able to directly respond to TNF and IL-1β. In addition, 
upregulation of ICAM-1 and VCAM-1 on pericytes suggests that these adhesion 
molecules may be regulated on pericytes at sites of inflammation. Similar results 
were previously reported for primary pericytes in culture. In this context, ICAM-1 
upregulation could be detected on rat and human brain pericytes, bovine retinal 
pericytes and human placental pericytes in response to TNF, IFN-γ, LPS, high 
glucose, fMLP and necrotic cell lysates in vitro (Kowluru et al., 2010; Maier and 
Pober, 2011; Verbeek et al., 1999; Stark et al., 2013). In contrast, VCAM-1 was not 
expressed on unstimulated or TNF-stimulated human placental pericytes in culture 
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(Maier and Pober, 2011), but upregulation has been detected on primary pericytes 
isolated from human brain upon TNF treatment (Verbeek et al., 1995).  
Both, ICAM-1 and VCAM-1 expression by pericytes were further associated with 
inflammatory diseases as demonstrated using biopsy samples of patients with 
rheumatoid arthritis (Kriegsmann et al., 1995), multiple sclerosis (Verbeek et al., 
1995) and bullous pemphigoid (Dahlman-Ghozlan et al., 2004). Hence, these 
studies strongly suggest that direct pericyte-leukocyte interaction can occur and that 
adhesion molecules on pericytes are regulated during inflammation.  
Recent in vivo data obtained within our laboratory and by others showed that TNF-
stimulated murine tissues also exhibited increased ICAM-1 expression on pericytes 
as compared to PBS-treated controls (Stark et al., 2013; Proebstl et al., 2012). 
Functional assays using confocal IVM further suggested a role for adhesion 
molecules on post-capillary pericytes in innate immune responses (Proebstl et al., 
2012). Interestingly, after penetration of the EC layer leukocytes crawl along 
pericyte processes. Sub-endothelial neutrophil migration was hardly seen in 
pericyte-deficient regions and seemed to be regulated by pericyte-leukocyte 
interactions. Similar to neutrophil crawling on ECs (Phillipson et al., 2006), ICAM-1 
was shown in this study to drive neutrophil crawling on pericytes through interaction 
with the integrins Mac-1 and LFA-1 on neutrophils. However, as ICAM-1 blocking 
antibodies did not completely abolish sub-endothelial neutrophil crawling, other 
pericyte-associated adhesion molecules might be involved in this process.  
In addition to facilitating neutrophil transmigration through the pericyte sheath, 
adhesion molecules on pericytes might also have other functions. Interactions 
between capillary and arterial pericytes and extravasated neutrophils and 
monocytes via ICAM-1 for example have recently been shown to facilitate their 
directional migration within the interstitial tissue (Stark et al., 2013). Pericytes have 
also been implicated in adaptive immune responses in neuroinflammatory 
processes and T-cell development in vitro and a role for pericytic ICAM-1 and 
VCAM-1 has been suggested in this process (Balabanov et al., 1999; Verbeek et 
al., 1995; Zachariah and Cyster, 2010). Furthermore, adhesion molecules on 
pericytes including integrins and members of the JAM family might play a role in 
mediating inflammatory responses by enabling pericyte-EC and pericyte-pericyte 
crosstalk and/or signalling through direct contact with BM components. However, 
these hypotheses remain elusive and further experiments are required. 
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Pericyte shape change in response to neutrophil chemoattractants 
In addition to regulating the expression of adhesion molecules on pericytes, TNF 
and IL-1β were recently shown to induce changes in pericyte morphology, resulting 
in an increase in size of gaps between adjacent pericytes (Proebstl et al., 2012). As 
part of this thesis, the effects and mechanisms of several neutrophil 
chemoattractants including LTB4, KC, C5a and fMLP on pericyte gap size were 
investigated in vivo. Results demonstrate that these neutrophil chemoattractants not 
only induce the migration of neutrophils into stimulated tissue, but also cause an 
increase in the size of pericyte gaps and BM protein LERs as analysed by 
immunofluorescent staining and confocal microscopy (Figure 7.2).  
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Figure 7.2: Chemoattractants induce changes in vascular morphology.  (a) Venular 
walls (sites of neutrophil transmigration) consist of the endothelium (grey), the pericyte layer 
(red) and their associated BM (blue). Whilst ECs form a monolayer with tight junctions 
between adjacent cells, pericytes form a discontinuous network around blood vessels, often 
with notable gaps between adjacent pericytes. These gaps are aligned with LERs, venular 
wall regions that have been previously shown to act as preferential exit sites by 
transmigrating leukocytes. (b) Inflammation induced by local injection of chemoattractants 
(e.g. LTB4, KC, C5a) was associated with leukocyte transmigration and an increase in size 
of gaps between adjacent pericytes and BM LERs in postcapillary venules. 
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A comparison of LTB4-induced pericyte gap-opening and neutrophil transmigration 
revealed that these events occurred within comparable time frames, both responses 
peaking at 4 h post tissue stimulation. Using neutropenic mice, as induced by 
antibody-based depletion of circulating neutrophils, the results demonstrated that 
the enlargement of pericyte gaps in response to chemoattractants is strictly 
neutrophil-dependent. This is in contrast to responses induced by the pro-
inflammatory cytokines TNF and IL-1β that can induce pericyte shape change in a 
neutrophil-independent manner via direct activation of pericyte expressed TNF and 
IL-1 receptors (Proebstl et al., 2012). To date there is no evidence for the presence 
of chemoattractant receptors on pericytes or the ability of chemoattractants to 
directly stimulate pericytes. Indeed, chemoattractants such as LTB4 are thought to 
primarily stimulate and recruit leukocytes as part of the host immune response 
(Bjork et al., 1982; Di et al., 2009; Ford-Hutchinson et al., 1980). Hence, pericyte 
gap enlargement in response to LTB4 might be an indirect effect of this 
chemoattractant on neutrophils.  
As pericyte gap enlargement occurred within 4 h of stimulation, we hypothesised 
that pericyte stimulation is mediated by rapidly released secondary factors. 
Neutrophils possess a high amount of granules and secretory vesicles within their 
cytoplasm, containing antimicrobial and cytotoxic substances, enzymes, and 
cytoplasmic membrane receptors (Ford-Hutchinson et al., 1980). During 
inflammation as induced by chemoattractants, activated neutrophils can release 
these substances following degranulation. Thus, the roles of several vasoactive 
factors, including PAF and ROS which are released by neutrophils following 
chemoattractant-induced inflammation (Auch-Schwelk et al., 1989; Kerkar et al., 
2001; Soloviev and Braquet, 1991; Sumimoto et al., 1984; Tessner et al., 1989) 
were analysed on stimulating pericyte shape change. Furthermore, the role of NE 
was investigated, as this serine protease is able to cleave BM components which 
might in turn regulate pericyte shape change. However, neither PAF nor ROS or NE 
had an effect on pericyte morphology in response to LTB4, as analysed in mice 
treated with a PAF-antagonist, ROS scavengers or as analysed in NE-/- mice, 
respectively. Notably, when ROS scavengers were used, pericyte gap opening 
occurred even in the absence of neutrophil transmigration (neutrophils accumulated 
within the vessel). This suggests that direct leukocyte-pericyte interaction is not 
crucial for the induction of pericyte shape change.  
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In contrast, a pivotal role for TNF in chemoattractant-induced pericyte gap 
enlargement was shown as this response was completely abolished in TNFR-/- mice 
upon LTB4, KC or C5a stimulation. Although activated macrophages are thought to 
be the primary source of TNF (Cavaillon et al., 1990; Schindler et al., 1990), 
neutrophils are also able to release TNF in different models of inflammation as 
induced by chemoattractants (KC or LTB4) (Chou et al., 2010; Gaudreault and 
Gosselin, 2009; Saiwai et al., 2010; Vieira et al., 2009) or other inflammatory 
mediators such as LPS and Y-IgG or upon exposure to Candida albicans (Bazzoni 
et al., 1991; Djeu et al., 1990; Dubravec et al., 1990; Haziot et al., 1993; Vieira et 
al., 2009). Though still a matter of debate (Kim et al., 2006), neutrophil-derived TNF 
expression downstream of the BLT1 (LTB4 receptor) signalling pathway has been 
shown recently in a murine model of inflammatory arthritis in vivo (Chou et al., 
2010). Quantitative RT-PCR of mRNA isolated from transmigrated neutrophils after 
spinal cord injury further revealed increased levels of TNF, which were abolished in 
BLT1-knockout mice and mice treated with a LTB4 receptor antagonist (Saiwai et 
al., 2010). In another study by Gaudreault and Gosselin LTB4 induced TNF 
secretion from isolated human neutrophils by potentiating CpG-mediated 
intracellular signalling (Gaudreault and Gosselin, 2009). Taken together, these 
studies indicate that TNF expression can be induced downstream of LTB4-BLT1 
signalling. However, further studies are needed to clarify whether neutrophils indeed 
secrete TNF in our model or whether this cytokine is secreted from other cells, such 
as ECs or pericytes in response to activated neutrophils directly or indirectly. Other 
potential sources of TNF and experimental approaches to investigate such issues in 
future studies are discussed in section 7.1.3., 7.2.1, respectively. 
Another issue that requires resolving is whether the observed changes in pericyte 
morphology noted in the present study are due to pericyte contraction or relaxation, 
as both phenomena have been shown in pericytes in response to different 
inflammatory mediators. Pericyte contraction can occur in response to VEGF 
(Donoghue et al., 2006), vasoactive substances such as histamine (Kelley et al., 
1987), serotonin (Speyer et al., 2000; Kelley et al., 1987) and bradykinin (Speyer et 
al., 2000), and inflammatory mediators such as PAF (Khoury and Langleben, 1998), 
TNF (Kerkar et al., 2006), IL-1β (Kerkar et al., 2006) and LPS (Khoury and 
Langleben, 1998; Speyer et al., 2000). TNF and IL-1β both activate small GTPases 
such as RhoA, Rac 1 and cdc42, which are known to regulate the actin cytoskeleton 
(Puls et al., 1999). Cdc41 is involved in regulating signalling pathways that control 
cell morphology by filopodial extension, Rac1 promotes an actin-dependent 
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protrusion activity via lamellopodia formation, and RhoA promotes focal adhesion 
and microfilament bundle assembly (Jaffe and Hall, 2005). Of interest, contractility 
of primary bovine retinal pericytes as observed by a marked decrease in cell size 
are mediated by RhoA–dependent disassembly of αSMA stress fibres and formation 
of non-muscle actin fibres (Kolyada et al., 2003); Rac1 and cdc42 appear to be not 
involved in pericyte shape change (Kolyada et al., 2003; Kutcher et al., 2007; 
Kutcher and Herman, 2009). In contrast, in another study IL-1β-induced pericyte 
shape change in postcapillary venules of the cremaster muscle has been recently 
associated with suppression of RhoA/ROCK signalling and hence, pericyte 
relaxation rather than contraction (Wang et al., 2012). However, whether pericyte 
shape change in our model of chemoattractant-induced responses is due to 
contraction or relaxation needs to be analysed in future experiments. 
 
7.1.2 Suggested roles of pericyte shape change during inflammation 
As shown recently by our group, pericyte gaps are aligned with BM LERs. These 
sites are preferentially used as exit points by transmigrating neutrophils, indicating a 
functional implication of these sites in leukocyte trafficking (Voisin et al., 2009; 
Voisin et al., 2010; Wang et al., 2006; Proebstl et al., 2012). Hence, it was 
hypothesised that besides direct leukocyte-pericyte interactions through adhesion 
molecules, pericytes may also regulate leukocyte extravasation through altered 
morphology and/or regulating the generation of extracellular BM.  As a result, the 
role of active pericyte shape change in several aspects of inflammation, including 
neutrophil transmigration, BM remodelling and deposition, and vascular permeability 
was investigated (Figure 7.3). For this purpose, TNFR-/- mice were used, mice in 
which pericyte gap opening in response to chemoattractants was inhibited.  
 
Role of pericyte shape change in leukocyte transmigration? 
In WT mice, the highest level of neutrophil transmigration in response to LTB4 was 
observed at the 4 h time point, when also pericyte gap size was at its maximum. 
However, blocking pericyte gap enlargement in TNFR-/- mice had no effect on the 
number of transmigrated neutrophils in our model. In an earlier study performed by 
our group, quantifications of the size of gaps used by transmigrating leukocytes 
revealed that migration of neutrophils into surrounding tissues primarily occurs 
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through enlarged gaps (Proebstl et al., 2012). Despite the tempting conclusion that 
leukocytes are attracted by increased pericyte gaps and hence, pericyte shape 
change supports leukocyte transmigration, it could also be that leukocyte 
engagement with the pericytes itself causes the gap enlargement as has been 
shown previously for LERs (Voisin et al., 2010; Wang et al., 2006). This is 
supported by a recent study demonstrating that PMN-pericyte contact mediates a 
change in pericyte morphology by inhibiting RhoA/ROCK signalling in vitro and in 
vivo (Wang et al., 2012). However, in contrast to this study, where Tolazoline-
induced pericyte shape change (relaxation) facilitated PMN transmigration, in the 
present work neutrophil transmigration occurred independently of pericyte gap 
enlargement and was indeed evident under conditions where pericyte shape 
change was blocked, i.e. in TNFR-/- mice. Based on these results, the role of TNF 
signalling in pericyte shape change needs to be investigated. 
Whilst the present results did not show a significant difference in the onset of LTB4-
induced neutrophil transmigration response between WT and TNFR-/- mice, a trend 
towards prolonged neutrophil infiltration could be observed in TNFR-deficient 
animals. Hence, the data indicate that pericyte shape change is not required for 
neutrophil transmigration per se, but might have a role in the termination of 
neutrophil transmigration. One possibility is that pericytes can negatively regulate 
leukocyte transmigration via venular contraction; but again, this requires further 
analysis. 
 
Role of pericyte shape change in regulating BM deposition? 
Pericytes synthesise and are embedded within the venular BM. With a pore size of 
~50nm, the vascular BM represents a barrier with a high resistance to 
transmigrating leukocytes and macromolecules (Rowe and Weiss, 2008). During 
inflammation, leukocyte transmigration through this layer is associated with a 
transient increase in permeability and reduced barrier function (Huber and Weiss, 
1989a; Hurley J.V., 1964). Similar to the pericyte sheath, the BM undergoes 
morphological changes in response to inflammatory stimuli (Reichel et al., 2008; 
Reichel et al., 2009; Reichel et al., 2011; Voisin et al., 2009; Voisin et al., 2010; 
Wang et al., 2006). In the present study, LTB4 induced a transient enlargement of 
collagen type IV and laminin LERs within the vascular BM. This response has been 
shown previously to be strictly neutrophil-dependent (Voisin et al., 2010; Wang et 
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al., 2006). BM remodelling in response to LTB4 was independent of TNF signalling 
and pericyte shape change in that LERs still increased in size when pericyte gap 
opening was completely blocked in TNFR-/- mice. In contrast, the enlargement of 
LERs was prolonged in these animals. Since TNFR-/- mice further exhibited a higher 
neutrophil transmigration response at later time points as compared to WT animals 
(not significant), LER size might have a role in regulating leukocyte transmigration. 
This hypothesis is supported by in vitro studies in which native EC-derived BM 
deposits delay neutrophil adhesion and migration depending on the concentration 
(Burton et al., 2011; Butler et al., 2008). The composition of BM can both facilitate 
and inhibit leukocyte transmigration due to the biophysical (Rowe and Weiss, 2008) 
and/or biochemical (Wondimu et al., 2004a), (Wu et al., 2009) properties of different 
BM components. As pericytes contribute to the generation of the BM and LERs are 
closely associated with pericyte gaps, pericytes are hypothesised to regulate the 
heterogeneous morphology of the BM. By regulating the size of LERs, pericytes 
might play an indirect role in regulating leukocyte transmigration through this layer. 
However, it has not yet been shown, whether inflammatory mediators indeed 
stimulate BM production and deposition by pericytes, and whether this impacts the 
transmigration response in vivo.  
Pericytes express receptors for key BM components including integrins α1β1, α2β1 
(collagen receptors), α3β1, α6β1, α7β1, α6β4 (laminin receptors), α4β1 and α5β1 
(fibronectin receptors) (Silva et al., 2008). Hence, in vivo pericytes may be able to 
detect changes in the BM morphology and consequently respond to them through 
adhesive mechanisms. As suggested previously for αSMA-positive myofibroblasts in 
fibrosis (Dulmovits and Herman, 2012), pericyte contraction may mediate the 
generation of de novo BM proteins through tightening previously secreted BM 
proteins and thereby generating space for further BM deposition. 
 
Pericyte shape change and vascular permeability 
Pericytes are associated with regulating vascular permeability by increasing the 
resistance of EC monolayers in vitro (Dohgu et al., 2005; McGuire et al., 2011; 
Dente et al., 2001; Hayashi et al., 2004) and regulating vascular leakage in the 
blood-brain barrier in vivo (Armulik et al., 2010; Daneman et al., 2010). However, 
whether pericytes also regulate vascular permeability during inflammation is not 
clear yet. An in vitro study using a pericyte-EC coculture model suggested that 
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inflammatory mediators (TNF and IL-1β) decrease the vascular barrier function by 
inducing pericyte shape change (Kerkar et al., 2006). However, in the present 
model vascular leakage to i.v. Evans Blue, as induced by chemoattractants, 
preceded pericyte gap opening. This argues against the hypothesis that pericyte 
shape change as observed following LTB4, KC and C5a treatment regulates 
vascular permeability during inflammation. However, vascular permeability might 
regulate pericyte shape change instead. Inflammation-induced tissue oedema is 
part of the host defence and regulates the supply of inflammatory mediators, 
antibodies, fibrin and other plasma proteins to the tissue. Hence, it is possible that 
factors in the plasma exudate might have a role in pericyte shape change. In this 
context, recent studies conducted by my colleague Dr Mathieu-Benoit Voisin 
demonstrated that under conditions where leukocyte transmigration is inhibited at 
the level of ECs (using an ICAM-1 blocking antibody 30 min post LTB4 injection), 
whilst pericyte gap enlargement was suppressed, vascular permeability was 
unaltered. These results indicate that increased leakage of plasma proteins is not 
sufficient to induce pericyte shape change. Furthermore, these data suggest that 
TNF regulates both processes, i.e. vascular permeability and pericyte shape 
change, in an independent-manner.  
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Figure 7.3: Proposed consequences of chemoattractant-induced pericyte shape 
change. Chemoattractants such as LTB4, KC or C5a activate neutrophils and induce 
vascular permeability, neutrophil transmigration, pericyte shape change and BM LER 
remodelling. Vascular permeability was reduced in TNFR
-/-
 mice, mice where pericyte gap 
opening in response to these stimuli was completely absent. Due to the time discrepancy 
(permeability preceded pericyte gap opening) it is unlikely that the increase in pericyte gap 
size regulates plasma leakage during inflammation. Neutrophil transmigration, which 
mediates BM LER enlargement, occurred independently of pericyte gap opening. In 
contrast, post-inflammatory BM deposition was delayed in TNFR
-/-
 mice, a process that 
might regulate the termination of neutrophil responses as a trend for higher levels of 
neutrophils within the tissue were visible in TNFR
-/-
 mice at later time points.  
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7.1.3 TNF as a secondary mediator of chemoattractant-induced changes in 
vascular morphology and permeability 
Chemoattractants mediate the directional movement of leukocytes along a 
chemotactic gradient to sites of inflammation and hence, represent potent inducers 
of neutrophil transmigration. In addition, these molecules can indirectly (i.e. via 
activation of leukocytes) modify components of the vessel wall leading to vascular 
vasodilation and reduced barrier function (Bjork et al., 1982; Wedmore and 
Williams, 1981). Many aspects of the mechanism of action of these factors, 
however, remain unclear. Specifically, although it is known that neutrophils are the 
main target of chemoattractants, how chemoattractants regulate vascular 
morphology remains elusive. The results of the present study demonstrate for the 
first time the ability of different types of neutrophil chemoattractants, namely “end-
target” chemoattractants (fMLP and C5a) and “intermediate” chemoattractants 
(LTB4 and KC) to act on pericytes by inducing shape change of these cells in vivo. 
While specifically the impairment of the vessel wall barrier function was directly 
correlated with the rapid recruitment and interactions of neutrophils with vascular 
ECs after inducing inflammation (Wedmore and Williams, 1981), the exact 
molecular pathway is unknown. The findings of this thesis demonstrate a role for 
TNF as a secondary mediator in chemoattractant-induced responses (Figure 7.4). 
LTB4-, KC- and C5a- induced pericyte shape change and vascular leakage were 
strictly TNF-dependent as demonstrated through the use of TNFR-deficient mice.  In 
addition, chemoattractant-induced endogenous TNF might also play a role in BM 
deposition post inflammation since the enlargement of LERs was prolonged in 
TNFR-deficient mice. Whilst leukocytes are the main targets for chemoattractants, 
TNF is well known to act on ECs (Orlinick and Chao, 1998; Hehlgans and Pfeffer, 
2005) and its ability to directly act on pericytes has also recently been shown 
(Proebstl et al., 2012).  
C5a des Arg, fMLP and LTB4 induce rapid plasma protein leakage in the rabbit skin 
in vivo which is unaffected by local inhibition of protein synthesis (Rampart and 
Williams, 1988), suggesting that this process involves rapid release of preformed 
mediators by neutrophils. Furthermore, the loss of barrier function is associated with 
the interaction of neutrophils with the endothelium via β2 integrins expressed on the 
surface of leukocytes (Arfors et al., 1987; Gautam et al., 2000; Kaslovsky et al., 
1990b). In these studies, inhibition of neutrophil-EC interactions via the use of an 
anti-β2 integrin blocking antibody, was shown to suppress plasma protein leakage in 
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vivo. This suggests the need for direct contact between neutrophils and ECs. The 
mechanisms involved in TNF release and origin of this cytokine in our model are not 
known. Although the principal cellular source of TNF is activated macrophages, the 
depletion of only neutrophils led to the inhibition of pericyte shape-change. Indeed, 
neutrophils are able to release TNF downstream of chemoattractants such as LTB4 
and KC (Chou et al., 2010; Gaudreault and Gosselin, 2009; Saiwai et al., 2010; 
Vieira et al., 2009). TNF can also be secreted by a number of other cell types 
including ECs, SMCs, mast cells and pericytes (Stark et al., 2013; Donnahoo et al., 
1999), and thus, interaction of neutrophils with these cells, as suggested above, 
might play a role in vascular leakage via the induction of intracellular signalling 
leading to TNF secretion by these cells. 
 
 
 
Figure 7.4: Endogenous TNF as a secondary mediator of chemoattractant-induced 
changes in vascular morphology and permeability.  Chemoattractants such as LTB4, KC 
and C5a activate neutrophils and promote their adhesion to the endothelium, as well as 
induce neutrophil-dependent alterations in the vessel wall. Based on the present findings, 
endogenously secreted TNF acts as a secondary mediator of these neutrophil 
chemoattractants by mediating vascular leakage, pericyte shape change and potentially 
post-inflammatory BM deposition. The source of TNF is not clear, but might involve the 
neutrophils themselves, ECs and/or pericytes. 
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7.2 Open questions and future perspectives 
7.2.1 What is the source of TNF in chemoattractant-induced inflammation? 
Chemoattractant-induced TNF may be produced by a number of different cell types, 
including macrophages, ECs, neutrophils, mast cells, vSMCs and pericytes (Stark et 
al., 2013; Donnahoo et al., 1999), however, the precise cellular source in our model 
is unclear. To investigate the involvement of neutrophils in TNF release, ELISA 
and/or western blot analysis of tissue lysates from neutrophil-depleted as compared 
to undepleted tissues could be analysed. In addition, supernatants of isolated bone 
marrow neutrophils (using percoll density gradient centrifugation) stimulated with 
chemoattractants in vitro could be assayed for secreted TNF.  Similar experiments 
could be performed in the presence of cultured pericytes and/or ECs to compare 
possible contributions of these cell types. As signalling through β2 integrins as 
induced by neutrophil-EC interactions was associated with vascular permeability 
(Arfors et al., 1987; Gautam et al., 2000; Kaslovsky et al., 1990b), the role of 
neutrophil adhesion in chemoattractant-induced endogenous TNF should be 
investigated. For this purpose, anti-β2 integrin blocking antibodies can be used, 
which block the adhesion of neutrophils to the endothelium. To analyse whether 
direct contact is also required for pericyte shape change the effect of these blockers 
on pericyte morphology could be analysed in vivo by immunofluorescent staining 
and confocal microscopy or in vitro using primary pericytes and time-lapse imaging.  
 
7.2.2 How does TNF induce pericyte shape change? Do ECs act as supporters 
in this event? 
Pericytes and ECs both express receptors for TNF (TNFR I and TNFR II) (Proebstl 
et al., 2012) and are thus able to directly respond to this cytokine. In addition, both 
cell types are in close interaction with each other and EC-pericyte cross-talk via 
direct contact or soluble factors play a crucial role in developmental and angiogenic 
events (Armulik et al., 2011). Co-culture experiments with primary pericytes and 
ECs could be established to investigate whether ECs play a supportive role in 
pericyte shape change and  possibly the ability of pericytes to generate BM 
constituents. Pericyte shape change in pericyte-EC co-culture models could be 
compared to pericytes alone using time-lapse microscopy. Furthermore, co-cultures 
of TNFR-/- pericytes (isolated from TNFR-/- mice) with WT ECs and vice versa could 
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be analysed to selectively investigate the involvement of these cell-types in TNF-
induced pericyte responses. 
 
7.2.3 What is the functional consequence of pericyte shape change?  
Does it support the migration of leukocyte subtypes other than neutrophils through 
the pericyte sheath? 
Different leukocyte subsets have been shown to use different mechanisms to 
penetrate the BM (Voisin et al., 2009). Whilst neutrophil transmigration does not 
require pericyte shape change as was shown in this study, pericyte shape change 
might play a role in the transmigration of other leukocyte subtypes. In addition, as 
neutrophils are the first leukocytes to enter sites of infection or injury, it is possible 
that they prepare the way (e.g. by inducing pericyte shape change) for other 
leukocyte subsets that follow later. Hence, future experiments should investigate the 
potential role of pericyte shape change in facilitating the transmigration of leukocyte 
subtypes other than neutrophils (e.g. monocytes). For this purpose, Lys-EGFP mice 
which exhibit EGFP-labelled myelomonocytic cells could be stained for monocyte 
markers to differentiate monocytes from neutrophils. Monocyte-pericyte interactions 
and monocyte transmigration through the pericyte sheath could be analysed in 
TNFR-/- mice (where neutrophils are still present, but pericyte gaps do not increase 
in size) and/or neutrophil-depleted mice as compared to WT and non-depleted 
animals using confocal IVM. 
 
Is there a role in the regulation of BM deposition? – And does this impact the 
termination of neutrophil transmigration? 
Previous in vitro studies suggest that native EC-derived BM consituents delay 
neutrophil adhesion and migration depending on the concentration deposited 
(Burton et al., 2011; Butler et al., 2008). Furthermore, different BM components 
exhibit distinctive adhesion properties for leukocytes (Hallmann et al., 2005; Sixt et 
al., 2001; Korpos et al., 2010). Hence, the composition of the BM might play a role 
in the regulation of leukocyte transmigration. Due to the close association of 
collagen and laminin LERs with pericyte gaps, pericytes are thought to be 
responsible for the heterogeneous expression profile of the BM. It would be of 
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interest to assess whether inflammatory stimuli can act on pericytes to induce de-
novo synthesis of matrix components, a response that could contribute to the 
“resealing” of the BM towards its basal state post inflammation and may indeed 
impact the termination rate of neutrophil migration. Thus, future in vivo experiments 
could aim to investigate the relative contribution of pericytes and ECs to this 
process.  
Preliminary in vitro or ex vivo experiments could be performed to quantify the 
expression of BM components by qPCR (stimulated vs. control tissue extracts or 
primary pericytes), by flow cytometry of permeabilised cells or via 
immunofluorescence staining and confocal microscopy. Later, these studies could 
be complemented with more physiological studies in vivo. This could include the 
establishment of a new method based on fluorescence in situ hybridisation (FISH) 
to analyse the localisation of transcription of BM components in vivo. The impact of 
pericyte-derived BM deposition on leukocyte transmigration could be investigated in 
vitro using a transwell assay, where pericytes are stimulated to produce 
extracellular matrix proteins for different amount of time before neutrophils are 
added. Furthermore, the role of pericyte shape change in this process could be 
analysed in vitro using inhibitors or activators of cell contraction or relaxation (e.g. 
Forskolin, Blebbistatin or lysophosphatidic acid, respectively). Since these reagents 
would affect all cell types if used in vivo and hence could potentially have significant 
non-specific effects, the drugs Norepinephrine (vasoconstrictor) and Tolazoline 
(vasodilator) could be used in mouse models. Mice expressing Lifeact-GFP (Riedl et 
al., 2010) might provide a powerful tool for this study in vivo showing the formation 
of actin stress fibres. 
 
7.2.4 Is pericyte gap opening specific to certain inflammatory mediators 
and/or tissues? Or is it a general phenomenon of inflammation? 
So far, pericyte gap opening has been shown in response to cytokines (TNF and IL-
1β) (Proebstl et al., 2012), as well as different types of neutrophil chemoattractants 
(LTB4, KC, C5a and fMLP) as part of this study, and hence, in acute inflammation. It 
would be of interest to investigate this phenomenon in the content of a wider range 
of stimuli to assess its generality and also occurrence in models of chronic 
inflammation and disease models. For this purpose multiple mediators and 
experimental models of chronic inflammation (e.g. experimental autoimmune 
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encephalomyelitis as a model for multiple sclerosis), as well as ischemia/reperfusion 
injury could be investigated. Also, vasoactive mediators that do not induce 
neutrophil transmigration, such as histamine, bradykinin or serotonin could be 
analysed for their effect on pericyte gap enhancement. 
In addition, changes in pericyte morphology could be compared in different vascular 
beds. Experiments performed by my colleague Dr Doris Proebstl previously showed 
a similar pattern of cytokine-induced pericyte gap enlargement in both the cremaster 
muscle and ear skin (Proebstl et al., 2012), indicating that this response might not 
be tissue-specific. This study further demonstrated that post-capillary venules of the 
mesentery exhibit pericyte gaps much bigger than those noted in postcapillary 
venules of the cremaster muscle and ear skin under basal conditions. Thus, 
investigations into pericyte responses in relation to leukocyte trafficking and 
vascular permeability under inflammatory conditions in the mesentery would be of 
particular interest. 
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7.3 Concluding remarks 
TNF is a pro-inflammatory cytokine that is implicated to the pathogenesis of 
numerous inflammatory conditions such as rheumatoid arthritis and cardiovascular 
disorders (Beutler et al., 1985; Ferrari, 1999). It is not usually expressed under 
healthy conditions, but increased levels in serum and tissue are detected during 
inflammation and infectious conditions. The vast success of anti-TNF therapies (e.g. 
in patients with rheumatoid arthritis and Crohn’s disease (Feldman et al., 1998)) has 
indicated that better understanding of TNF functions and TNF-driven inflammation 
has a real potential for extending the current use of TNF blockers. Collectively, the 
findings of this work have shed significant light onto the mechanism by which 
neutrophil chemoattractants exert their pro-inflammatory effects, findings that could 
be exploited for additional therapeutic strategies that target TNF. 
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